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Chapter 1 
GENERAL INTRODUCTION 
Encased within the bones of the body~ there exists an organ system, the bone 
marrow, in which a large number of different cell types develops. Most bone 
marrow (BM) cells belong to the hemopoietic and lymphatic lineages (i.e. 
erythrocytes, platelets, granulocytes, macrophages and lymphocytes). Other cell 
types have also been shown to be derived from precursor cells that are present 
in the BM: tissue mast cells (Kitamura et al., 1977 and 1981), dendritic cells 
(Steinman et a!., 1974; Pugh et a!, 1983), Kupffer cells (van Furth, 1980; 
Bouwens and Wisse, 1980) and osteoclasts (Ash et al, 1980). The bone marrow is 
thus a source of cells which have a wide variety of functions and which can be 
found in many tissues of the body. Most BM cells are mature cells. Although 
the mature cells are important for the homeostasis of the body, they will not be 
considered in this thesis. 
Many experiments have been and still are performed with the intention to 
characterize and isolate the cell(s) that give rise to the above mentioned 
mature cell types. The concept of a pluripotent hemopoietic stem cell {PHSC) 
has arisen from these experiments. It has been hypothesized that the PHSC, 
after the proper stimulation, can give rise to all BM derived cell types. 
Another important characteristic of the PHSC is its capacity for self renewal. 
This will be discussed below. 
Other experiments have pointed to the existence of cells in the BM that have 
only a limited capacity for differentiating and self renewal potential when 
compared to the PHSC. These "restricted" stem cells can only give rise to 
descendants in one or two closely related differentiation pathways. These stem 
cells are often referred to as progenitor cells or committed precursor cells and 
as uni(or bi)potent hemopoietic stem cells. This stem cell type receives little 
attention in this thesis. 
In between the two compartments of hemopoietic stem cells (HSC)(i.e. PHSC 
and unipotent hemopoietic stem cells), other stem cells can be detected. They 
have a certain capacity to remake themselves (self renewal) and to generate a, 
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Fig4 141 Models for differentiation of hemopoietic stem cells. A4 Committment 
of stem cells4 Differentiation (e4g4 induced by hemopoietic factors) causes 
stem cells to produce end cells that belong to only one lineage. Relatively few 
different stem cells are necessary in such a model4 8. Restriction of stem 
cells4 Differentiation causes the exclusion of one (or more) lineages in the 
differentiation repertoire of the stern cells4 If the restriction of the various 
lineages can occur independently many different types of stem cells are formed4 
Neither differentiation mechanism can 7 presently, be excluded4 
sometimes, large number of diverse cell types. These cells are called 
multipotent hemopoietic stem cells (MHSC)(see below). It is highly probable 
that there exists an overlap between the three compartments. Some investigators 
favor the idea that there exists a continuum of cells, changing gradually in 
self renewal capacity and in differentiation status (Fig. 1.1) (Hellman et al, 
1978; Botnick et al, 1979; Ogawa et al, 1983)4 Others favor the existence of a 
few distinct cell types with different properties (Rosendaal et al, 1979, 
Hodgson and Bradley, 1979; Micklem, 1983). It is not known whether hemopoietic 
stem cells differentiate as a result of committment to a certain lineage or 
whether stem cells lose the potential to differentiate into certain lineages 
(restriction). Most multipotent and committed stem cells are defined by their 
ability to produce a particular type of colony or cluster in vitro. This occurs 
under the influence of factors. Each cell lineage is under the regulation of 
specific growth factors4 However, it is very difficult to ascertain whether the 
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Fig. 1.2 A differentiation scheme of in vivo stem cells and early in vitro 
progenitor cells. The scheme is constructed from literature data. 1: Visser et 
al~ 1984; 2: Roosendaal et al 7 1976, 1979, and Hodgson and Bradley, 1979; 3: 
Johnson, 1980 and Hara and Ogawa, 1978; 4: Keller et al, 1982; 5: Nakahata et 
al, 1982; 6: Humphries et al, 1981; 7: Nakahata et al, 1982. 
absence of a cell lineage in a colony is due to the lack in differentiation 
potential of the colony forming cell or due to culture conditions and random 
events.. A definite differentiation scheme of hemopoietic stem cells into mature 
cells is therefore not yet possible. Fig. 1.2 shows a differentiation model of 
the most primitive hemopoietic stem cells which is constructed from literature 
data. It compares stem cells that can be detected in vivo with those that grow 
in vitro. A recently published scheme of stem cells that grow and differentiate 
in vitro is presented in Fig. 1.3. 
Among the diverse array of BM cells there are cells that have the capacity 
to travel to the thymus and to give rise to thymocytes. These cells are defined 
as prothymocytes. There is evidence that the prothymocyte is distinct from 
other progenitor cells (Abramson et al, 1977; Boersma et al, 1981b; Mulder et 
al, 1984). The prothymocyte and its predecessors have not yet properly been 
placed among the above mentioned HSC. For instance, it is not known at which 
level, beyond that of the PHSC, the HSC lose the potential to generate 
thymocytes (Fig. 1.4). Very few murine hemopoietic stem cells produce (T) 
lymphocytes in vitro (e.g.: Lim et al, 1984). This resulted in the notion that 
the potential for lymphoid differentiation separates very early from that for 
the other lineages. In most published schemes differentiation into lymphocytes 
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Fig. 1.3 A differentiation scheme of in vitro progenitor cells. Derived from 
Ogawa et al, 1983. Abbreviations indicate: G: neutrophil; M': macrophage 
(monocyte); Eo: eosinophil; M: megakaryocyte; E: erythrocyte. 
deviates from that of the other lineages at the level of the pluripotent stem 
cell (e,g,: Moore and Metcalf, 1971; Ogawa, 1983; Fig, 1,3), One of the 
purposes of this thesis is to delineate more clearly which of the most primitive 
HSC do or do not have the potential to generate T lymphocytes. This may help 
to clarify the interrelationships of various HSC more clearly. 
Prothymocytes travel to the thymus. Few cells do so under steady state 
conditions in the adult mouse (Harris et al, 1964). Large numbers enter the 
avian thymus at three specific times during ontogeny (Le Douarin and Jotereau, 
1975; Jotereau and Le Douarin, 1982), This has not (yet) been observed in the 
murine and human thymus. After total body irradiation (TBI) with a lethal dose 
and transplantation with a relatively high number (107) of BM cells, donor cells 
can be detected in the thymus as early as the third to fourth day after 
transplantation (Boersma et al, 1982). Other investigators reported on a later 
detection (8-12 days) of donor type cells (Kadish and Basch, 1976; Ceredig and 
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Fig. 1.4 Precursor cells of prothymocytes. It is not known at which level of 
hemopoietic differentiation the prothymocyte is derived. 
MacDonald, 1982; Sharrow et al, 1983). Virtually nothing is known about what 
happens in the thymus between transplantation and the detection of the first 
donor thymocytes. For example, it is not known when and at which site the 
prothymocytes enter the irradiated thymus. We also lack the knowledge about the 
first differentiation events of prothymocytes. The study of the events that 
occur to recognizable progenitor cells that have recently entered the thymus may 
help to clarify the first differentiation steps in the thymus. It is one of the 
purposes of this thesis to solve the problem when thymocyte precursor cells 
enter the thymus after lethal irradiation and BMT. 
In the following sections a detailed description is presented of the 
murine (pluripotent) hemopoietic stem cell and their assays: the spleen colony 
assay (CFU-S assay) and several in vitro assays. The prothymocyte is reviewed 
and several assays are discussed with emphasis to the so-called thymus 
repopulation assay. Next, the thymus, its possible functions, the thymocyte 
subpopulations and their known and unknown relationships are discussed. 
5 
Pluripotent hemopoietic stem cells 
After irradiation of mice with a high dose of TBI, followed by BMT, it was 
found that the bone marrow contains precursor cells that can multiply and 
differentiate in the host (Ford et al, 1956; Vos et al, 1956; Nowell et al, 
1956). The take of a BM graft depends on the dose of irradiation: with higher 
irradiation doses one finds a higher frequency of permanent takes and less 
transient ones (Gengozian and Makinodan, 1957; Santos et al, 1958). This is due 
to a decrease in the number of surviving lymphoid host cells that can reject the 
graft. Lethal irradiation of mice damages the hemopoietic cells severely. This 
leads to a rapid depletion of the hemopoietic tissues and most animals die in 
the second week after irradiation. This is caused by anemia, hemorrhages and 
infections (van Bekkum and de Vries, 1967). The hemopoietic tissues can be 
restored by bone marrow transplantation and the survival of lethally irradiated 
mice depends only on the dose of BM cells transplanted (van Bekkum and Vos, 
1957). Visser showed that an almost pure stem cell population enriched from 
normal bone marrow cells possessed the ability to protect lethally irradiated 
mice (Visser et al, 1984). This indicates that survival after lethal 
irradiation depends on a small fraction obtained from normal BM which consists 
most probably of pluripotent hemopoietic stem cells (van Bekkum et al, 1983). 
By using a chromosome marker technique, it was established that there are 
cells in the bone marrow that could give rise to descendents in all hemopoietic 
lineages (Ford et a!. 1956; Micklem et a!, 1968; Wu et a! 1968a; Abramson et 
al, 1977). These experiments showed that some of the cells in the bone marrow 
are pluripotent. 
The study of hemopoietic stem cells was greatly aided by the discovery that 
spleen colonies appear on the spleen surface after transplantation of bone 
marrow cells into lethally irradiated mice (Till and McCulloch, 1961). These 
spleen colonies were shown to be clones and to contain cells of the erythroid, 
granulocytic and megakaryocytic lineages, but no lymphocytes (Becker et al, 
1963; Curry and Trentin, 1967; Wu et al, 1967). The cells responsible for the 
colony formation (colony forming cells-spleen; CFC-S) were found to relate 
closely with survival after lethal irradiation. This indicates that CFC-S are, 
if not identical, closely related to the pluripotent hemopoietic stem cell. A 
proportion of injected CFC-S give rise to a spleen colony in lethally irradiated 
mice. The number of spleen colonies is called the number of CFU-$ (colony 
forming unit-spleen). Each CFU-S represents a number of CFC-S. 
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The CFU-S assay 
The spleen colony assay estimates the number of hemopoietic stem cells in a 
graft. Discrete nodules appear on the surface of the spleen of irradiated and 
bone marrow transplanted mice (Till and McCulloch, 1961). They become 
macroscopically visible from the sixth day after BMT onwards (Curry and Trentin, 
1967; Hodgson and Bradley, 1979, Magli et al, 1982). Only 50 % of total nine 
day spleen colonies are macroscopically visible (Lewis et al, 1968). The number 
of spleen colonies is linear with the number of transplanted cells (Till and 
McCulloch, 1961). The colonies were shown to be clones by Wu et al, (1967) 
using irradiated bone marrow cells containing CFC-s with unique karyotypes. 
Using the same technique it was also shown that more than one spleen colony may 
contain the unique karyotype (Barnes et al, 1968). This suggests that a stem 
cell may produce more than one spleen colony, probably by (re)circulation of the 
CFU-S. When normal bone marrow cells are transplanted the number of spleen 
colonies is constant until 14 days after transplantation (Lewis and Trobaugh, 
1964; Curry and Trentin, 1967; Hodgson and Bradley, 1979). However, after 
lethal irradiation combined with tail shielding or after sublethal TBI, spleen 
colonies are present at day 5. They dissappear rapidly in the subsequent days 
(Robinson, 1967; Gregory et al, 1975; Boggs et al, 1973). Direct inspection of 
the spleen after irradiation and BMT showed that many 7-8 day colonies disappear 
within 72 hours (Magli et al, 1982; Wolf, 1984). Other spleen colonies can 
persist for a longer period and still other colonies appear as late as the 
12-14th day after transplantation (Hodgson and Bradley, 1979; Magli et al, 1982; 
Wolf, 1984). The question that arises from these experiments is whether the CFC 
that give rise to the colonies at different times (i.e. day-8 CFU-S, day-12 
CFU-s etc.) are different cells or whether they belong to a single cell type, 
but start to proliferate at different times or home differently after BMT. 
Recently, an antigenic difference was found between day 8 and day-12 CFU-S: 
day-12 CFU-S were Qa-m2 positive, while day-8 CFU-S lacked this antigen (Harris 
et al, 1984). Subsequent analysis of other Qa determinants on the CFU-S, 
revealed that there were similar differences in the expression of Qa-m 7 and 
Qa-m8 between CFU-S that give rise to early and late colonies (Harris et al, 
1985). Two other antigenic differences between these cell types (H-2K and 
Thy-1) are presented in Chapter 4. Day-8 CFU-S were further shown to stain more 
intensely with the supravital DNA stain Hoechst 33342 than day-12 CFU-S (Baines 
and Visser, 1983). From this it can be concluded that spleen colonies appearing 
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00 
Treatment or source 
of stem cells 
S~, Endotoxin, -24h 
BM, Vinblastin, -24h 
BM, Vinbastin 
BM, Vincristin 
Regenerating spleen 
Regenerating spleen 
Fetal liver cells 
Peripheral blood 
BM, hydroxyurea, -12h 
Regenerating BM 
BM separated by 
velocity sedimentation 
BM, Ara-C, -16h 
Table 1.1 
Effects of various treatments on the seeding efficiency of CFU-S 
Effect of the treatment 
? 
kill + ? 
" 
" 
cycling CFU-S 
cycling CFU-S 
cycling CFU-S 
cycling CFU-5 
size difference and 
cycle difference 
cycling CFU-S 
Effect of 
compared 
3h 
~ 
~ 
I 
I 
I 
I 
I ~ 
f-factor 
to NBM 
24h 
I 
Explanation of change 
by the authors 
none 
qualitative difference 
in the CFU-S population 
trauma to cycling cells 
causes lower f-factor 
loss of CFU-S by early 
differentiation 
functional difference 
between the CFU-S 
subpopulation of the 
heterogenous BM CFU-S 
cycling CFU-S have 
a lower f-factor 
cycling CFU-S do not 
differ in f-factor 
Reference 
Fred and Smith, 1968 
Smith et al, 1968 
Kretchmar and Conover, 1969 
Lahiri et al, 1970 
Moore et al, 1970 
Gidali et al, 1974 
Monette and Demello, 1979 
Dumenil et al, 1984 
at different days after BMT are the products of different cells. Experiments 
with mice that were pretreated with89sr or with mice whose spleens were 
reirradiated three days after irradiation and BMT showed that part of the day-12 
CFU-S can arrive in the spleen with a delay of at least three days (van Zant, 
1984; Wolf, personal communication). This suggests that day-8 and day-12 CFU-S 
have a different seeding fraction to the spleen and the bone marrow. 
Only a fraction (3-25%) of the HSC present in a bone marrow transplant 
arrives in the spleen three hours after transplantation (reviewed in Quesenberry 
and Levitt, 1979; Siminovitch et al, 1963; Schooley, 1966; Lahiri and van 
Putten, 1969, and many others). This fraction, the f-factor, is regarded as a 
measure for the seeding efficiency to the spleen and is determined by 
retransplantation of spleen cells shortly after BMT. The f-factor has been 
shown to depend both on the donor BM and the recipient mice. For instance, the 
f-factor decreases when the interval between irradiation and transplantation is 
lengthened (Lahiri et al, 1970). This is probably not caused by the shrinkage 
of the spleen following irradiation (Till and McCulloch, 1972), but may be 
related to an increased removal of transplanted cells during the first days 
after transplantation (Orbach-Arbouys et al, 1982). Alternatively, the CFC-$ 
may differentiate with loss of the ability to produce a colony. Manipulation of 
the BM also may change the f-factor (Table 1.1). Most treatments cause a 
decrease in the seeding fraction of the CFU-S to the femur. Many of the 
treatments also cause an increase in the fraction of cycling CFU-S (Table 1.1). 
This led Monette and Demello (1979) to postulate that cycling cells have a lower 
f-factor when compared to non-cycling cells. However, peripheral CFU-S, which 
are actively cycling, have an increased f-factor (Gidali et al, 1974). 
Furthermore, sixteen hours after i. v. injection of cytosine arabinoside (Ara C) 
when approximately half of the CFU-S are in $-phase (Frindel et al, 1980), the 
f-factor is similar to that of NBM (Dumenil et al, 1984). Mitotic activity of 
the CFU-S population, therefore, does not sufficiently explain differences in 
the f-factor. When day-8 CFU-S arrive in the spleen early after transplantation 
and day-12 CFU-S do so a few days later~ it can be expected that the seeding 
fraction of CFU-S in cell suspensions that are depleted of early appearing CFU-S 
is low. Preliminary results from our laboratory indicate that there is no clear 
difference in the f-factor of day-8 and day-12 CFU-S obtained from normal bone 
marrow at 2h after BMT (Visser, personal communication; Mulder, unpublished 
results). This is in contradiction with the results by van Zant and by Wolf, 
which were both mentioned above. It is clear that for a good understanding of 
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the CFU-8 assay, the homing of CFU-S to spleen or bone marrow should be 
resolved. 
The use and the interpretation of the spleen colony assay, regarding the 
recent developments, has become complicated. Spleen colony counts should be 
performed at different days after transplantation. If differences in the 
f-factor exist between the different types of CFU-S, comparison of CFU-S counts 
from two different sources of BM cells are quite useless when the f-factors are 
not known. 
In vitro detection of (pluripotent) hemopoietic stem cells 
An in vitro assay of the PHSC may be the one described by Keller and 
Phillips (1982) and by Nakahata and Ogawa (1982). They described a colony type, 
the stem cell colony that consists exclusively of undifferentiated cells. The 
colonies grow in methyl-cellulose cultures that are supplemented with 
conditioned medium obtained from pokeweed mitogen-stimulated spleen cells. The 
colony is present between 8 and 16 days after the initiation of the culture. 
The progenitor cells that give rise to this colony ("CFU-stem") has the capacity 
to renew itself and the colony contains CF'U-S (Nakahara and Ogawa, 1982; Keller 
et al, 1984). The spleen colonies produced by these CFU-S are present at eight 
days after transplantation, but not at twelve days (Keller at al, 1984}. Stem 
cell colonies also contain large numbers of multipotent stem cells (e.g. the 
CFU-GEMM, a CFU that gives rise to colonies containing granulocytes, 
erythrocytes, macrophages and megakaryocytes (Nakahata and Ogawa, 1982). It has 
previously been suggested that the CFU-GEMM and day-8 CFU-S represent similar 
cell types (Hara and Ogawa, 1978; Johnson, 1980). This indicates that the cell 
that gives rise to the stem cell colony (CFU-stem) may be a more primitive cell 
than the day-8 CFU-S. 
Self renewal- of (pluripotent) hemopoietic stem cells 
Self renewal or the ability to produce a daughter cell that has the same 
properties as the parent cell is one of the presumed characteristics of the 
PHSC. Differentiated hemopoietic stem cells also have this ability, but 
probably to a lower extent. Self renewal has been detected in several assays: 
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After lethal irradiation and BMT a recovery of the bone marrow occurs. All the 
quantitative assays of hemopoietic stem cells show normal numbers of stem cells 
three to four weeks after BMT. After serial BMT a decline in the bone marrow 
repopulating ability occurs (e.g. Barnes et al, 1959; van Bekkum and Weyzen, 
1961). This is not caused by ageing of the stem cell, because young and old BM 
were shown to have equal repopulating ability (Ogden and Micklem, 1976; 
Harrison, 1982, 1983; Boggs et al, I 984). This indicates that PHSC are lost 
during retransplantation. When the interval between transplantations is 
lengthened, the repopulating capacity improves (van Bekkum and Weyzen, 1961). 
Up to 13 passages could be passaged without evidence of diminishing repopulating 
ability (van Bekkum and Weyzen, 1961). This must be due to renewal of the PHSC. 
It has been observed that the loss of repopulating capacity can occur with, 
initially, little change in CFU-S numbers (Ogden and Micklem, 1976; Ross et al, 
1982). This suggests that at least some CFU-S are not pluripotent stem cells. 
Self renewal of the CFU-S is measured by the presence of CFU-S in spleen 
colonies (Siminovitch et al, 1963; Lewis and Trobaugh, 1964). The number of 
CFU-S per spleen colony is higher in later appearing I)odules when compared to 
those present early after BMT (Vogel et al, 1968, Magli et al, 1982; Johnson and 
Nicola, 1984). These CFU-S could be derived from stem cells migrating into the 
spleen colony or could be produced in it. Although, direct evidence for either 
of the two possibilities has not been presented, it is assumed that the CFU-S 
are produced in the spleen colony. The distribution of the number of CFU-S per 
spleen colony was shown to follow a gamma distribution, but not that of a 
Poisson distribution (Till et al, 1964). A gamma distribution is a continous 
distribution for which the variance may exceed the mean. This indicates that 
the variation from colony to colony is greater than might be expected from 
sampling errors alone (Till et al, 1964). From such a distribution of CFU-S 
among spleen colonies, it can be expected that self renewal and differentiation 
of stem cells is governed by random processes (Till et al, 1964). In these 
studies, it was assumed that the CFU-S belong to a homogenous population of stem 
cells. However, this seems not to be the case: cru-s with a relatively low 
sedimentation rate (i.e. small cells) have an increased capacity to produce 
secondary CFU-S (Worton et al, 1969a). The CFU-S surviving treatment of the BM 
donors with isopropyl methane sulphonate produce spleen colonies that contain 
very few secondary CFU-S (Schofield and Lajtha, 1973). In contrast, the CFU-5 
that survive treatment with hydroxyurea (HU) and 5-fluoruracil (5-FU) and CFU-S 
from fetal liver produce spleen colonies that contain very large numbers of 
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secondary CFU-S (Rosendaal et a!, 1976,1979; Hodgson and Bradley, 1979). In 
addition it has been observed that circulating CFU-S have a low capacity for 
self renewal (Micklem et al, 1975). The population of cells that gives rise to 
spleen colonies is thus heterogeneous with respect to self renewal. The 
distribution of CFU-S in the spleen colonies can then also be explained by 
differences between the CFU-S instead of stochastic processes which govern self 
renewal. 
In in vitro assays of hemopoietic stem cells, self renewal has also been 
shown (Dicke et al, 1971 ). Thirty-five out of 68 stem cell colonies were able 
to produce new stem cell colonies upon replating (Nakahata et al, 1982}. 
Thirteen out of 49 GEMM colonies were found to produce new GEMM colonies 
upon replating (Humphries et al, 1981). In contrast, every stem cell colony 
contains, sometimes large numbers of CFU-GEMM (Nakahata et al, 1982). Very 
few colonies containing erythroid and megakaryocytic cells produced the same 
colonies after replating (Humphries et al, 1979; Metcalf et al, 1979). And the 
colonies containing cells of a single lineage do not contain precursor cells for 
secondary colonies (Suda et a!, 1983). 
From the above studies it can be concluded that there are several different 
stem cells that have self renewing capacity although to a different extent 
(PHSC, as measured by survival, CFU-S, CFU-stem, CFU-GEMM). From this the 
notion appears that hemopoietic stem cells are arranged such that more primitive 
stem cells have a higher self renewal capacity than do more differentiated 
precursors (Figs.. 1.1 and L2; Hellman et al, 1978; Rosendaal et al, 1979, 
Ogawa et al, 1983). This model favours the continued presence of PHSC and 
predicts, eventually, the disapearance of clones produced by more 
differentiated cells. 
Our knowledge of the mechanisms that regulate the process of self renewal 
(proliferation) is far from complete: in normal cells the control of growth and 
differentiation is coupled. Uncoupling of pathways of gene expression that 
control growth and differentiation can occur in malignant cells (Sachs, 1980). 
Culture of bone marrow cells infected with the erythroleukemic Friend virus (FV) 
complex, which consists of the lymphoid leukemia helper virus and the defective 
spleen focus forming virus causes prolonged production of the CFU-5 (Dexter et 
al, 1977; Greenberger et al, 1983). However, the CFU-S in cultures that are 
10-35 weeks old lose the ability to protect lethally irradiated mice (Dexter et 
al, 1977; Greenberger et al, 1983). The spleen colonies of these CFU-S consist 
predominantly of small granulocytic colonies (Dexter et al, 1977; Greenberger et 
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al, 1983). In contrast, serial transplantation of FV infected BM into leukemia 
resistant C57Bl/6 mice could be continued as long as the FV complex was present 
(Le. up to 18 passages)(Eckner et al, 1982). The molecular events that lead 
to the production of large numbers of CFU-S is not yet known. Infection of long 
term bone marrow cultures (LTBMC) with a recombinant Rous sarcoma virus has also 
been shown to extend the self-renewal of the CFU-S (Boettiger et al., 1984). In 
contrast with the CFU-S in cultures infected with the FV complex, the CFU-S in 
src infected LTBMC protected lethally irradiated mice as good as those in NBM. 
Serial transplantation of src infected BM could also be performed much longer 
than that of NBM (Boettiger et al, 1984). Thus, although the exact regulation 
of self renewal of hemopoietic stern cells is still unclear, manipulation of gene 
expression with viral genes and or gene products can cause prolonged 
proliferation and maintenance of hemopoietic stem cells in vitro. 
The prothymocyte 
It was mentioned above that the prothymocyte is a precursor cell which is 
committed to the T cell lineage with the capacity to home to and to have progeny 
in the thymus. Extrathymic thymocyte precursors (e.g. PHSC, prothymocyte) have 
the potential to give rise to thymocytes. Thymocyte precursors have been 
identified in mouse bone marrow {Gengozian et at, 1957; Popp, 1962; Micklem et 
at, 1968), spleen {Muramatsu et al., 1976; Shisa et at, 1977) and fetal liver 
{Vos et al.., 1960; Tyan et al., 1964; LOwenberg, 1974). In the chicken, the 
yolk sac has also been shown to contain thymocyte precursor cells {Tyan, 1968). 
Although the exact mechanism that induces the migration of prothymocytes to the 
thymus is not known, it has been demonstrated in vitro that the thymus can 
generate a (chemotactic) stimulus that causes migration of BM or fetal liver 
cells into the thymus (Fontaine-Perus et al, 1981; Pyke and Bach, 1981; Pyke et 
al, 1983). The prothymocytes enter the thymus which is a lobulated organ 
located in the upper mediastinum in the thoracic cavity. The thymus can 
microscopically be devided in a cortex and a medulla. The cortex is very 
densily packed with thymocytes, while the medulla has a lower density of 
lymphoid cells with many epithelial cells in between. Functional thymocytes are 
mostly found in the medulla. 
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Assays of prothymocytes 
Thymus repopulation after lethal irradiation and BMT can be used to 
determine the presence of and quantify the number of thymocyte precursors 
(Kadish and Basch, 1976; Boersma et al, 198la). The repopulation kinetics has 
been used as a measure of the number of prothymocytes. A linear relationship 
between the number of donor cells transplanted and the number of donor 
thymocytes was described during the repopulation phase (Boersma et al, 1981a, 
Boersma, 1982). The assay has the disadvantage that it is not clonal and that 
all cells that can produce thyrnocytes (i.e. the PHSC, the prothymocyte and 
unknown intermediate cell types) are measured in the same assay. It was shown 
that thymocytes and other hemopoietic cells can be derived from one hemopoietic 
stem cell (Abramson et al, 1977) and that thymocyte precursor cells and 
hemopoietic stem cells share more characteristics with each other than with most 
thymocytes or T cells (Basch and Kadish, et al, 1977; Boersma, et al, 1981b: 
Boersma, 1982; Mulder et al, 1985). This indicates that thymus repopulating 
ability is one of the characteristics of hemopoietic stem cells. 
The expression of T cell antigens after in vivo presentation of a stimulus 
has been used as a measure for the number of prothymocytes in cell suspensions 
(Komuro and Boyse, 1973; Janes-Villeneuve et al., 1980; Greiner et al., 1982). 
However, many T cell markers are present only on a subpopulation of T cells, or 
if present on all T cells, they are not confined to the T cell lineage (e.g. 
the Thy-1 antigen; Prystowsky et al.,l978; Schrader et al., 1982; Basch and 
Berman, 1982). A T cell marker can in this case not be used for quantification 
of prothymocytes. With mouse thymus extract and thymopoietin, spleen and BM 
cells can be induced to express the Thy-! antigen (Komuro and Boyse, 1973). 
Thymus repopulating ability of the induced cells resided among the Thy-1 
positive cells, while thymocyte precursors from untreated, normal BM were Thy-1 
negative (Komuro et al, 1975). Thymocyte precursor cells can, apparently, 
express the Thy-1 antigen without loss of repopulation function. It is very 
unfortunate that the sensitivity of the cru-s to anti-Thy-! treatment was not 
also tested, because recent results indicate that the CFU-S may also express low 
levels of the Thy-1 antigen on the cell membrane (Basch and Berman, 1982; see 
also Chapter 4). This indicates that the expression of Thy-1 on the cell 
surface of bone marrow cells by thymus hormones cannot be used for the 
quantification of prothymocytes. 
In vitro T cell colonies are another way of enumerating T cell precursors.. 
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The murine T cell colony was reported to be derived from two (perhaps three) 
cells (Ching and Miller, 1980, 1981, 1982). One of the cells is Thy-! • and the 
second is Thy-1 - (Ching and Miller, 1981). The frequency of precursors of 
these T cell colonies in various organs was found to correlate with the 
frequency of mature T cells : low in BM and thymic cortex, higher in peripheral 
lymph nodes, and highest in the blood and thoracic duct lymphocytes (Ropke 
1984). Human T cell colony precursor cells were shown to have a similar organ 
distribution and to be derived from mature T cells. (Klein et al, 1981, 1982; 
C!aeson et a!, !977a and b, 1981; Goube de Laforest and Rozenszajn, 1984). Few 
(±1 %) human mixed colonies contain T cells (Lim et al, 1984). Multilineage 
colonies containing T cells that develop from glucose-6-phosphate-dehydrogenase 
heterozygous human peripheral blood cells were shown to be clones, because of 
the presence of only one isoenzyme in the cells (Lim et al, 1984). These 
results indicate that pluri - or multipotent stem cells can produce T cells. 
However it remains to be determined whether the lineages in the colony reflects 
the total differentiation potential of the stem cells or whether there is a 
variable expression of the differentiation potential by the stem cells (e.g. 
stochastic processes) at the initiation of the culture. Due to this and the low 
frequency of T cell containing multilineage colonies, it is unlikely that 
multilineage colonies can be used as a quantitative measure of T cell 
precursors. These experiments do show, however, that T cells can develop in the 
absence of a thymus (Ching and Miller, 1981; Triebel et al, 1981; Lim et al, 
1984).. This agrees with the presence of T cells in athymic, nude mice (Raff, 
1973; MacDonald et a!, 1981; Reimann and Miller, 1983). 
Because of the lack of specificity for mouse pan-T cell markers, the 
formation of T cell colonies by mature T cells and the very low incidence of 
multilineage colonies with T cells it may be concluded that, at present, a 
thymus repopulation assay is the most reliable and quantitative assay for 
thymocyte precursors. Since this assay may also measure stem cells that are 
developmentally younger than prothymocytes, experiments were performed, with the 
object of finding differences between the prothymocyte and other hemopoietic 
precursors (most often the CFU-S). The thymocyte precursors as defined in the 
thymus repopulation assay and the CFU-S were shown to have the same (low) 
density, sedimentation velocity, electrophoretic mobility and not to differ in 
the presence of several membrane markers (Basch and Kadish, 1977; Boersma et al, 
I98lb; Boersma, 1982). On the other hand, cell suspensions from NBM, 
regenerating BM, BM cultures, spleen and fetal liver show large differences in 
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the ratio of the number of CFU-S and the potential for thymus repopulation. For 
instance, regenerating BM and long term BM cultures have few thymus repopulating 
capacity as compared to the number of CFU-S (van Bekkum et al, 1984; Boersma, 
1983). Secondly, with the use of BM with unique radiation-induced chromosomal 
markers, it was shown that the BM contains precursor cells that gave exclusively 
descendants in the thymus {Abramson et al, 1977). And thirdly, the sensitivity 
to in vitro gamma irradiatiOn of day-8 CFU-S {Do=l.22Gy) was significantly lower 
than that of thymocyte precursors (Do=0.92Gy)(Boersma et al, 1983). The 
sensitivity to gamma irradiation of day-12 CFU-S and thymocyte precursors has 
not been compared directly, but it has been observed that the day-12 CFU-S are 
less sensitive than the day-8 CFU-S (Visser and Platenburg, personal 
communication). This indicates that with regard to the sensitivity to in vitro 
gamma irradiation, the thymocyte precursor differs from both the day-8 and the 
day-12 CFU-S. Progenitor cells, responsible for early thymus repopulation 
(prothymocytes), were found to express less class I H-2 antigens than do day-12 
CFU-S (Mulder et al, 1984). These results show that the prothymocyte and the 
CFU-S are two different cell types. 
Entry of precursor cells in the thymus 
The entry of thymocyte precursors in the thymus has been the subject of 
various investigations. Four weeks after joining mice into parabiosis, only ten 
percent of the dividing thymocytes were shown to be derived from the partner 
(Harris et al, 1964). After lethal irradiation and transplantation of mixtures 
of syngeneic but chromosomally distinguishable BM cells a high variation in the 
ratio of descendants from the two BM sources was found between the two lobes 
(Wallis et al, 1975). This was later also found with the use of Thy-1 congenic 
mouse strains as BM donors {Ezine et al, 1984). These results suggest that low 
numbers of precursor cells enter the adult thymus with (Wallis et al, 1975; 
Ezine et al, 1984) or without (Harris et al, 1964) previous irradiation. 
Precursor cells present in the yolk sac were found to arrive in the thymus, only 
after passage through the bone marrow (Stutman, 1976, 1977). This indicates 
that at least some thymocyte precursor cells are not attracted directly to the 
irradiated thymus after transplantation and suggests that these cells receive a 
differentiation stimulus before their travel to the thymus. 
An interesting experiment presented by Kadish and Basch (1976) deals with 
16 
the time of entry of thymocyte precursors. The experiment was designed as 
follows. 48 hours after lethal irradiation and transplantation of spleen cells 
from donor A, variable numbers of BM cells from donor B were transplanted. The 
percentage of donor A derived thymocytes was determined 14 days after the first 
transplant. It was considered that thymocyte precursor cells from BM B should 
compete with those in the first graft. The results showed that there was a 
decrease in the number of A derived thymocytes when higher numbers of B BM 
cells were injected and it was concluded that "the entry into the irradiated 
thymus must occur soon after injection of the precursor cells" (Kadish and 
Basch, 1976). However, because the number of A derived thymocytes can be 
influenced by BM B as late as 48 h after the first grafting, these results 
rather suggest that the precursor cells enter the thymus at 48 h after BMT. 
If it is assumed that thymocyte progenitors arrive in the thymus soon after 
BMT and that thymus repopulation occurs exponentially, then extrapolation of the 
thymus repopulation curve to the day of BMT results in 300 precursor cells per 
106 BM cells (Boersma et al, 198la). In a direct assay, the group of Weissman 
showed that less than 0.1 % of normal, labeled BM cells home within three hours 
into an irradiated thymus (Lepault and Weissman, 1981). Analysis of the 
immigrants indicated that 1/4-1/3 of the cells were macrophages or mature 
lymphocytes (Lepault et al, 1983). These experiments did not show whether the 
immigrated cells could give rise to thymocytes. The entry of injected cells 
decreased when the interval between irradiation and BMT was increased (Varlet et 
al, 1982). In addition, the number of immigrants at 16 h post-transplantation 
was 6-fold higher than that at 3 h. (Varlet et al, 1982). These result show 
that the number of thymus-seeking cells depends not only on the size of the BMT, 
but also on the conditioning of the recipient. From these studies it can be 
concluded that within a few hours after BMT there are donor cells present in the 
thymus, but it remains to be determined whether these cells are prothymocytes. 
It is uncertain where thymocyte progenitor cells lodge after their arrival 
in the thymus. Early experiments show that most immigrants (at 3 days after 
BMT) are present in the medulla and the corticomedullary area (Brumby and 
Metcalf, 1967). The few migrants in the cortex are in close proximity of blood 
vessels (Brumby and Metcalf, 1967). The presence of lymphocytes in the wall of 
the postcapillary venule, which is situated at the corticomedullary junction 
indicates that here lymphocytes passage to and from the medulla or 
corticomedullarry junction (Hwang, et al, 1974). Other studies suggest that 
there is a traffic of cells in the thymus from the subcapsular area to the 
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cortex and then to the medulla (Weissman, 1967, 1973; Fathman et al, 1975). 
This would indicate that intrathymic thymocyte precursors are present in the 
subcapsular area. Recent data have shown that there exists a small population 
in the thymus that has the capacity to give rise to thymocytes after isolation 
and transplantation (Mathieson and Fowlkes, 1984; Fowlkes et al, 1985). The 
phenotype of this subpopulation (see below) has been described to be present in 
the subcapsular area (van Ewijk et al, 1981). The above experiments point to 
two places where thymocyte precursor cells can be found: the subcapsular area 
and the corticomedullary junction. Other contributions to the literature 
suggest that the thymus contains more than one, parallel or independent T cell 
lineages (Shortman and Jackson, 1974; Boersma et al, 1983; Ezine et al, 1984). 
One for the cortex and one for the medulla. Although definite proof of this has 
not been presented, these studies suggest that the cells that enter the thymus 
can be expected to immigrate at different sites. 
The thymus 
The thymus is a complex organ in which epithelial cells, macrophages, 
dendritic cells and lymphocytes are present. The non-lymphoid cells comprise 
only a small fraction of the number of thymus cells (<5%). However, a close 
interaction occurs between all the cell types {Wekerle et al, 1980; Kyewski et 
al, 1982, 1984). The thymus produces several hormones (Bach and Dardenne, 1973; 
Goldstein, 1975; Goldschneider et al, 1981) which have important immunological 
functions. Neonatal thymectomy of mice severely impairs immunological functions 
(e.g. Miller et al, 1962). The immunological defect could be restored with 
thymus transplants (Miller, 1962) or with a thymoma graft (Stutman et al, 1969). 
The restored immune function in these recipients was mediated by host derived 
lymphocytes (Stutman et al, 1969). This indicates that the nonlymphocytic 
elements in the thymus play an important role in the development of T cell 
function. Several of the various non-lymphocytic cell types that produce the 
thymic hormones will be described next. 
Three, phenotypically different epithelial cells have been described in the 
thymus. One type can be recognized in the cortex and two types (either I-A 
positive or negative) are present in the medulla (van Vliet et al, 1984, van 
Vliet, 1985). Thymic epithelial cells together with thymocytes can be isolated 
in complexes that are called thymic nurse cells (TNC; Wekerle et al, 1980). The 
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TNC consists of a large epithelial cell enclosing many thymocytes. They can 
also be found in situ (van de Wijngaert et al, 1983).. TNC are predominantly 
located in the outer cortical area (Kyewski and Kaplan, 1982). The TNC are not 
the port of entry of the prothymocyte (Kyewski et al, 1982; Mulder and van 
Bekkum, 1983; Houben deFresne et al, 1984). However, relatively early after 
lethal irradiation and BMT the TNC enclose relatively higher proportions of 
donor type thymocytes (Kyewski et al, 1984). The thymocytes in the TNC 
resemble, phenotypically, the thymocytes that are present in the cortex, which 
are predominantly non-functional cells (Kyewski and Kaplan, 1982). Th~ 
thymocytes in the TNC, however, were shown to display several functions that are 
usually ascribed to more mature thymocytes, like helper activity (Vakharia and 
Mitchison, 1984), a high spontaneous proliferation rate and the presence of 
cytotoxic lymphocyte precursor cells (Fink et al, 1984). These results 
supported the notion that TNC are involved in one of the maturation steps of 
thymocytes (Wekerle, et al, 1980). 
Thymic epithelial cells can also be grown succesfully in vitro (Jason and 
Janeway, 1984; Small, 1984). Cultured epithelial cells can ingest large numbers 
of syngeneic thymocytes, which remain viable for at least 24 h. (Jason and 
] aneway, 1984). Haptenated cultured thymic epithelial cells, injected i. v. can 
induce a contact hypersensitivity which can be transferred to a second recipient 
by transplantation of spleen cells (Britz, 1984). This indicates that some of 
the epithelial cells can function as an antigen presenting cell, like the 
Langerhans cell of the skin (Ptak et al, 1980) and the spleen dendritic cell 
(Steinman et al, 1974). Thymic epithelial cells and/or culture supernatants 
were shown to increase the proliferative response of lectin stimulated 
lymphocytes (Waksal et al, 1975; Stimson and Crilly, 1981; Boniver et al, 1981) 
and the mixed lymphocyte reaction (MLR), to augment the production of cytotoxic 
lymphocytes (Kruisbeek et al, 1979; Glimcher et al, 1983) and to induce Graft 
versus Host reactivity to cocultured spleen cells (Waksal, et al, 1975). These 
results support the notion that thymic epithelial cells stimulate thyrnocytes, 
during their maturation process. 
Thymic macrophages, also a heterogeneous population, were shown to increase 
the expression of H-2 antigens of cortical thymocytes (Beller and Unanue, 1977) .. 
I-A positive macrophages augment and I-A negative macrophages suppress mitogen 
induced proliferation of thymocytes (Zepp et al, 1984a and b). These findings 
suggest that rnacrophages also have a regulatory role in the differentiation and 
proliferation of thymocytes. Closely related to macrophages are the Antigen 
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Presenting Cells (APC) which include the dendritic cells (Van Voorhis et a!, 
1983). Although differences between APC and macrophages have been described 
(Van Voorhis et al, 1983), it is possible that in the studies with thymic 
macrophages, APC were also included (Beller and Unanue, 1977; Zepp et al, 1984). 
APC, defined by their ability to stimulate lymphocytes in a mixed lymphocyte 
reaction appear in the thymus around the fourteenth gestational day {GD) 
(Robinson, 1983). Thymic lymphopoiesis initiates at this time. Experiments 
with f 1 to parent BM chimeras indicate that APC of donor type appear after the 
second month after BMT (Longo and Schwartz, 1980). At eight months after BMT 
many peripheral T cells show proliferative responses against soluble antigens 
that are characteristic for the host genotype (i.e. they are under control of 
class II H-2 genes). After administration of anti-thymocytes serum and 
cortisone and subsequent repopulation of the lymphoid tissues the response 
pattern to the soluble antigens changes to that of the donor Fl strain (Longo 
and Schwartz, 1980). In a subsequent study it was shown that with a higher dose 
of irradiation (i.e. 12 Gy), the APC are present in the thymus as soon as three 
weeks after BMT. The responses to soluble antigens of the peripheral T cells in 
these recipients correlated with that of the BM donor (Longo and Davis, 1983). 
These studies suggest that thymic APC may be responsible for learning the 
maturing thymocytes to recognize class II I-A antigens. Recognition of class 
H-2 antigens, however, appears not to be influenced by the APC (Bradley et al, 
1982; Zinkernagel, 1982). The APC can aiso stimulate syngeneic thymocytes in 
vitro which start to proliferate (Born and Wekerle, 1982; Papiernik et al, 
!983). 
From the above it appears that most if not all the non-lymphocytic cells in 
the thymus are somehow involved with the differentiative and proliferative 
processes of the thymocytes. Why divers cell types such as the epithelial and 
dendritic cells display similar immunological activities is unanswered, but may 
be related to the difficulty in obtaining good separation between these 
relatively infrequent cells. 
Thymocytes 
The vast majority of the cells in the thymus are lymphocytes. Despite 
intensive investigation, the differentiation pathways of the lymphocytes in the 
thymus is not known. T cells which develop from thymocytes have been shown to 
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be present in athymic (nude) mice (Raff, 1973; MacDonald et al, 1981; Reimann 
and Miller, 1983). One of the most prominent features of the thymus is that 
there is much proliferative activity. However, few (1 %) cells leave the thymus. 
This indicates that many (cortical) thymocytes die (30% per day) (Metcalf, 1966; 
McPhee et al, 1979; Shortman and Jackson; 1974, Scollay et al, 1980). From this 
it was speculated that cortical thymocytes are subject to a selection and that 
most of them are destined to die (Shortman and Jackson, 1974). Because the 
events that take place in the thymus are not understood much effort has been put 
into the description of subpopulations of thymocytes and the investigation of 
their interrelationships (Shortman and Jackson, 1974; fathman et al, 1975; 
Hopper and Shortman, 1976; Cantor and Weissman, 1976; Stutman, 1977; Mathieson 
et al, 1981; Chen et al, 1983a and b; Leiserson et al, 1983; Scollay and 
Shortman, 1983; Immunol. Rev. 82). Before reviewing this subject, several 
thymocyte cell surface markers, their functions, and their appearance during 
ontogeny will be discussed. 
V-dom<>ins. 
MHC ANTIGENS 
T-RECEPTOR CLASS l CLASS 11 
f.-om 
the dat<l guesswork 
NH] 
Thy-l 
COOH COOH COOH COOH 
Cytopl<>sm 
Fig. 1 .5 Structure of membrane molecules that are present on thymocytes and T 
cells. Redrawn from Jensenius and Williams, 1982 and Williams, 1984. For 
comparison the structure of immunoglobulins is also shown. Circles marked V are 
like an immunoglobulin V domain, those marked C are more like an immunoglo_bul~n 
c domain. Also shown are intrachain disulphide bonds (~), intercha~n 
disulphide bonds (S S) and N-linked carbohydrate structures (--.). I~ is highly 
probable that the class I structure applies also to the Qa and Tl ant~gens. 
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Major Histocompatibility Complex antigens on thymocytes and T cells 
Class I Major Histocompatibility Complex-2 (MHC; H-2) (Fig. 1.5) antigens 
are present on all thymocyte precursor cells, but on only 15-25% of thymocytes 
(Winn et al, 1969 - Mulder et al, 1984). The H-2K positive thymocytes are 
present in de medulla (Scollay et al, 1980; van Ewijk et al, 1981; Goldschneider 
et al, 1982; Scollay and Shortman, 1983). All the precursors of cytotoxic and 
IL-2 producing cells in the thymus are H-2K positive (Ceredig et al, !982a). 
The majority of thymocytes that have no or few H-2K antigens on their cell 
surface belong to a short-lived cell population from which few functional 
activity can be recovered (Hopper and Shortman, 1976; Hopper et al, 1978). The 
peripheral T (and B) lymphocytes express large amounts of class I antigens (e.g. 
Winn et al, 1969). Class II MHC antigens can be detected on 50 % of the 
thymocytes {Sharrow et al, 1980). Their presence is not associated with 
thymocyte function (Sharrow et al, 1980). 
The function of H-2 antigens in the thymus 
The class I and II MHC antigens have been shown to direct the immune 
response at several levels: antigen recognition and cellular interactions. 
Recognition of MHC antigens by lymphocytes is often necessary for immune 
reactions to initiate or to have an effect. A lack of recognition may lead to 
unresponsiveness of lymphocytes: peripheral T cells may cooperate only with 
class II histocompatible macrophages (Rosenthal and Shevach, 1973). This has 
led to the notion that MHC antigens are involved in the restriction of immune 
responses, the MHC restriction (Zinkernagel et al, 1978, 1983; Klein et al, 
1982b; reviewed in Immunol.Rev. 42 and 57). Helper T cells can recognize and 
are restricted by class II antigens (Katz et al, 1973; Kappler and Marrack, 
1977; Sprent, 1978; Hodes et al, 1980; von Boehmer and Haas, 1980). The 
development of these helper T cells has been suggested to depend on the 
expression of class II antigens in the thymus (Singer et al, 1981, 1982; 
Kruisbeek et al, 1984; Kast et al, 1984; Stockinger et al, 1980; van Vliet, 
1985). For instance, T cells restricted to class II region determinants are 
absent from nude, but present in the BM of euthymic littermates. They develop 
in nude BM when transplanted into parental euthymic mice and they recognize and 
react only in association with class II antigens expressed by the host thymus 
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(Kruisbeek et al, 1984). T cells have been shown to recognize and respond to 
class II antigen on accesory cells. For instance, normal thymocytes 
(predominantly the 'mature' medullary type) respond in vitro only to Thy-! 
negative stimulator cells from the thymus with syngeneic I-A antigens (Born and 
Wekerle, 1982; Rock and Benacerraf, 1984). From this it may be suggested that 
class II antigens in the thymus stimulate and learn subpopulations of thymocytes 
to react only in association with that class II molecule. 
Cytotoxic T cells (CTL) are, generally, restricted in their effector 
functions by class I MHC molecules that are present on the target cell. For 
instance, CTL originally stimulated against virus infected cells only lyse virus 
infected target cells with the class I H-2 haplotype of the stimulator cell 
(Zink.ernagel et al, I 978). The acquisition of MHC restriction by CTL is a 
matter of considerable controversy: the genotype of the responding CTL, the 
thymus in which the T cells develop and unknown extrathymic influences have all 
been shown to modify the MHC restriction patterns of CTL (Zinkernagel et al, 
1980, Wagner et al, 1980; von Boehmer et al, 1975; Bevan and Fink, 1978; 
Zinkernagel et al, 1978; von Boehmer and Ha~ 1980; Fink and Bevan, 1981; 
Kruisbeek et al, 1981, 1983a). However, with the finding that the T cell 
receptor (see below) may have a binding site for both the antigen and the MHC 
molecule one may hope that the question how class I MHC restriction is generated 
will be solved (Patten et a!, 1984). 
The T cell receptor 
A receptor on the T cell (Fig. 1.5), specific for antigen and major 
histocompatibility antigens has been postulated (Doherty et al, 1976; Hunig and 
Bevan, 1981). Until recently there was no direct evidence for its existence 
(J ensenius and Williams, 1982). Recently, class I and II specific T cell 
hybridomas were shown to have heterodimeric receptors of approximately the same 
size (75-80,000 MW), but differing slightly in charge (Allison et a!, 1982; 
Haskins et al, 1983; Kappler et al, 1983a; Meuer et al, 1983). Tryptic peptide 
mapping of the different T cell clones showed that these cell surface molecules 
have variable and constant regions (Kappler et al, 1983b; Mcintyre and Allison, 
1983; Acuto and Reinherz, 1985). Cloned and sequenced T cell specific mRNA 's 
also showed extensivily similarities to immunoglobulin genes (Hedrick et al, 
1984a and b; Yanagi et a!, 1983). An interesting difference with 
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immunoglobulins, the presence of hypervariable regions outside the classical 
immunoglobulin binding site, suggests that here the interactions may be 
occurring with MHC determinants (Patten et al, 1984). It was further shown 
that, similar to that with the immunoglobulin genes in B cells, rearrangements 
of the .B chain of the T cell receptor gene are present in thymocytes, T cells 
and some Iymphoproliferative disorders (Hedrick et al, 1984; Minden et al, 1985, 
O'Connor et al, 1985). Rearrangements of the .B chain was found to be different 
between functional T cell subsets: helper and cytotoxic T cells show 
rearrangements of the .B gene, while suppressor T cells do not and appear to have 
the .B locus deleted (Hedrick et al, 1985). In a recent publication a small 
subpopulation of thymocytes was investigated for the expression of the a and .B 
chain (Samelson et al, 1985). This subpopulation, consisting .of Ly-1 dull, Ly-2 
negative, L3T4 negative thymocytes (see also below), has been suggested to 
represent intrathymic precursor cells (Fowlkes, 1984, Mathieson and Fowlkes, 
1984; Fowlkes et al, 1985). Part of these cells showed no rearrangement of the 
.B chain and no expression of the a. chain and others did show rearrangements of 
the .B genes, but still no expression of the ex gene (Samelson et al, 1985). The 
presence of the T cell receptor on cortical type thymocytes suggests that in 
these cells both the gene loci are rearranged (Roehm et al, 1984). 
Rearrangements in the T cell receptor gene and the expression of the receptor 
can thus be used as differerentiation markers for developing thymocytes. 
Certain monoclonal antibodies raised against the T cell receptor can predict 
the antigen and MHC specificity of T cells. This was shown by binding of the 
MCA to T cell hybridomas and inhibition of their reactivity to an antigen 
(Marrack, et al, 1983). About 10 % of the thymocytes expressed the cell surface 
molecule, especially among cortisone resistant and PNA negative thymocytes 
(Roehm et al, 1984). However, lower amounts were also present on PNA positive 
thymocytes, suggesting the presence of this receptor on the 'immature' cortical 
thymocytes (Roehm et al, 1984; Snodgrass et al, 1985). 
From these studies it can be concluded that the T cell receptor can explain 
the recognition of both antigen and MHC products, the generation of diversity 
for antigen recqgnition (similar to that of the immunoglobulins) and that the 
arrangement of the T receptor gene already gives a clearer insight in the first 
differentiation steps of the thymocyte. 
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The Thy-! antigen 
The Thy-! antigen (Fig. 1.5), originally discovered by Reif and Allen 
(1963) is a cell surface glycoprotein with unknown function and is abundantly 
present on mouse thymocytes and T cells. Homology of Thy-1 and immunoglobulin 
at both the protein (Williams and Gagnon, 1982) and DNA level (Moriuchi et al, 
1983) suggests that the genes have evolved from a common ancestral gene.. In the 
rat the Thy-1 antigen can be found on all lymphohemopoietic cells and the 
density of Thy-1 is inversely related to their differentiation status 
(Goldschneider et al, 1980; Castagnola et al, 1983). In the· mouse the Thy-1 
antigen was also found on cells lining the otocyst (Prystowsky et al, 1978), 
brain tissue (Reif and Allen, 1964), fibroblasts (Stern, 1973), epidermal cells 
(Scheid et al, 1972), mammary cells (Lennon et al, 1978), and on hemopoietic 
progenitor cells (Schrader et al, 1982; Basch and Berman, 1982; Miller et al, 
1985). In the thymus, the Thy-1 antigen is present in a high density on the 
cortical type thymocytes and in a lower density on the cortisone resistant, 
medullary thymocytes and the peripheral T cells (Fathman et al, 1975; Shortman 
et al, 1979). Thy-1 molecules on T cell clones show structural heterogeneity of 
the Thy-1 molecule. This was found to be due to differences in the N-linked 
olichosaccharide residues (Pont et al, 1985). In agreement with this it was 
found that one anti-Thy-1 MCA fails to label cortical thymocytes, while 
cortisone resistant thymocytes and peripheral T cells are normally labeled 
(Auchincloss et al, 1982). This could also explain the inconcistencies detected 
by immunofluorescence staining with different anti-Thy-1 MCA (Scollay, 1982). 
Together, these data suggests that that the Thy-1 antigen may represent a 
clonospecific cell surface molecule. In several publications the Thy-1 molecule 
has been postulated to play a role in cell-cell interactions, but direct 
evidence is still lacking (Dulbecco et al, 1979; Levy et al, 1985). 
Other antigens present on thymocytes 
The Ly-1, 2 and 3 antigens were originally described by Boyse et al, 1968. 
All thymocytes and T cells express some Ly-1 antigen (Ledbetter et a!, 1981). A 
high density of Ly-1 on thymocytes and peripheral T cells (and the absence of 
Ly-2) is correlated with helper T cell function (Cantor and Boyse, 1975). 
Addition of anti-Ly-1 MCA to mixed lymphocyte reactions (MLR) enhances DNA 
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synthesis (Hollander et a!, 1981). This is probably caused by the production of 
IL-2, because the culture supernatants, collected after 24 h, were also able to 
augment a mixed lymphocyte reaction (Hollander et al, 1981) .. 
A new monoclonal antibody, L3T4, delineates more clearly the helper 
lymphocytes. The L3T4 cell surface molecule, recognized by MCA GK1.5 
resembled the human T4 molecule in tissue distribution and in biochemical 
properties (reviewed in Dialynas et al, 1983). 87-91, 33 and 19 percent of the 
nucleated cells in thymus, bone marrow and spleen, respectively, can be labeled 
with GK!.S (Ceredig et a!, 1983c; Dialynas et a!, 1983). Ly-2 (see also below) 
and L3T4 are expressed on separate cell populations of cortisone resistant 
thymocytes (Ceredig et al, 1983c; Dialynas et al, 1983). An association of the 
murine L3T4 with reactivity to class II H-2 antigens has been demonstrated 
(Dialynas et al, 1983; Wilde et al, 1982, Greenstein et al, 1983, Swain et al, 
1984). One possible function of the L3T4 molecule was studied with T cell 
hybridomas that are reactive to ovalbumine in association with I-A. These 
hybridomas showed a difference in sensitivity to ova/1-A: the clones with a low 
sensitivity to ova/1-A contained only small amounts of L3T4 on the cell surface 
and were difficult to inhibit with the MCA (Marrack et al, 1983b). These data 
suggest that L3T4 may stabilize the binding of the T cell to its target. 
Ly-2 antigens are glycoproteins that are present on subpopulations of 
thymocytes and T cells (Boyse et a!, 1968). Cytotoxic T cells and their 
precursors have been reported to be Ly-2 positive (=Ly-2 +) (Kisielow et al, 
1975; Cantor and Boyse, 1975; Ceredig et al, 1982a). Loss of Ly-2 expression 
was accompanied by the loss of cytotoxic activity Dialynas et al, 1981). Most 
Ly-1 negative (=Ly-1 -), Ly-2 + cytotoxic T cells or clones recognize class I 
H-2 antigens (Swain, 1981; Rao et al, 1983). This and the finding that CTL 
directed against class II H-2 antigens are Ly-1 + Ly-2 -, has led to the notion 
that the Ly-2 gene product is associated with class I H-2 antigens instead of a 
particular (killer) T cell function (Swain, 1981; Vidovic et al, 1984; Rao et 
al, 1983). In contradiction to this hypothesis it was shown that primary 
(anti-class II) CTL (Miller and Stutman, 1982) and secondary (anti-class I) CTL 
(Vidovic et al, 1984) can be Ly-2 +. Antisera or MCA directed against Ly-2 were 
shown to block cytolytic activity (Nakayama et al, 1979; Shinohara and Sachs, 
1979; Sarmiento et al, 1980). However not all cytolytic T cell clones are 
equally inhibited by anti-Ly-2 (MacDonald et a!, 1982) and anti-class II CTL are 
relatively resistant to blocking by anti-Ly-2 (Shinohara and Kojima, 1984). 
Thus, although the function of the Ly-2 molecule is not exactly known at the 
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present time, it is evident that the molecule is necessary for the killing of 
target cells (Dialynas et al, 1981) and primarily associated with class I H-2 
molecules (Swain, 1981). 
Ontogeny of some cell surface markers in the thymus 
Around the eleventh gestational day 
in the thymus (Owen and Ritter, 1969). 
(GD) large basophilic stem cells arrive 
Until the 14th GD the thymocytes are a 
homogenous population with the expression of the following membrane antigens: 
H-2K+, Thy-1+, Ly-1-, Ly-2-, L3T4- (Kamarck and Gottlieb, 1977; van Ewijk et al, 
1982; Ceredig et a!, !983b; Kisielow et al, 1984). At the !3-14th GD the first 
Ly-1+ cells appear (Mathieson et al, 1981; Ceredig et al, 1983b; Habu and 
Okumura, 1985) and one day later Ly-2 and L3T4 can be detected on small numbers 
of thymocytes (Kamarck and Gottlieb, 1977; Mathieson et al, 1981; Kisielow et 
al, 1984; Ceredig et al, 1983b). Two thymocyte subpopulation, the Ly-1-, Ly-2+ 
and Ly-1+, Ly-2- have previously been assumed to be derived from a Ly-1+, Ly-2+ 
precursor population (Cantor and Boyse, 1975). The appearance of Ly-1 before 
that of Ly-2 in the fetal thymus suggests that this may not be the case and that 
the two populations may be derived from other intrathymic precursor cells 
(Mathieson et al, 1981). In the subsequent days the number of thymocytes 
expressing T cell markers increases to that present in the neonatal thymus. The 
ontogeny of T cell markers has also been studied by culturing fetal thymus in 
vitro. These cultures were shown to result in the development of viable and 
functionally active thymocytes {Mandel and Russel, 1971, Robinson and Owen, 
1976, 1977; Ceredig et al, I982b; Kisielow et al, 1984). The expression of cell 
membrane markers of an 13-14 GD fetal thymus in vitro follows the intra-uterine 
development (Ceredig et al, 1982b; Kisielow et al, 1984). Thereafter there is, 
in general, a selection for the medullary type thymocyte, which may vary widely 
in the expression of Ly-2 and L3T4 (Kisielow et a!, 1984). 
Thymocyte subpopulatlons 
Ly-1, Ly-2 and L3T4 delineate at least four major subpopulations that differ 
in phenotype (Mathieson and Fowlkes, !984). These are listed in Table II. The 
first expresses low levels of Ly-1 and is negative for both Ly-2 and L3T4. 
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Isolation and transplantation of these cells results in the production of 
thymocytes belonging to the other subpopulations (Fowlkes, 1984; Leiserson et 
al, 1984; Fowlkes et al, 1985), but not that of spleen colonies (Mathieson and 
Fowlkes, 1984). Further study of this interesting subpopulation (<3% of total 
thymocytes) has shown that many of the cells express IL-2 receptors, while most 
thymocytes do not (Ceredig et al, 1985). The genes for the T cell receptor are 
not rearranged in most cells (see above, Samelson et al, 1985). This is good 
evidence that these subcortical cells may function as intrathymic progenitors 
for other thymocytes. 
Table 1.2 
Thymocyte subpopulations 
Group 
I 
II 
III 
IV 
Percentage of 
thymocytes 
80-65 
8 
5 
Phenotype 
dull Ly-1, Ly-2-, L3T4-
Ly-1+, Ly-2+, L3T4+ 
Ly-1++, Ly-2-, L3T4+ 
dull Ly-1, Ly-2+, L3T4-
Localization 
subscapsular 
cortex 
medulla 
medulla 
The other thymocyte subpopulations can, broadly, be devided in cortical 
(high expression of Thy-!) and medullary thymocytes (low Thy-!). The phenotypic 
characterization of thymocytes which is usually performed by flow cytometry, 
does not give information about the localization of the cell in the thymus. 
But, comparison of flow cytometric data and immunohistochemical staining of 
frozen thymus sections indicates that a good correlation exists between the 
phenotype and the localization of the major subsets in the thymus (van Ewijk, et 
a!, 198!). The majority of the thymocytes expresses Ly-1, Ly-2 and L3T4 (II, 
Table 1.2). This subpopulation comprises the cortical thymocytes. The medulla 
contains at least two subsets of thymocytes: with the 'helper' Ly-2-, L3T4+ and 
'suppressor' Ly-2+, L3T4- phenotype (III and IV, Table 1.2). All these subsets 
contain proliferating cells (Goldschneider et ai, 1982; Scollay and Shortman, 
1983; Mathieson and Fowlkes, 1984). In addition to these major subsets, several 
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minor subsets can be discriminated when other T cell markers are used (Scollay 
et al, 1984; Mathieson and Fowlkes, 1984; Huiskamp and van Ewijk, 1985; see also 
van Vliet, 1985). 
The study of thymocytes subpopulations has given little insight in the 
interrelationships of the various subpopulations (see below). One exception is 
the delineation of the subcapsular weakly Ly-1 postive blast cell which was 
shown to be an intrathymic precursor cell (Fowlkes, 1984; Mathieson and Fowlkes, 
1984). Another exception may be the finding that the two major medullary 
subsets (dull Ly-1, Ly-2+, L3T4-; Ly-1+, Ly-2-, L3T4-) do not necessarily have 
to be derived from Ly-1+, Ly-2+ precursor cells that are very abundant in the 
thymus (Mathieson et al, 1981; Ceredig et al, 1983a). In these instances the 
static delineation of subpopulation was aided by sequential analysis of the 
development of other thymocyte subpopulations in vivo (Mathieson et al, 1981) or 
in vitro (Ceredig et al, 1983a). 
Interrelationship of thymocyte subpopu1ations 
Very few facts can be reviewed concerning the relation between the various 
thymocyte subpopulations. This was amply reviewed by Scollay and Shortman 
(1983). As stated above, there are precursor cells (probably present in the 
subcortical area) that can give rise to the other subpopulations of thymocytes 
(Mathieson and Fowlkes, 1984). A major dilemma concerns the relation of 
cortical cells to those in the medulla. Initially, a single pathway from cortex 
to the medulla was proposed (Weissman, 1973; Cantor and Boyse, 1975). The 
cortex containing the maturing and proliferating cells which finally arrived in 
the medulla. More recent experiments indicate that cortex and medulla may have 
separate precursor cells. Boersma showed different repopulation kinetics of 
thymocytes expressing a low or a high amount of Thy-!: the Thy-1 dull thymocytes 
were the first cells that appeared after TBI and BMT (Boersma et al, 1982). 
Similarly, the first donor derived thymocytes are present in the medulla 
(Ceredig and Schreyer, 1984). In another study, regenerating thymuses from bone 
marrow chimeras injected with low doses of BM cells were sectioned and analyzed 
for the presence of donor derived thymocytes. It was demonstrated that 
regeneration of either the cortex or the medulla could occur (Ezine et al, 
1984). These results suggest that two independent differentiation pathways may 
be present in the thymus. The two lineage model was first proposed by 
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Schlesinger (1972) and Shortman and Jackson (1974). The latter proposed that, 
because of the large number of dying cortical thymocytes (30 % per day) cortical 
thymocytes represent a sterile pathway with no end cell (Shortman and jackson~ 
1974, Hopper and Shortman, 1976, Scollay et al, 1984). Another two lineage 
model proposes that the two functional subpopulations (helper and 
cytotoxic/suppressor) develop independently (Mathieson et al, 1981; Mathieson 
and Fowlkes, 1984; Scollay, 1983). Where the split between these two 
populations occurs is, however, 'totally unclear' (Mathieson and Fowlkes, 1984). 
Aim and outline of this thesis 
From the literature reviewed in this Chapter it is concluded that, the 
differentiation of hemopoietic stem cells into the T lymphoid lineage can best 
be studied in a thymus repopulation assay in vivo. The characterization of 
progenitor cells that have thymus repopulating ability can give insight in the 
early differentiation events of the T cell lineage. Since the potential for 
differentiation into T cells appears to be confined to primitive hemopoietic 
stem cells and to committed precursors cells, the characterization of stem cells 
with and without thymus repopulating ability can also give information about the 
organization and interrelationships of hemopoietic stem cells. These 
experiments are described in Chapter 3, 4 and 5. 
BM cells that arrive shortly after BMT into the thymus can be regarded 
as a ceil population enriched for stem cells committed for the T cell lineage. 
Variables that influence the direct homing of BM cells into the thymus may help 
characterize these immigrant cells. These experiments are described in Chapter 
6. The functional assay of thymus repopulation was also used for the 
determination of the time of entry of thymocyte precursors after lethal 
irradiation and BMT. This was measured by reirradiation of the thymus only or 
by reirradiation of the mice with shielding of the thymus at several times after 
BMT. The presence of donor derived thymocytes was measured from 14-30 days 
after BMT. These experiments are described in Chapter 7 of this thesis.. One 
may expect that more data concerning the entry of thymocyte precursor cells, may 
help elucidating the unknown relationships of thymocyte subpopulations and the 
maturation events in the thymus. 
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Chapter 2 
MATERIALS AND METHODS 
Mice 
The mice that were used in this study were bred at the Radiobiological 
Institute TNO. They were maintained under specific pathogen free (SPF) 
conditions until the initiation of the experiment. Thereafter, the mice were 
housed in a conventional animal room. Bone marrow was obtained from mice which 
were 8 to 9 weeks old. The recipient mice in the survival studies, in the 
thymus regeneration -, the competitive repopulation - and the homing assays (see 
below) were 8 weeks old. For the CFU-8 assay the oldest mice were used, usually 
12-14 weeks old. The age of the recipient mice did not influence the number of 
spleen colonies in the CFU-S assay. The mouse strains used in this thesis are 
shown in Table 2.1. Several cell surface markers present on BM cells or 
thymocytes are also shown. 
Table 2.1 
Mouse strains used in this study 
mouse strain abbrevation H-2-haplotype Thy-1-haplotype 
---------------------
-----------
---------- -----------------
(CS?Bl/RijxC3H/Law)F1 BC3 b/k Thy-1 .2 
(C3H/LawxAKR)F1 C3AK k/k Thy-1 .. 1 and Thy-1 .2 
C3H/Law C3H k Thy-1 .. 2 
In vivo pretreatment of BM donor mice with 5-fluorouracil (5-FU) 
In some experiments, donor mice were injected i.v. with 150 mg 5-FU per kg 
body weight. At the times indicated BM was obtained from these mice.. BM cells 
from mice four days after 5-FU injection is referred to as day-4 FUBM, etc. 
31 
Irradiations 
Lethal irradiations were performed with a137 Cs Gamma-Cell-20 small animal 
irradiator (Atomic Energy of Canada, Ltd). A maximum of 25 mice was irradiated 
in an animal container flushed with air. The radiation unit contains twin 
137 Cs gamma-ray sources, one located above and one below the irradiation 
compartment. The dose rate at the position of the mice was 0. 79 Gy/min. 
Irradiated mice received a total dose of 9.0 Gy. 
Reirradiation of lethally irradiated and BM transplanted mice was performed 
with a Philips-M.E.L. linear accelerator, type SL 75. It produces 6 MV X Rays 
at a dose rate of L3 Gy/min. The total dose delivered refers to the absorbed 
dose in muscle tissue. The mice were irradiated either with thymus shielding or 
at the thymic area only. For thymus shielding a leaden, cylindrical bar (0=12 
mm) or block (30 mm x 35 mm), both with a height of 10 em were used. For 
irradiation of the thymus only a 10 em high leaden block with an aperture of 23 
mm diameter was used. Dosimetry was performed with a calibrated ionization 
chamber. The dose under the shielded area was about 10 % of the total delivered 
dose (Zoetelief). 
Cell suspensions 
Organs were removed after asphyxiation of mice with COz. These included the 
spleen, thymus, mesenteric lymph nodes, femur and tibia. The cell suspensions 
were prepared with Hanks' balanced salt solution (300 mosmol; pH 6.9), 
containing 5 % fetal calf serum (FCS, Seromed) and when indicated 0.02 % sodium 
azide. This medium is abbreviated as HSA (Hanks', Serum, Azide). The BM cells 
were prepared by flushing the femur and tibia with medium from a needle inside 
the bone. The BM cells were subsequently pipetted through a nylon gauze. 
Spleen, thymus and lymph node suspensions were prepared by gently pressing the 
organ through a nylon gauze premoistened with medium. The total number of 
nucleated cells was counted in a Biirker hemocytometer. 
Labeling of cell suspensions with monoclonal antibodies 
Nucleated cells were labeled with monoclonal antibodies (MCA) as follows: 
10 6 nucleated cells were incubated in 50 ul of the appropriate dilution of the 
MCA in HSA for 45 minutes on ice. The cells were washed with HSA and 
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centrifuged once. The cells were subsequently labeled for 30 minutes on ice 
with either goat-anti-mouse-FITC {GAM/FITC, Nordic Immunological Laboratories 
B. V., Tilburg, the Netherlands), diluted 50 times in HSA or avidin/FITC, diluted 
50 times in HSA. The MCA's used in this study were: anti-H-2Kk, clone 11-41 
{Oi et al, 1979) which reacts with class I H-2 antigens from the k, p, q and r 
haplotype. The antibody was diluted 100 times in HSA for incubations. 
Anti-Thy-!.! MCA (New England Nuclear, NEIOI4) and anti-Thy-1.2. MCA (Becton 
Dickinson, Sunnyvale CA) were diluted I 00 times in HSA. 
Labeling of cell suspensions with rhodamine 123 (Rhl23) 
BM cells were labeled with Rh123 as described by Bertoncello et al, (1985). 
Rhl23 {Eastman Kodak, Rochester, N.Y.) was dissolved in distilled water 
{1 JJg/ml). 106 BM cells per ml were incubated in Hanks' salt solution 
containing 5 % FCS and 0.1 JJg/ml Rh123 for 20 minutes at 37°C. The cells were 
centrifuged twice, resuspended and incubated for 15 minutes in Hanks' with 5 o/o 
FCS. The cell suspension was centrifuged again and. resuspended {3-4xl06/ml). 
Labeling of cell suspensions with Hoechst 33342 
BM cells were labeled with Hoechst 33342 as described by Baines and Visser 
{1983). 107 cells per ml were incubated for 90 minutes in HSA containing 
20 Jlg/ml bisbenzimide Hoechst 33342 (Riedel- de Haan AG, Seelze-Hannover, 
W.Germany) at 37°C. Hoechst 33342 was added to the medium shortly before use 
from a stock solution, containing 200 Jlg/ml Hoechst 33342 in saline. After the 
incubation the cells were washed once, centrifuged and resuspended in HSA. 
Flow microfluorometric analysis of (labeled) cells 
Cell suspensions were analyzed on a modified fluorescence activated cell 
sorter (FACS II, Becton Dickinson, Sunnyvale, CA). The machine was adapted to 
measure two light signals perpendicular {70-11 0 degrees) to the laser beam by 
introducing an achromatic beam splitter and a second photomultiplier. Forward 
light scatter {FLS) was collected over the angles 0.5-13 degrees with respect to 
the axis of the laser beam. The horizontal laser light blocking bar was set as 
narrowly as possibly {1 mm). Green fluorescence was measured by an S20 type 
photomultiplier after passing through a broad band multicavity interference 
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filter {520-550 nm, Pomfrett, Stamford, Conn.) and a colored glass filter 
transmitting light above 530 nm (Ditric, series D). In most studies the laser 
was tuned at 488 nrn with an output of 0.4-0.5 W. In sorting experiments the 
sheath fluid consisted of Hanks' balanced salt solution. In experiments were 
cells were analyzed for scatter of laser light or fluorescence intensity the 
sheath fluid was saline. 
The light scatter characteristics of BM cells discrimate between several 
subpopulations. Since this was used in most cell sorting experiments, it will 
be reviewed briefly. FLS was shown to be proportional to the square of the 
radius of Sephadex spheres (Visser et al, 1 978a). Therefore, FLS is regarded as 
a parameter for cell size. PLS is a reflection of light illuminated by a 
particle. It was suggested by van den Engh that the PLS signal reflects cell 
structure in the sense that cells with many intracellular particles or cells 
with an oddly shaped nucleus give relatively high scatter signals in the 
perpendicular direction {van den Engh et al, 1979). Visser et al, (1978b) and 
van den Engh et al (1979) described that with normal BM cells four clusters can 
readily be recognized by light scatter alone. This is shown in Fig. 2.1. 
Erythocytes have a low FLS (because they are small cells) and a wide variety in 
PLS (because of the variable positioning of the concave cells with respect to 
the laser beam). In sorting experiments the erythrocytes were usually neglected 
by setting a trigger threshold for the FLS signal. A narrow cluster of cells 
with higher FLS and low PLS consists of lymphocytes and maturing erythroid cells 
(normoblasts). At still higher FLS, two cell populations are present which can 
be discriminated by the PLS signal: the granulocytes which have a high PLS 
(because of their lobulated nuclei) and undifferentiated cells with a relatively 
low PLS. This so-called blast-cell population was comprised of large, 
undifferentiated cells. It was found to contain 80 % of the CFU-S (van den Engh 
et al, 1979). 
Preparation of purified stem cells 
Purified stem cells were prepared as described by Visser et al. (1984). 
This procedure· consists of three separation steps. In the first step, low 
density BM cells were obtained with the use of a discontinuous metrizamide 
density gradient (Nyegaard, Oslo). Discontinuous gradients were prepared by 
pipetting I ml of a 1.100 g/cm3 solution (in Hanks' with I g BSA per 100 ml) 
onto the bottom of a 15 ml tube (Falcon, Oxnard, CA, 2057). 3 ml of a 1.081 
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forwar-d light scatter 
Fig. 2.1 Forward versus perpendicular light scatter intensity of normal mouse 
bone marrow cells. Each point represents one cell. E=Erythrocytes; 
L=Lymphocytes; G=Granulocytes; B=Blast cells. The l~st population contains 80 % 
of the CFU-5. 
g/cm3 solution was put on top of the bottom layer and 1 ml of a 1.055 g/cm3 
solution, containing 5x10 7 cells was used as the top layer. The cells were 
centrifuged for 10 min at 1.000 g, the ceils at the interfaces were collected, 
washed, centrifuged and counted. During centrifugation of the gradient, the 
bone marrow cells were expos·ed to wheat germ agglutinin-FITC (WGA-FITC; final 
concentration 0.03-0.1 )lg/ml; Polysciences, Inc., Warrington, PA). The low 
density cells were subsequently analyzed on a fluorescent activated cell sorter 
(FACS !1). The WGA-FITC positive cells with relatively high FLS and low PLS 
(the so-called blast window) were sorted. The collected cells were then 
incubated with an isotonic solution containing 0.2 M N-acetyl-D-glucosamine 
(Polysciences) for 15 minutes at 37°C. This removes the WGA-FITC. The BM cells 
were subsequently incubated with biotinylated anti-H-2K MCA and avidin/FITC as 
described above. In a second run on the cell sorter, cells with a high 
fluorescence intensity, a relatively high FLS and a low PLS were sorte<L In a 
typical experiment, this fraction contained 30 % of the nucleated cells that 
were collected during the first sort, 3 % of the low density cells and 0.3 % of 
the original BM cell suspension. 
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Chromium labeling of cell suspensions 
Cell suspensions were centrifuged (500 g, 5 min.) and resuspended in 300 )ll 
medium, consisting of 200 Jll HSA and 100 Jll saline, containing 20 pCi Na51 cro4 
(Amersham, Buckinghamshire, England; specific activity 200 JlCilpg chromium). 
The cells were incubated at 37°C for 30 minutes. The cells were washed three 
times with HSA, centrifuged and resuspended. The last supernatant was checked 
for the absence of radioactivity. The suspensions were adjusted to the given 
concentrations and injected into lethally irradiated animals. At the times 
indicated the spleen, liver, femoral BM, thymus, kidneys, heart, lungs and 
injections site at the tail were removed and counted for the presence of 
radioactivity by a Packard 5360 gamma counter. 
Velocity sedimentation 
Velocity sedimentation was performed as described by Miller and Phillips 
(1969). A siliconized glass sedimentation chamber with a diameter of 14.5 em 
and a glass baffle mounted above the inlet was used. A buffered step gradient 
from 0.2-2 % BSA (Sigma, St.Louis, Mo.) in phosphate buffered saline (PBS) was 
used. This prevents the occurrence of streaming. After loading the 
sedimentation chamber with 30 ml PBS, 2x10 8 nucleated BM cells in 30 ml 0.2 % 
BSA in PBS were entered. Subsequently, a 1-2 % BSA in PBS gradient of 800 ml 
was generated underneath the cells. After sedimentation of the cells for 3 to 
3.5 h in the cold room, the chamber was unloaded. The first 150 ml was 
discarded and the remainder was collected in fractions of 30 ml. The cells were 
recovered by centrifugation (500 g, 10 min), resuspended in 1 or 2 ml Hanks' 
solution containing 5 % FCS and counted in a hemocytometer. 80 % of the 
nucleated cells were recovered with this procedure. The cells were subsequently 
diluted and injected for the assay of day-8 and day-12 CFU-S. 
Bone marrow cultures 
Bone marrow cells were incubated in preparations containing stem cell 
activating factor (SAF, which is identical to interleukin-3, IL-3), in serum 
free suspension cultures at 37°C for a period of four days. SAF was a gift from 
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G. Wagemaker. In some experiments the culture was terminated at other times 
(as indicated). One unit of SAF is defined as the quantity for 50 % 
proliferation of the IL-3 dependent cell line DA-1. In exp. listed in Table 
3.1, SAF was prepared from mouse spleen conditioned medium by affinity 
chromatography using ConA sepharose and gel filtration as described by Wagemaker 
et al (1980). The specific activity as measured by the CFU-S assay increased 
approximately 50,000-fold by this procedure. For experiments II-IV listed in 
Table 3.1, and Figs. 3.2-3.8 a preparation from WEHI-3 conditioned medium was 
used that was partially purified by concentration using hollow fibers, 
adsorption to ConA-Sepharose and reverse phase chromatography as described by 
Wagemaker {manuscript in preparation). The active material shares many 
properties with IL-3 (Dorssers et al, 1984; Ihle et al, 1981). The specific 
activity of this preparation was approximately 200,000 units per mg protein. 
The cells were incubated at a concentration of 1-2x106 cells per ml in the 
presence of approximately 60 units SAF. The medium consisted of an enriched 
Dulbecco's medium supplemented with bovine serum albumine, human transferrin, 
selenite, cholesterol, linoleic acid and nucleosides as described before 
(Merchav et al, 1984). The medium was further supplemented with I J.IM 
hydrocortisone (Sigma, St.Louis) and 1 J.IM isoproterenol (Sigma). The cultures 
were terminated with Hankst balanced salt solution prior to intravenous 
injection into recipient mice. Bone marrow cells cultured for four days as 
described here will be abbreviated as SAFBM throughout this thesis. Unless 
noted otherwise, the number of cells or cell types in SAFBM refer to the number 
of nucleated BM cells at the onset of the culture. 
CFU-s assay 
The spleen colony assay of Till and McCulloch (1961) was used. Lethally 
irradiated mice received the indicated number of cells. The spleens were 
removed at several times after transplantation, fixed in Tellyesniczky's 
solution and counted for the presence of macroscopically visible spleen 
colonies.. Hemopoietic stem cells that gave rise to spleen colonies at day-S are 
referred to as day-8 CFU-S, at day-12 as day-12 CFU-S, etc. The standard 
deviation of the presented data fell within that described for a poisson 
distribution (i.e. the square root of the mean value; see also van den Engh, 
1976 and Bol, 1982). 
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Microscopy of spleen colonies 
The morphology of spleen colonies was determined on sections from spleens 
fixed in 4% formaldehyde. The sections were 2-3 J,Im thick and were stained with 
hematoxilin, phloxin and saffrane (HPS). 
Survival assay 
NBM, SAFBM, BM cells incubated with Rh123 or fractions of the latter cell 
suspension were transplanted at several dilutions in groups of 10 mice. A 
dilution of the same suspensions was used for determination of the CFU-S content 
of the graft. The fraction of mice surviving 30 days after irradiation was 
determined. Most of the nonsurviving animals died in the second week after 
irradiation. The number of BM cells or the number of day-8 or day-12 CFU-S 
needed for survival of 50 % of lethally irradiated mice (EDSO values; effective 
dose) was calculated from these data by probit analysis. 
Thymus regeneration assay 
The prothymocyte assay (Fig. 2.2) was based on that described by Kadish and 
Basch (1976) and modified by Boersma et a!. (1981). C3AK donor bone marrow was 
transplanted into C3H recipients. C3AK derived thymocytes are Thy-1.1 and 
Thy-1.2 positive, while C3H thymocytes have only the Thy-1.2 determinant on 
their cell surface. Donor-derived thymocytes could thus be recognized because 
of this alloantigenic difference. At various times after transplantation of 
10 6 nucleated BM cells, the animals were killed and their thymuses removed. 
The total number of thymocytes per organ was determined. Thymocytes were 
incubated with anti-Thy 1.1 and anti-Thy-1 as described above. The labeled 
cells were analyzed in a fluorescence activated cell sorter and the fraction of 
Thy 1.1-positive was determined. The results of thymus regeneration experiments 
are expressed either as the total number of donor cells per thymus or as the 
total number of donor thymocytes per CFU-S transplanted. The sensitivity of the 
thymus regeneration assay was determined by Boersma (1982). He showed that a 
twofold difference in the content of thymocyte progenitor causes a significant 
delay (i.e. I day) in thymus regeneration (Boersma, 1982). 
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Fig. 2.2 The prothymocyte assay. See text for explanation. 
Competitive repopulation assay 
In experiments, described in Chapter 3, mixtures of BM cells were 
transplanted into lethally irradiated mice. These mixtures consisted of C3H and 
C3AK BM cells and were treated or isolated as indicated. After a relatively 
long period of regeneration (i.e. 1, 2 and 4 months) the proportion of C3H or 
C3AK derived thymocytes was determined with methods similar to that of the 
thymus regeneration assay. 
Direct homing assay 
The direct homing assay was similar to that described by Lepault and 
Weissman (1981). Variable numbers of BM cells labeled with Hoechst 33342 (see 
above) were injected into preirradiated mice. The interval between irradiation 
and BMT was varied in several experiments and is indicated. At several times 
after BMT suspensions were prepared from thymus, spleen and BM. The number of 
cells per organ was counted and the number of Hoechst 33342 labeled cells was 
analyzed on a fluorescence activated cell sorter. The laser was set to produce 
UV light (351-362 nm). For the detection of Hoechst 33342 fluorescence the S-20 
photomultiplier was protected from scattered light by two Schott (Mainz, 
W.Germany) KV 408, UV absorbing filters of 3 mm thickness each. 
The frequency of labeled cells in a cell suspensions was determined as 
follows: with the use of labeled cells that were not injected, a scatter and 
fluorescence window was set that contained all the fluorescent nucleated cells. 
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Next, the frequency of cells, fullfilling the criteria of the electronic window 
in cell suspensions from irradiated, but not transplanted mice was determined.. 
Finally, the cell suspensions from the recipients of the labeled BM cells were 
analyzed (10 5-10 6 cells were analyzed, depending on the frequency of labeled 
cells) and the number of cells falling in the electronic window was counted. 
The results are expressed as the frequency of labeled cells per 105 cells or as 
the frequency of labeled cells per organ per 10 6 transplanted cells. The 
results were corrected for background fluorescence by subtraction of the number 
of fluoresceing cells in the cell suspension of not transplanted control mice. 
In initial experiments FITC was used as a tracer of the injected cells. 
A high background fluorescence was measured with this dye. Hoechst 33342, which 
is excited at a different wave lenghth did not present such problems and was 
used in all suhsequent experiments. 
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Chapter 3 
SPLEEN COLONY FORMATION, RADIOPROTECTION AND THYMUS 
REPOPULATION BY BONE MARROW CELLS CULTURED WITH 
STEM CELL ACTIVATING FACTOR 
Introduction 
After culture of normal bone marrow cells in the presence of fibroblast-
conditioned medium, spleen-conditioned medium or WEHI-conditioned medium a 
production of CFU-S occurs (LOwenberg and Dicke, 1974; LOwenberg and Dicke, 
1975; Wagemaker et al, 1982, Garland and Crompton, 1983; Prystowsky et al, 1984; 
Mulder et al, 1985). The active material in these media, called stem cell 
activating factor (SAF) in our laboratory (LOwenberg and Dicke, 1974), is 
identical to interleukin-3 (IL-3)(Dorssers et a!, !984)(Ihle et a!, 1981). 
Recently it was found that NBM cultured in the presence of stem cell activating 
factor has a different ratio of day-8 and day-12 CFU-S. (Mulder et al, 1985; 
Migliaccio et al, 1986, in press). Differences between day-8 and day-12 CFU-S 
were reviewed in Chapter 1 (antigenic differences, differences in homing to 
spleen and bone marrow, copurification of day-12 CFU-S and PHSC). Since BM 
cells cultured with SAF (SAFBM) are one of the few sources in which day-8 CFU-S 
are enriched, it was of interest to study the functional capacity of the CFU-S 
in these cui tures. 
The cultured BM cells were tested for the presence of day-8 and day-12 CFU-S 
after stimulation with a relatively high dose of SAF. The morphology of the 
spleen colonies was studied. The capacity of cultured BM cells to protect 
lethally irradiated mice was tested and the ability of SAFBM to produce 
offspring in the thymus was determined. Finally SAFBM was tested for its 
capacity to compete with other BM cells (NBM and BM from mice pretreated with 
5-FU) after injection in lethally irradiated mice. This was measured by the 
ability of SAFBM to produce progeny among thymocytes in comparison with that 
by NBM and FUBM. 
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Table 3.1 
CFU-5 content of bone marrow cells cultured with SAF 
5 
Exp. CFU-S/10 nucleated bone marrow cells 
day-6 day-8 day-9 day-1 0 day-12 
I NBM 19.1 16.6 21.8 
SAFBM 35.4 20 0 
II NBM 20.0 24.4 26.0 
SAFBM 118.0 40.8 24.8 
III NBM 14.0 14.8 15.6 
SAFBM 71 .o 62.4 37.2 
IV NBM 18.4 19.6 19.6 
SAFBM 65.6 48.0 29.6 
5x10 5 bone marrow c:ells were cultured under serum free conditions with SAF as 
described in Chapter 2. The number of CFU-5 from SAFBM is expressed per 10 5 
initially cultured cells. After four days the recovery of nucleated cells was 
determined (25% in exp. I, 60-65% in exp. II-IV). 
Day-8 and day-12 CFU-S content of NBM and of SAFBM 
(C3HxAKR)FI (C3AK) BM cells were cultured for four days in the presence of 
SAF, transplanted into lethally irradiated Syngeneic recipients and tested for 
the ability to produce spleen colonies at various days after transplantation 
(Table 3.1). Normal bone marrow cells produced similar numbers of spleen 
colonies at various days after transplantation. This is in agreement with 
results obtained by others (Curry and Trentin, 1967; Hodgson and Bradley, 1979). 
Bone marrow cells cultured for four days in the presence of SAF (SAFBM) showed 
an increase in the number of early spleen colonies. The number of spleen 
colonies at' day-12 was maintained or somewhat increased in SAF cultures. The 
average day-12 CFU-S/day-6 CFU-S ratio was 0.33. In normal BM the day-12/ 
day-6 CFU-S ratio is 1.10. This indicates that SAF predominantly induces the 
production of cells' which form early spleen colonies. 
Source of 
the CFU-S 
--------
NBM d 8 
d 12 
SAFBM d 8 
d 12 
Table 3.2 
Gross morphological appearance of spleen colonies 
Total number of 
spleen colonies 
---------------
66 
70 
99 
51 
Desintegrating 
colony 
-----------
n (%) 
4 (7) 
3 (4) 
32 (32) 
13 (25) 
Partly desint. 
colony 
-----------
n (%) 
6 (9) 
7 (1 0) 
15 (15) 
5 (10) 
Dense 
colony 
-------
n (%) 
56 (85) 
60 (86) 
52 (52) 
33 (65) 
Spleens from lethally irradiated mice injected with NBM or SAFBM were removed at 
8 and 12 days after BMT for spleen colony counts and histology of the colonies. 
The colonies were categorized in desintegrating colonies (i.e. a colony that 
consists of many areas of maturing (erythroid) cells intermingled with large 
numbers of erythocytes)7 dense colonies (i.e. a colony consisting entirely of 
nucleated and mostly immature cells with few ery.throcytes) and partly 
desintegrating spleen colonies (a mixture of the two colony types). n=number. 
Gross morphology of the spleen colonies from NBM and SAFBM 
Spleens from mice that were injected with NBM or SAFBM were sectioned and 
stained as described in Chapter 2. Two sections, one at one third and one at 
two thirds of the thickness of the spleen were examined. Double observations of 
the same spleen colony were avoided by drawing the position of the colony in 
relation to the spleen contour. The gross morphology of spleen colonies 
revealed a large difference between NBM and SAFBM: one third of day-8 and one 
quarter of day-12 spleen colonies in SAFBM were of a desintegrating type whereas 
less than 10 % of the spleen colonies from NBM showed desintegration (Table 
3.2). Typical examples of these and other colonies are shown in Fig. 3.1. 
Desintegrating colonies consisted of many small areas of maturing nucleated 
cells (mostly erythroid) with many erythrocytes in between. 
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Fig. 3.1 Morphology of spleen colonies. Day 8 (A-B) and day 12 (C-D) spleens 
were prepared as described in Chapter 2. A and C: Oesintegrating spleen colonies 
8 and C: dense colonies. 
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Fig. 3.2 Survival of lethally irradiated mice after transplantation of NBM (A) 
or SAFBM (B). Time versus survival. A. Groups of ten lethally irradiated C3H 
mice were transplanted with the indicated number of bone marrow cells and 
checked for survival. The BM contained 28 day-S CFU-S and 23.5 day-12 CFU-5 per 
10S cells. 8. Similar to A., but transplanted with SAFBM. The number of cells 
transplanted represents the number of cells that were initially cultured. SAFBM 
contained 40.6 day-8 CFU-5 and 15 day-12 CFU-S per 105 initially cultured 
cells. 
Survival of lethally irradiated mice with SAFBM 
Pluripotent hemopoietic stem cells (PHSC) can be measured by their ability 
to protect lethally irradiated mice from bone marrow failure. Bone marrow cells 
enriched in day-12 CFU-S were shown to have a similar radioprotective capacity 
as did unseparated bone marrow cells on a per day-12 CFU-S basis (Visser et al, 
1984). Bone marrow cells from donor mice pretreated with 5-FU or hydroxyurea 
(HU) (devoid of day-8 CFU-S) were shown to have a greater capacity for self 
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Fig. 3.3 Survival of lethally irradiated mice after transplantation of NBM (e) 
or SAFBM (o). Number of cells transplanted versus 30 day survival (see also 
Fig. 2). The lines result from probit analysis (see also Chapter 2). 
renewal and to produce more megakaryocytic precursors than did those from normal 
bone marrow (Rosendaal et al, 1976; Hodgson and Bradley, 1979). Such treated BM 
cells when coinjected with untreated BM cells was found to 
progeny that was produced by the NBM (Ross et a!, 1982). 
gradually replace the 
AI though it has been 
established by now that day-8 - and day-12 CFU-S are different cells (Harris et 
al, 1984; Baines and Visser, 1983; Table 4.1 and Figs. 4.1, 4.2 and 4.4), it is 
not known to what extent these cells are functionally different. Therefore, we 
determined the radioprotective capacity of bone marrow cells cultured for four 
days with SAF. These cells, as shown in Table 3.1, are enriched in day-8 CFU-S. 
In the survival experiment presented, fresh bone marrow cells contained 28 day-8 
CFU-S and 23.5 day-12 CFU-S per 105 cells. After culture for four days in the 
presence of SAF, there were 40.8 day-S CFU-S and 15 day-12 CFU-S. In Fig. 3.2A 
and B survival of lethally irradiated mice transplanted with varying dosages of 
fresh (Fig. 3.2A) or cultured (Fig. 3.2B) bone marrow cells is shown. Fig. 
3.3 presents the 30-day survival versus the number of bone marrow cells 
transplanted (in the case of fresh bone marrow cells) or versus the number of 
bone marrow cells that were cultured and transplanted four days later. Fig. 
3.3 shows that culture of bone marrow with SAF is associated with a loss of 
survival capacity. This occurs despite a production of CFU-S. The EDSO 
(effective dose that protects 50 % of lethally irradiated mice) of normal and 
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Fig. 3.4 Survival of lethally irradiated mice after transplantation of NBM (•~~) 
or SAFBM (o;o). Number of CFU-S transplanted versus 30 day survival (see also 
Figs. 2 and 3). A. Survival per day-S CFU-5. B. Survival per day-12 CFU-5. 
Squares and circles represent different experiments. The lines result from 
probit analysis. 
cultured bone marrow cells is 5.1xl04±0.77 and 58.5xl04±I6 nucleated cells, 
respectively (see Chapter 2 for the calculations). Fig. 3.4 A and B presents 
the 30-day survival versus the different types of CFU-S in fresh and cultured 
bone marrow cells. The ED50 level of normal day-8 and day-12 CFU-S is 
approximately the same: 14.4 ±2.17 and 12.1 ±1.8, respectively. These numbers 
are in agreement with previously obtained ED50 values in this laboratory (e.g. 
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Visser et al, 1984). These figures are considerably higher for SAFBM: 
SAFBM: 234.9 t56.8 day-8 CFU-S or 86.4 ±20.8 day-12 CFU-S are needed for a 50% 
survival of lethally irradiated mice. In another experiment we found similar 
high ED50 values for SAFBM: 194 ±52 day-6 CFU-S; 66.9 ±18.3 day-9 CFU-S and 
40.8 ±11.1 day-12 CFU-S. This experiment is also shown in Fig. 3.4. These 
data indicate that the CFU-S produced in SAFBM (Table 3.1) have a decreased 
capacity to protect recipients from radiation induced bone marrow failure (Figs. 
3.2-4). 
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Fig. 3.5 Thymus repopulation by bone marrow cells incubated in the presence of 
SAF. Lethally irradiated mice were transplanted with either 106 NBM (•) or 
graded numbers of SAFBM. (3x106: o ; 106: o ; 0.3x106: 1::.; 0.1x106: v ). 
CFU-5 content of NBM (per 106 cells): day-6: 200; day-9: 244; day-12: 260. 
CFU-S content of SAFBM (per 10 6 cells): day-6: 1180; day-9: 408; day-12: 248. 
Each point represents the mean value of donor thymocytes per 3-4 mice. 
Thymus repopulation by SAF cultured bone marrow cells 
The previous results showed that the capacity of stem cells in SAFBM to 
produce spleen colonies early after transplantation is not correlated with 
radioprotection. Another function of hemopoietic stem cells, the capacity to 
repopulate the thymus is limited to few progenitor cells: pluripotent 
hemopoietic stem cells and prothymocytes. This is illustrated in several 
differentiation schemes in which the capacity for lymphoid differentiation is 
the first lineage to separate from all the others (Moore and Metcalf, 1971; 
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Fig. 3.6 Thymus regeneration by bone marrow cells incubated in the presence of 
SAF. Lethally irradiated mice were transplanted with either 106 NBM (•) or 
106 SAFBM (o). For CFU-S content of BM transplants see Fig. 3.5. A. Thymus 
regeneration per day-6 CFU-5. B. Thymus regeneration per day-12 CFU-5. 
Ogawa et al, 1983; Fig. 1.4). In order to test the functional capacity of 
CFU-S in SAFBM, the thymus regeneration ability of SAFBM was tested.. 
data of these experiments were shown in Table 3.1 (exp. II). In Fig. 
The CFU-S 
3.5 
thymus repopulation following transplantation of SAFBM is presented and compared 
to that following grafting of fresh bone marrow cells which were obtained from 
littermates of the donors of the SAF cultures. Normal bone marr~w cells (106 
nucleated cells containing 244 day-9 CFU-S) show a rapid increase in the number 
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of donor thymocytes in the third week after transplantation. A plateau is 
reached around day 23. This is in agreement with results obtained by others 
(Kadish and Basch, 1976; Boersma et a!, !98!a). SAFBM on the other hand did not 
give rise to donor thymocytes in the first three weeks in four out of five 
experiments (data not shown). As shown in Fig. 3.5 transplantation of 10 6 
cultured BM cells, containing ! 180 day-6 CFU-S, 408 day-9 CFU-S and 248 day-12 
CFU-S, results in a 7-8 day delay in thymus repopulation despite the presence of 
a large number of day-6-9 CFU-S. Thereafter there is an increase until a 
plateau is reached at 35-40 days after transplantation. In one experiment we 
observed low numbers of donor thymocytes as early as 18 days after 
transplantation of 106 initially cultured BM. The titration experiment shown 
in Fig. 3.5 also indicates the extent to which SAFBM is depleted in thymus 
repopulating ability: after extrapolation of the data with SAFBM, it can be 
calculated that one needs I 00 times more cells cultured with SAF to obtain an 
equivalent thymus regeneration as that obtained with fresh bone marrow cells. 
Expression of thymus repopulation per transplanted CFU-s relates the presence of 
thymocyte precursor cells in the various cell suspensions to that of CFU-S. 
This is shown for SAFBM in Fig. 3.6 A and B. Thymus regeneration by SAFBM is 
expressed per transplanted day-12 and day-6 CFU-S, respectively. Thymus 
regeneration per day-6 CFU-S is delayed twelve days. Thymus regeneration per 
day-!2 CFU-S from SAFBM is delayed eight days when compared to that by day-12 
CFU-S from NBM. 
Competitive repopulation of the thymus by normal bone marrow or bone marrow 
cells enricbed in either day-8 or day-12 CFU-S 
Experiments have shown that under steady state conditions there is a 
continuous influx of cells from the bone marrow into the thymus (Ford et al, 
1968). This indicates that ultimately the thymus of a stable mixed chimera 
reflects the mixed composition of pluripotent stem cells in the bone marrow. 
C3H recipient mice were lethally irradiated and transplanted with a mixture of 
C3H and C3AK BM cells. Either NBM, SAFBM or BM cells from mice pretreated with 
5-FU four days earlier (day-4 FUBM) was used. The CFU-S content of the 
experimental groups is presented in Table 3.3.. At one, two and four months 
after BMT, the thymuses were removed and the percentage of Thy-1.1 (i.e. C3AK 
derived) positive thymocytes was determined as described in Chapter 2. Fig. 
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Table 3.3 
CFU-5 content of mixed bone marrow transplants into C3H mice 
Group Strain Source Number of CFU-S transplanted 
--------------------------------
day-6 day-9 day-12 
I C3AK NBM 18.4 19.6 19.6 
C3H NBM 14.0 14.8 15.6 
II C3AK SAFBM 65.6 48.0 29.5 
C3H NBM 14.0 14.8 15.6 
III C3AK FUBM 2.3 2.8 16.0 
C3H NBM 14.0 14.8 15.6 
IV C3AK FU8M 2.3 2.8 16.0 
C3H SAFBM 71.2 62.4 37.2 
v C3AK SAFBM 65.6 48.0 29.5 
C3H FUBM 0 0 2.7 
The CFU-5 content of the mixed BM grafts was determined by i.v. injection of 
the separate components into lethally irradiated C3H mice. The results are 
expressed as the total number of CFU-S that were transplanted into the mixed 
chimeras (NBM and SAFBM 10Scells and day-4 FUBM 4x10 4 cells). See also Fig.' 
3.7. 
3. 7 A shows the percentage of C3AK derived thymocytes in mice that received 10 5 
normal C3H BM together with variously treated C3AK bone marrow cells: normal 
C3AK BM, SAFBM, or day-4 FUBM. C3AK SAFBM produced less offspring in the 
thymus when coinjected with C3H NBM than C3AK NBM and C3AK FUBM 
(Fig. 3. 7 A). This occured despite the presence of 3-4 fold higher numbers of 
CFU-S that give rise to early spleen colonies and also higher numbers of day-12 
CFU-S in SAFBM than in NBM and FUBM (Table 3.3). Fig. 3. 7B shows the 
percentage of donor thymocytes in thymuses of mice that had received a mixture 
of SAFBM and FUBM: (IV) C3AK SAFBM and C3H FUBM or (V) C3AK FUBM 
and C3H SAFBM. SAFBM of either C3AK or C3H origin produced very few offspring 
when coinjected with FUBM of the other strain (Fig. 3. 7B). The SAFBM in these 
transplants contained much higher numbers of day-6-9 CFU-S, and also larger 
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Fig. 3.7 A. Competitive thymus repopulation after injection of mixtures of 
variously treated BM cells. All lethally irradiated C3H mice received 105 C3H 
NBM and either I. 105 NBM (•) or II. 4x1D4 day-4 FUBM (•) or III. Sx105 SAFBM 
(A) from C3AK mice. B. Lethally irradiated C3H mice received either IV. 4x104 
C3AK day-4 FUBM and 105 C3H SAFBM (~) or V. 105 C3AK SAFBM and 4X104 C3H day-4 
FUBM (+). See Table 3.3 for the CFlJ-S content of the various BM grafts. 
numbers of day-12 CFU-s than the FUBM (Table 3.3). The recipient mice showed no 
obvious signs of Graft versus Host disease, there was no mortality, and the 
thymuses had a normal cellularity. 
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Discussion 
The results can be summarized as follows: SAFBM is enriched in CFU-S 
producing early spleen colonies (Table 3.1). One third of day-8 and one quarter 
of day-12 CFU-S from SAFBM are desintegrating spleen colonies (Fig. 3.1 and 
Table 3.2). Radioprotection by SAFBM is, per day-8 and day-12 CFU-S lower than 
by NBM (Figs. 3.2-3.4). SAFBM causes delayed thymus regeneration despite a 
production of CFU-S (Figs. 3.5 and 3.6). SAFBM injected with other BM sources 
has relatively very little offspring among thymocytes (Figs. 3.8). 
Bone marrow cells cultured in the presence of SAF is a rich source of CFU-S 
that give rise to early spleen colonies 6-8 days after transplantion (Table 
3.1). Late appearing spleen colonies are, however, still present. The 
possibility exists that, after transplantation of day-8 colony forming cells a 
number of early appearing colonies are still visible around twelve days after 
BMT. Such persistent spleen colonies have been described (Magli et al, 1982; 
Wolf and Priestly, 1984). The production of progenitor cells giving rise to 
"early" spleen colonies from NBM after in vitro stimulation by SAF may be the 
result of self renewal of stem cells or of differentiation from more primitive 
precursor cells. The experiments described in this Chapter cannot discriminate 
between these possibilities. In experiments, described in the two following 
Chapters, indirect evidence was obtained suggesting that the day-12 CFU-S can 
give rise to day-8 CFU-S. The origin of day-8 CFU-S in SAFBM will therefore be 
discussed later. 
The appearance of up to one third, desintegrating spleen colonies was a 
surprising finding. The almost exclusive presence of maturing nucleated 
erythroid cells and erythocytes at both day-8 and day-12 in these colonies, 
suggests that the CFU resembles the in vitro growing burst-forming unit (BFU-E). 
The difference in the number of desintegrating colonies between NBM and SAFBM 
shows that a CFU-S in SAFBM, no matter at what day it is scored, cannot be 
compared to a CFU-S in NBM. This is also apparent from the survival data 
presented in, Figs. 3.2-3.4. Of any type of CFU-S present in SAFBM 4-20 times 
more are necessary for survival after lethally irradiation then after 
transplantation of NBM. The difference in EDSO expressed in CFU-S numbers from 
NBM and from SAFBM becomes less with spleen colonies counted later. This 
indicates that the day-12 CFU-S from SAFBM is more closely associated with the 
pluripotent hemopoietic stem cell than the day-8 CFU-S. Survival after lethally 
irradiation should occur after transplantation of the same number of day-12 
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CFU-S from NBM or SAFBM if the day-12 CFU-S and the PHSC were two totally 
overlapping cell populations. This is clearly not the case and this suggests 
that either the day-12 CFU-S in SAFBM and NBM are not similar or that NBM 
contains an even more immature stem cell, the pre-CFU-S, which is depleted in 
SAFBM. 
It was shown that SAFBM contains relatively large numbers of day-8 CFU-S 
(Table 3.1). Despite this, there is a loss of thymus repopulating ability 
(Figs. 3.5 and 3.6). From titration studies of NBM and SAFBM it follows that 
the thymus repopulating ability is decreased 100-200 fold when compared to that 
of fresh bone marrow cells (see also below). The most likely explanation for 
this is that part of the CFU-S have lost the capacity for lymphoid 
differentiation. These restricted CFU-S are probably the day-8 CFU-S. Thymus 
regeneration, although delayed, does occur eventually after transplantation of 
SAFBM. Therefore a source of thymocyte progenitors must be present in this 
material. It is possible that these precursors are present among the remaining 
day-12 CFU-S. Thymus regeneration per day-12 CFU-8, as was the case in the 
survival experiments, remains delayed when compared to that by NBM. This 
indicates that either the day-12 CFU-S in SAFBM and NBM are different or that 
SAFBM lacks another, as yet not identified precursor cell, the pre-CFU-S. 
From the competition experiments in which two types of BM cells (two from 
NBM,- SAFBM or day-4 FUBM) were grafted to proliferate in a host for several 
months, it also appeared that SAFBM gave rise to relatively low and transient 
numbers of thymocytes. This indicates that the progenitor cells present in 
SAFBM, apart from causing a delayed thymus regeneration, are at a disadvantage 
in settling in a host in the presence of progenitor cells from NBM and day-4 
FUBM. From this it is concluded that the day-8 CFU-S in SAFBM are not 
pluripotent progenitor cells and that they have lost the potential to 
differentiate into thymocytes. It explains the loss of the capacity to protect 
lethally irradiated mice and the markedly delayed thymus regeneration and the 
inability to compete with NBM and FUBM or SAFBM. It has, however, been reported 
that some 7-day old spleen colonies contain day-12 CFU-S (Johnson and Nicola, 
1984). This suggests that the day-7 CFU-$ can give rise to the day-12 CFU-S. 
After observing the appearance and disapearance of spleen colonies by a spleen 
window technique, it was found that about half of the spleen colonies that are 
present at twelve days are already visible at eight days after BMT (Wolf and 
Priestley, 1984). The day-12 CFU-S present in an early spleen colonies may 
therefore be derived from persistent and not from a transient spleen colony that 
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is enriched in the SAFBM. Spleen colonies were shown to contain more CFU-S when 
the colony was excised at a later time after transplantation (Vogel et al, 1968; 
Magli et a!, 1982; Johnson and Nicola, 1984). It has been assumed that this was 
due to the proliferation of CFU-S in the spleen colony (Vogel et al, 1968). 
However, when early and late spleen colonies are derived from different cells 
(see the next Chapter), it is also possible that secondary CFU-S are absent in 
the transient and present in the persistent and late appearing spleen colonies. 
In summarry, the data described in this Chapter, support the existence of CFU-S 
that differ in differentiation potential (Rosendaal et al, 1979; Hellman et al, 
1978; Hodgson and Bradley, 1979; Micklem, 1983; Ogawa et a!, 1983). 
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Conclusions 
1. Bone marrow cells cultured in the presence of SAF are enriched in day-8 
CFU-S. 
2. Part of the spleen colonies produced by SAFBM are desintegrating. 
3. SAFBM, despite its net increased number of CFU-S, has fewer capacity to 
protect lethally irradiated mice. 
4.. SAFBM causes a delayed thymus regeneration. 
5. SAFBM, coinjected with NBM or FUBM, has few or no progeny in the thymus 
late after transplantation. This is probably caused by the gradual 
replacement of the stem cells in SAFBM by those present in NBM and fUBM. 
6. The day-8 CFU-S in SAFBM and possibly also in NBM is a restricted hemopoietic 
stem cell that has lost the potential for T cell differentiation. 
7. The stem cell population in SAFBM differs from that in NBM. The data 
indicate that SAFBM contains relatively many differentiated progenitor cells 
that can still produce spleen colonies. Expression of the functional tests 
(thymus regeneration and radioprotection) per day-6-8 or day-12 CFU-S 
indicates that more of these cells from SAFBM have to be injected for a 
similar effect when compared to NBM. This indicates that either 
- day-12 CFU-S in SAFBM are different from those in NBM which is supported 
by the relatively high frequency of desintegrating spleen colonies by 
day-12 CFU-S from SAF or that 
- SAFBM contains less precursor cells that are responsible for 
radioprotection and thymus repopulation. This cell precedes the day-12 
CFU-S in the differentiation sequence.. 
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Chapter 4 
CELLS FORMING LATE SPLEEN COLONIES (DAY-12 CFU-S) IN RELATION TO 
CELLS FORMING EARLY SPLEEN COLONIES (DAY-8 CFU-S). 
Introduction 
The literature about day-8 - and day-12 spleen colony forming units has been 
reviewed in Chapter 1. It can be summarized as follows: Some of the spleen 
colonies present at 8 days after transplantation of normal bone marrow cells 
(NBM) have disappeared at day 12 (Magli et a!, 1982; Wolf and Priestley, 1984), 
other spleen colonies appear late (i.e. after 8-9 days) after transplantation 
(Hodgson and Bradley, 1979, Magli et a!, 1982, Wolf and Priestley, 1984). In 
two instances, day-8 and day-12 CFU-S from NBM were separated: Firstly, a 
difference in binding of an anti-Qa-2 monoclonal antibody was found between 
day-8 and day-12 CFU-S (Hogarth et a!, 1982; Harris et a!, 1984). The two types 
of CFU-S could be separated with the use of a light-activated cell sorter 
(Harris et al, 1984). Secondly, after incubation of NBM with Hoechst 33342, the 
day-12 CFU-S contains less dye than the day-8 CFU-S (Baines and Visser, 1983). 
These data allow the conclusion that different cells can produce spleen colonies 
that appear at different times after transplantation. 
It has been argued that a difference in the cell cycle status of CFU-S 
causes the difference in the time of appearance of spleen colonies (i.e. 
cycling CFU-S give rise to early spleen colonies and quiescent CFU-s produce 
late colonies; Baines and Visser, 1983). However, removal of cycling cells in 
fetal liver, regenerating BM, regenerating spleen (i.e BM or spleen seven days 
after lethal irradiation and BMT) or long-term bone marrow cultures by 
short-term exposure to hydroxyurea did not affect the ratio of day-7-8 - to 
day-11-12 CFU-S (Johnson and Nicola, 1984; van Zant, 1984; Chertkov and Drize, 
1984). Most CFU-S in these cell suspensions are rapidly cycling (Boersma, 1982; 
Duplan, 1970; Chertkov and Drize, 1984). Also no difference in the fraction of 
cycling day-7 and day-11 CFU-S in regenerating spleen could be detected with the 
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use of other procedures ((3H)TdR, Ara-C)(Chertkov and Drize, 1984). 
Furthermore, day-4 FUBM contains almost exclusively day-12 CFU-S, most of which 
are cycling. However, in bone marrow from mice that received 2.0 Gy TBI three 
days previously a larger fraction of the day-7 CFU-S was cycling when compared 
to that of the day-11 CFU-S (Chertkov and Drize, !984). Others did not find 
this difference (Wright et a!, 1985). All day-8 CFU-S have finished at least 
one cell cycle in a 7-17 day period, while only 20-40% of day-12 CFU-S went 
through S-phase in such a time period (Hodgson and Bradley, 1984; N.S. Wolf, 
personal communication). From these data it cannot be concluded that day-8 
CFU-S in NBM are cycling cells, and that day-12 CFU-S are quiescent. The 
shorter turnover time of day-8 CFU-S may then be explained by a difference in 
the length of Gl or the presence of a Go phase among the day-12 CFU-S. 
The relationship of day-8 and day-12 CFU-S is not yet clear. The most 
plausible relationship is that the day-12 CFU-S is the predecessor of the day-8 
CFU-S. It has been postulated that there exists a pre-CFU-S that can give rise 
to the day-12 Cru-s (Hodgson and Bradley, 1979). The pre-CFU-5 has been 
suggested to survive treatment with 5 fluorouracil (5-FU) (Hodgson and Bradley, 
1979). We tried to separate the day-8 and day-12 CFU-S and to deduce their 
relationship by studying the appearance of day-8 CFU-S in vivo and in vitro from 
cell populations devoid of day-8 CFU-S. BM cells were separated or isolated by 
various methods and analyzed for the content of day-8 and day-12 CFU-S. These 
methods included flow cytometry, velocity sedimentation and differential killing 
of CFU-5 with 5-FU. Separation of day-8 and day-12 CFU-S by flow cytometry 
turned out to be possible with monoclonal antibodies directed against class I 
H-2 and Thy-1.1 antigens and with rhodamine 123, a supravital fluorescent dye 
which is specific for mitochondria. Velocity sedimentation of BM cells was 
carried out because it was reported that slowly sedimenting cells have a high 
rate of self renewal (Worton et al, 1969a). This might have been due to 
differences in the proportions of day-8 and day-12 CFU-S in the various 
fractions. This hypothesis turned out to be incorrect. 5-FU was used to enrich 
for day-12 cru-s (Hodgson and Bradley, 1979). The recovery of the CFU-S was 
studied in v.ivo and BM cells were also cultured in vitro in the presence of stem 
cell activating factor, because this substance was found to result in the 
production of large numbers of early appearing spleen colonies from NBM 
(Chapter 3). 
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Fig. 4.1 A. Fluorescence of anti-H-2K treated bone marrow cells. C3H BM cells 
were incubated with biotinylated anti-H-ZK and avidin/FITC as described in 
Chapter 2. The cells were sorted in the fractions indicated by roman figures. 
The thin line shows the fluorescence of 6M cells incubated with avidin/FITC 
only. B. CFU-S content of BM fractions differing in H-2K density. The CFU-S 
content is expressed as the number of spleen colonies per fraction sorted from 
105 incubated cells. Day-8 CFU-S (o); day-12 CFU-S (a). Unseparated BM cells 
contained 29 and 17.7 day-S and day-12 CFU-5. 
Density of H-2K molecules on day-S and day-12 CFU-S 
H-2K antigenic determinants are located on class I molecules which are 
encoded for by the H-2 complex on chromosome 17 (Klein, 1975; Klein et al, 
1983). This class consists of molecules controled by at least three different 
loci in the H-2 complex: H-2K, H-2D, and H-2L The monomeric gene product 
consists of three domains outside the plasma membrane, a transmembrane and a 
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Table 4.1 
Distribution of day-S and day-12 CFU-S in bone marrow fractions differing in 
density of class I H-2 antigens 
Treatment % of all number of number of Ratio of 
nucl. cells day-8 CFU-S day-12 CFU-S day-12/day-8 
sorted /10 5 /105 
--------
--------- ----------- ------------ ----------
Incubation 93 29 17.7 0.61 
with medium 
Incub. with 95 28 20.8 0.74 
MCA 
Incub. with 39 1 .3 1 .4 
MCA Fr.I 
Incub. with 30 7.4 2 0.27 
MCA Fr.II 
Incub. with 19 17.2 4.4 0.25 
MCA Fr.III 
Incub. with 8 4.4 9.8 2.23 
MCA Fr. IV 
See legend of Fig. 4.1 for details 
-------------------------------------------------------------------------
cytoplasmic sequence (Maloy and Coligan, 1983). The molecule has a size of 
40.000-45.000 daltons (Coligan et a!, 1982). It was reported that CFU-S have 
such class I H-2 antigens on their cell surface (Russel and van den Engh, 1979). 
With the use of a monoclonal antibody (MCA) directed against H-2K molecules a 
high enrichment of CFU-S can be obtained (Mulder et al, 1984; Visser et al, 
1984). The MCA used in this study reacts with cells from strains carrying the 
k, p, q, and r haplotype (Oi et al, 1979). This strain distribution has not 
been observed with alloantisera before (Oi et al, 1979), but it corresponds with 
the distribution of H-2K.m3 which is detected by a monoclonal antibody (Klein et 
a!, 1979). 
A difference in the density of Qa antigens was found on day-8 and day-12 
CFU-S (Harris et a!, 1984). Since both the Qa and H-2K molecules belong to the 
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Table 4.2 
Histology of spleen colonies from bone marrow fractions differing in density of 
class I H-2 antigens. 
Treatment Colony Undiff. E G Meg E/Meg E/G G/Meg E/G/Meg 
age (days) 
------ --------- ------- ------ ----- ----- ----- ------ ----- -------
Fr. I 8 1 0 0 0 0 0 0 0 
12 6 3 0 0 0 2 0 0 
Fr.II 8 8 11 0 0 0 0 0 
12 3 5 0 0 0 0 
Fr.III 8 15 37 0 0 0 1 0 1 
12 10 0 0 2 1 5 
Fr. IV 8 12 20 0 0 1 2 
12 6 22 0 3 10 0 2 
The spleens from lethally irradiated mice that received BM fractions, separated 
on the amount of H-2K antigens, were sectioned and the colony type was scored 
microscopically. Undiff=undifferentiated, E=erythroid; G=granulocytic; 
Meg=megakaryocytic. See also Fig.1 and Table 4.1. 
class I antigens of the MaJor Histocompatibility Complex (MHC) (Klein et al, 
1983), it seemed worthwhile to investigate whether day-8 and day-12 CFU-S also 
differ in the density of H-2K molecules. 
Normal C3H bone marrow cells were incubated with biotinylated anti-H-2K MCA 
and avidin/FITC as described in Chapter 2. The fluorescence distribution of the 
nucleated cells is presented in Fig. 4.1A. Virtually all nucleated cells are 
labeled with the MCA when compared to cells that were incubated with avidin/FITC 
only. Anti-H-2K treated cells were separated on fluorescence intensity with a 
fluorescence activated cells sorter (see Chapter 2 for details). The fractions 
that were sorted are shown in Fig. 4.1A The distribution of the CFU-S among the 
various fractions is shown in Fig. 4.1B and Table 4.1. 63 % of day-12 CFU-5 
were recovered from the brightest fluoresceing fraction. This fraction 
contained only 27.4 % of the day-8 CFU-S. In contrast, fraction III contained 
most day-8 CFU-S, while only 20 % of the day-12 CFU-S were present (3 exp.). 
This shows that day-12 CFU-S have a higher density of H-2K molecules than have 
day-8 CFU-S. 
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The H-2K separation was added to two other purification methods (separation 
on boyant density and on the density of membrane receptors for wheat germ 
agglutinin) that were shown to enrich for CFU-S by Visser (Visser et al, 1984). 
The purified cells were enriched for day-12 CFU-S (ratio day-12/day-8 
CFU-S=4.2). In NBM this ratio is 1.2 (Visser et a!, 1984; See also Chapter 5). 
Culture of these cells with SAF resulted in the production of large numbers of 
day-8 CFU-S (2.5 to 3.2 fold increase), CFU-C2 (7.9 to 14 fold increase) and 
BFU-E (9.4 to 13 fold increase), but loss of day-12 CFU-S (0.9 to 0.4 fold 
increase) (Visser, personal communication). 
Spleen colonies have been shown to change in morphology with time: Early 
spleen colonies were shown to be mainly erythroid, while later spleen colonies 
were shown to contain large numbers of other cell types (Curry and Trentin, 
1967, Moore and Metcalf, 1971; Johnson and Nicola, 1984). If the morphology of 
the spleen colonies is dependent on the type of CFU-S transplanted instead of 
the age of the colony one can expect to find a relation between the morphology 
of the spleen colonies and the fluorescence intensity with anti-H-2K. The 
spleens were sectioned, stained and their morphology was determined as described 
in Chapter 2. The results are presented in Table 4.2. Spleen colonies 
consisted predominantly of erythroid and undifferentiated cells at 8 days after 
transplantation. Four days later the spleen colonies showed a more 
heterogeneous cell distribution. This pattern was found in all groups.. 
However, half of the day-12 erythroid spleen colonies from Fraction III are 
desintegrating. In unseparated BM less than 10 % of the day-12 spleen colonies 
are falling apart. Example of these colonies were presented in Fig. 3.1. 
These results indicate that some spleen colonies produced by a fraction enriched 
in day-8 CFU-S, are still present at day-12, but in a desintegrating state. 
Density of Thy-! molecules on day-8 and day-12 CFU-S 
The Thy-1 antigen was described as an antigen with specificity for T cells 
(Reif and Allen, 1963). The antigen was, however, also found on several other 
cell types as brain cells, cells lining the otocyst, fibroblasts and epidermal 
cells (Reif and Allen, 1963; Prystowsky et al, 1978; Stern, 1973; Scheid et al, 
1972). Hemopoietic stem cells were reported to be Thy-1 negative (Thierfelder, 
1977, Russel and van den Engh, 1979). Prothymocytes were also shown to be Thy-1 
negative (Kadish and Basch, 1976; Boersma, 1982). More recent experiments, 
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Fig. 4.2 A/8. Fluorescence of anti-Thy-1.1 treated bone marrow cells. C3AK 
F1 BM cells were incubated with anti-Thy-1.1 and GAM/FITC as described in 
Chapter 2. The cells were sorted in the fractions indicated by the roman 
figures. The thin lines shows the fluorescence distribution of BM cells 
incubated with GAM/FITC only. C/0. CFU-S content of BM fractions differing in 
Thy-1.1 density. The CFU-S content is expressed as the number of spleen 
colonies per fraction sorted from 105 incubated cells. Oay-8 CFU-S (o); day-12 
CFU-S (e). Unseparated BM cells contained 16.5 and 19.5 day-S and day-12 CFU-S 
(A/C) and 18.6 and 17 day-S and day-12 CFU-S (8/D), respectively per 10 5 cells. 
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employing monoclonal antibodies indicate that the CFU-S and the thymocyte 
progenitor do have low amounts of Thy-1 antigens on their cell surfaces (Basch 
and Berman, 1982). 
In initial experiments in which C3AK Fl BM cells were incubated with 
anti-Thy-1.1 and complement an insignificant reduction of day-10 CFU-S was 
observed (data not shown). In sorting experiments in which BM cells were 
labeled with anti-Thy-1.1 and goat-anti-mouse/FITC and separated on fluorescence 
intensity, day-10 CFU-S were predominantly present in the fluoresceing fractions 
(data not shown). These experiments were repeated and spleen colonies were 
65 
Table 4.3 
Effect of anti-Thy-1.1 treatment of C3AK 8M on day-S and day-12 CFU-S 
Treatment 
medium control 
Thy-1.1 incub. 
C' incub. 
Thy-1 .. 1 and C' 
5 
day-S CFU-S/1 0 NBM 
19.1±4.6 
16.0±?.2 
19.4±4.2 
19.1±5.1 
5 
day-12 CFU-S/1 0 NBM 
17.2±3.? 
1?.3±3.4 
16.2±4.0 
1 0.0±1 .. 5 
C3AK F1 8M cells were incubated with anti-Thy-1 .. 1 and/or complement as described 
in Chapter 2. Appropriate numbers of cells were subsequently injected into 
lethally irradiated recipients and assayed for day-S and day-12 spleen colonies. 
counted at both day-8 and day-12.. Table 4.3 shows the cytotoxic effect of 
incubation of C3AK BM cells with anti-Thy1.1 and complement. Neither of the 
incubation procedures affected the number of day-8 cru-s, but antibody labeling 
and complement treatment reduced the number of day-12 CFU-S to 55 % (Table 4.3). 
Fig. 4.2A and C shows the fluorescence distribution of C3AK BM cells 
labeled with anti-Thy-!.! and GAM/FITC or with GAM/FITC only. When BM cells are 
labeled with GAM/FJTC, B cells and small numbers of large cells fluoresce. 
After incubation with anti-Thy-1.1 and GAM/FITC a larger number of cells is 
labeled. Most of the additional fluoresceing cells are T cells, as indicated by 
there presence in the lymphocyte population (see Chapter 2). The distribution 
of day-8 and day-12 CFU-5 in the sorted fractions is presented in Fig. 4.28 and 
D. Two third of the day-12 CFU-s are found in a fraction labeled with 
anti-Thy-!.!. 
CFU-S. Part 
In the negatively stained fraction there are few or no day-12 
of the day 8-CFU-S are Thy-1 .. 1 positive, but there is also a 
fraction Thy-.1.1 negative day-S CFU-S. 
The presence of CFU-S in the fluorescing fraction might be due to binding of 
GAM/FITC to the CFU-S. In order to exclude this (C57Bl/RijxC3H/Law)F1 (BC3) 
mice (Thy-1.1 negative) were incubated with anti-Thy-1 .. 1 and GAM/FITC and sorted 
on fluorescence intensity. The fractions were assayed for the content of day-8 
and day-12 CFU-S. This is presented in Fig. 4.3A and B. The Thy-1.1 antigen 
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Fig. 4.3 A. Fluorescence of anti-Thy-1 .1 treated bone marrow cells. BC3 F1 BM 
cells were incubated with anti-Thy-1.1 and GAM/FITC as described in Chapter 2. 
See also legend of Fig. 4.2A. B. CFU-S content of BM fractions differing in 
Thy-1.1 density. Unseparated BM cells contained 18.8 and 19.6 day-S and day-12 
CFU-S per 1 o-5 cells. 
is absent from BC3 BM cells (Fig. 4.3A) and day-8 or day-12 CFU-S are not 
enriched in the fluorescing fraction. This indicates that GAM/FITC does not 
bind to day-8 or day-12 CFU-S. 
These results indicate that the day-12 CFU-S from C3AK mice are Thy-1.1 
positive and that day 8-CFU-S can be Thy-1.1 positive or negative. 
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Table 4.4 
Distribution of day-S and day-12 CFU-S in bone marrow fractions 
differing in the uptake of Rhodamine 123 
Fraction 
Weakly 
Rh123 
positive 
Brightly 
Rh123 
positive 
% of all 
nucl. Cells 
sorted 
----------
40 
40-50 
number of 
day-S CFU-S 
/105 
----------
2.0±2.1 
17 .6±5.9 
number of Ratio of 
day-12 CFU-S 
/105 
day-12/day-S 
---------- ------------
7 .5±3.9 3.8 
12.2±2.1 0. 7 
Normal bone marrow cells were labeled with Rhodamine 123 as described in Chapter 
2. The BM cells were subsequently separated in two fractions with a light 
activated cell sorter and assayed for the content of day-S and day-12 CFU-S. 
The results are expressed as the total number of CFU-S sorted from 10S cells. 
Uptake of Rhodamine 123 by day-8 and day-12 CFU-S 
Rhodamine 123 (Rh123) is a supravital dye which accumulates specifically in 
mitochondria (] ohnson et al, 1980). Mitochondria are synthesized throughout the 
cell cycle (James and Bohman, 1981). Lymphocytes stimulated with 
phytohemagglutinin show maximal Rh123 uptake when maximal numbers of cells are 
in S phase and in mitosis (Darzynkiewicz et al, I 981). Other studies also 
showed that there is a relationship between active cell cycle and Rhl23 uptake 
(Cohen et al, 1981; James and Bohman, 1981). This indicates that cycling CFU-S 
may be discriminated from resting ones by their uptake of Rhl23. 
C3AK BM cells were labeled with Rhi23 as described in Chapter 2. They were 
subsequently separated in fractions that differed in Rhl23 fluorescence and 
assayed for CFU-S content. Fig. 4..4A shows the fluorescence distribution of BM 
cells incubated with or without Rh123. Fig. 4.4B shows the distribution of 
day-8 and day-12 CFU-S in four fractions differing in Rh123 uptake. Most day-8 
CFU-S contained a relatively high amount of Rh123, while the day-12 CFU-S were 
present in all the fractions. Table 4.4 shows the mean results of six 
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Fig. 4.4 A. Fluorescence of bone marrow cells incubated with Rh123. C3AK F1 
BM cells were incubated with Rh123 as described in Chapter 2. The cells were 
sorted in the fraction indicated by the roman figures. The thin line shows the 
fluorescence distribution of control BM cells. B. CFU-S content of fractions 
differing in Rh123 content. The number of CFU-5 is expressed as the number of 
spleen colonies per fraction sorted from 10S BM cells. 
experiments in which Rh123 labeled cells were devided in two fractions that 
differed in Rhl23 fluorescence. Most day-S CFU-S were brightly labeled, while 
the day-12 CFU-S are present in both fractions. This indicates that day-8 CFU-S 
have more or more active mitochondria than most of the day-12 CFU-S. 
In two experiments the radioprotective capacity of the weakly and brightly 
labeled BM cells was tested in a 30-day survival assay (See chapter 2). The two 
experiments are shown in Fig. 4.5. Thirty day survival is expressed per day-12 
CFU-S injected. In both experiments the survival of lethally irradiated mice 
was better with BM cells that were weakly labeled with rhodamine 123. The 
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Rh+ BM ( o ) and Rh++ BM ( o ) • Groups of ten irradiated mice were transplanted 
with varying numbers of cells. The survival 
day-12 CFU-S. Two experiments are shown 
probit analysis. 
is expressed per transplanted 
(A and B). The lines result from 
numbers of day-12 CFU-S for 50 % survival by the Rhl23+ fraction were 1.22±0.28 
and 2.1±0.54,. respectively. For the Rh123++ fractions these values were 
14.2±2.88 and 9.6±1.4 respectively. This indicates that the CFU-S with low 
Rhl23 uptake have better repopulating ability when compared to those that 
incorporate a larger amount of Fth123. 
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Fig. 4.6 A. Velocity sedimentation distribution of BC3 F1 BM cells. BM cells 
sedimented for 3 hours at 1 g as described in Chapter 2. B. CFU-S content of 
BM fractions differing in velocity sedimentation. The CFU-S are expressed as 
the number of CFU-S per 105 fractionated cells. Unseparated BM cells contained 
22 and 23.4 day-S and day-12 CFU-S per 105 cells. 
Velocity sedimentation of day-S and day-12 CFU-S 
Fig.. 4.6A shows the velocity sedimentation profile of nucleated NBM after 
three hours of sedimentation. The technique is described in Chapter 2. The two 
peaks that can be recognized sediment at 3.60 and 4 .. 75 mm/h.. This is in 
agreement with results that were obtained before .(van den Engh, 1976). Fig. 
4.68 shows the number of day-8 and day-12 CFU-S in the various fractions. From 
this it is concluded that there is no difference in sedimentation velocity of 
the day-8 and the day-12 CFU-S, suggesting that the two cell types have a 
similar size. 
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Regeneration kinetics of CFU-S in vivo and in vitro after treatment of mice 
with 5-flurouracil 
5-Fluorouracil (5-FU) has been shown to be toxic for the CFU-S (Bruce et al, 
1966). During the first days after i.v administration of 150 mg/kg 5-FU very 
few day-8 and day-12 CFU-S are detectable. The day-12 CFU-S recover before the 
day-8 CFU-5. Between 7 and 11 days after treatment high numbers of day-8 and 
day-12 CFU-S can be recovered from the bone marrow which return to normal values 
a few days later. This pattern of regeneration is presented in Fig. 4.7. 
Culture of bone marrow cells in the presence of SAF results in the 
production of CFU-S (Tables 3.1 and 3.3). However, NBM is a mixture of early 
and late spleen colony forming cells. 5-FUBM contains virtually no day-8 CFU-S 
during the first days after administration. The development of these precursors 
may therefore be studied by culturing 5-FUBM with SAF. Fig. 4.8A shows the 
results of culture of FUBM, collected four days after 5-FU treatment (day-4 
FUBM) in the presence of SAF. At the beginning of the culture there were very 
low numbers of day-8 CFU-S. The day-12/day-8 CFU-S ratio at the initiation of 
the cultures was 20.8. During a one week culture the number of day-12 CFU-S 
increases slowly. Parallel to this, with a delay of three-four days, followed a 
production of day-8 CFU-S. 
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Fig. 4.8 CFU-5 production in vitro from FUSM. A. BfYI, four days after 5-FU 
administration, was cultured in the presence of SAF. See Chapter 2 for culture 
conditions. At the days indicated, the cultured cells were collected, counted 
and assayed for day-S and day-12 CFU-S content. The CFU-S are expressed as the 
number of CFU-S per 105 initially cultured cells. B. BM, seven days after 
5-FU administration was cultured in the presence of SAF. C. SM, eleven days 
after 5-FU administration was cultured in the presence of SAF. 
In day-7 FUBM high numbers of day-12 and some day-8 CFU-S were present 
(Fig 4. 7). These cells were also cultured in the presence of SAF (Fig. 4.8B). 
The number of day-12 CFU-S increased until the first (2 exp.) or second (1 exp.) 
day after initiation of the culture, after which a rapid decrease could be 
observed. A second phase with a slower decline rate occured until 14 days of 
culture, after which the day-12 CFU-S was no longer present. Day-8 CFU-S from 
day-7 FUBM showed a different growth pattern in vitro (Fig. 4.8B): Maximal 
numbers of day-8 CFU-S were found later and the decline also starts at a later 
time. The decline in day-8 CFU-S paralleled that of the Day-12 CFU-S with a 
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delay of about one week. 
Culture of day-11 FUBM resulted in the immediate onset of the decline of the 
day-12 CFU-S. The frequency of day-S CFU-S was also initially decreased, but a 
production occured at a later time (Fig. 4.8C). · This suggests that the day-8 
CFU-S do not renew themselves but are produced from other stem cells, like the 
day-12 CFU-S or a pre-CFU-S. 
Discussion 
CFU-S can be separated into two subsets that produce spleen colonies at 
different days after transplantation (Harris et al, 1984; Baines and Visser, 
19S3). Day-12 CFU-S differ from day-S CFU-S in the cell surface density of 
class I MHC antigens (Harris et al, 1984; Fig. 4.1). Part of the day-S CFU-S 
are Thy-1 negative, while most day-12 CFU-S and the remaining day-S CFU-S are 
(weakly) Thy-! positive. Day-12 CFU-S can be subdivided in the ability to take 
up the mitochondrial dye Rh!23 (Fig. 4.4). Both day-S CFU-S and day-12 CFU-S 
show the same sedimentation velocity (Fig. 4.6), indicating these cells have 
the same diameter. From this it can be speculated that the day-12 CFU-S are 
heterogenous (Rh123-+ and Rh123++) and that there are two day S-CFU-S (Thy-1 + 
and Thy-! -). 
The function of a large number of class I H-2 antigens on the surface of 
day-12 CFU-S is unknown. The only cell types that have a comparable antigen 
density are B and T lymphocytes (see also Chapter 4). Immature BM cells and 
Kupffer cells also have many membrane bound class_ I H-2 antigens, but at a lower 
density (Fig. 4.1, Basch and Stetson, 1962). Class I H-2 antigens are further 
present on other tissues like the epithelial cells of the uterus, colon, 
salivary ducts, small intestine, breast and skin (Ponder et al, 1983). All 
these tissues contain stem cells. However, other tissues with stem cells like 
sperm and ova have very few class I H-2 antigens (Palm et al, 1971, Johnson and 
Edidin, 1972; Klein, 1975). Class I H-2 antigens are recognized by cytotoxic T 
lymphocytes (CTL) in association with an antigenic determinant. Absence of the 
class I H-2 antigen on a cell causes nonresponsiveness of the CTL, despite the 
presence of the antigen. This indicates that cells with a high level of class I 
antigens are potential target cells for a CTL From this it could be speculated 
that stem cells have a high density of class I antigens to facilitate the 
recognition of abnormalities, like malignancies, by CTL (Klein, 1975). 
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The labeling of CFU-S with anti-Thy-1.1 MCA is in agreement with the results 
obtained by Basch and Berman {1982). However, the heterogenous labeling of 
day-8 CFU-S with anti-Thyl.1 is as yet unexplained. The most likely possibility 
appears to be that there are two day-8 CFU-S, the Thy-1.1 positive cell being an 
intermediate CFU-S type. Experiments are in progress to determine whether in a 
cell population consisting of relatively mature CFU-S (SAFBM) the day-8 CFU-S 
are predominantly Thy-1.1 negative. The relatively high uptake of Rh123 by all 
day-8 CFU-S (Fig. 4.4) and the notion that Rhl23 uptake and state of cell cycle 
are correlated (Cohen et al, 1981; Darzynkiewicz et al, 1981; James and Bohman, 
1981 ), suggests that all day-8 CFU-S are in active cell cycle. The variable 
uptake of Rh123 by the day-12 CFU-S suggests that this population consists of 
cycling and resting cells. This difference in cell cycle status between the 
day-8 and day-12 CFU-S is in contrast with studies showing that few day-8 and 
day-12 CFU-S are cycling (<10 %; See introduction; Johnson and Nicola, 1984; van 
Zant, 1984; Chertkov and Drize, 1984; Wright, 1985). It could be that the 
S-phase specific treatments used in these studies (cytosine arabinoside, (3H)TdR 
and hydroxyurea) are less sensitive to detect differences in the cell cycle 
status of day-8 and day-12 CFU-S than studies with Rh123, because mitochondria 
are synthesized throughout the cell cycle (James and Bohman, 1981). However, 
when all day-8 CFU-S are cycling, as indicated by the high Rhl23 uptake, about 
50 % of these cells should be killed by the S-phase specific agents. This is 
clearly not the case and suggests that a high uptake of Rhl23 depends not only 
on cell cycle status. It is suggested that the differentiation processes in 
which the day-8 CFU-S appears to be involved also cause the presence of many or 
very active mitochondria. 
The difference in radioprotective capacity per day-12 CFU-S between Rh123+ 
and Rh123++ cell populations shows, similar to the results with SAFBM (Chapter 
3), that the number of spleen colonies at day-12 does not accurately predict the 
presence of pluripotent hemopoietic stem cells. On the other hand it has been 
demonstrated that in a bone marrow fraction in which day-12 CFU-S have been 
enriched 130-fold, the radioprotective capacity was enriched 180-fold. This 
indicates that day-12 CFU-S and PHSC are at least coenriched in the purified 
stem cell suspension. The present results indicate that the purified stem cell 
population is either a selection of the day-12 CFU-S from NBM (i.e. Rh+ day-12 
CFU-S) or that another more immature stem cell, the pre-CFU-S is also present. 
Experiments are in progress to determine the ability to incorporate Rh123 by the 
purified stem cells. The presence of most of the day-S CFU-S in the Rh++ cell 
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population and the loss of radioprotective capacity when compared the the Rh+ 
cells suggests that they have no major role in the protection against bone 
marrow failure after lethal irradiation. 
In a recent publication it was shown that low density BM cells, weakly 
labeled with Rh123, contained 92 % of the precursor cells that can give rise to 
CFU-C2 at 13 days after BMT (marrow repopulating ability), 77 % of the platelet 
precursors (platelet repopulating ability) and 38 % of the day-13 CFU-S (see 
also Table 1) when compared to unseparated low density BM cells (Bertoncello et 
al, 1985). These results are in agreement with ours and indicate that the 
hemopoietic stem cells in the weakly and brightly Rh 123 labeled fraction are 
qualitatively different. 
The recovery of the day-12 CfU-S before that of the day-8 CfU-S after 
treatment of mice with 5-FU in vivo suggests that day-8 CFU-S are derived from 
the day-12 CfU-S (fig. 4.7). This is also indicated by the appearance of day-8 
CFU-S after culture of day 4 FUBM, which is virtually devoid of these cells, in 
the presence of SAF as well as by the disappearance of the day-8 CFU-S one week 
after the disappearance of the day-12 CfU-S in such cultures (fig. 4.8A). The 
growth patterns of day-8 and day-12 CFU-S from BM collected at different days 
after 5-FU treatment in vitro are markedly different. During the early 
regeneration phase a production of day-12 CFU-S occured and a delayed appearance 
of day-8 CFU-S was apparent (Fig. 4.8A). Culture of BM cells 7 days after 5-FU 
caused a transient (1-2 days) production of day-12 CFU-S, an immediate 
production of day-8 CFU-S followed by a decline that paralleled that of the 
day-12 CFU-S with a delay of four-five days (Fig. 4.68). Culture of FUBM after 
the in vivo regeneration had reached its maximum, was associated with a drop in 
the numbers of day-12 CFU-S and a diminished production of day-8 CFU-S (Fig. 
4.8C). These results suggest that the day-8 CFU-S are derived from a precursor 
cell, like the day-12 CFU-S or the pre-CFU-5 (Hodgson and Bradley, 1979). 
From the results described in this Chapter it is concluded that day-8 and 
day-12 CFU-S are phenotypically different cells. Indirect evidence suggests 
that day-12 CFU-s give rise to day-8 CFU-S. This is in agreement with results 
obtained after culture of purified hemopoietic stem cells from NBM which, after 
in vitro culture in the presence of SAF, also gave rise to large numbers of 
day-8 CFU-s, CFU-C2 and BFU-E (Visser et al, manuscript in preparation). These 
results are further in agreement with data alluding to the heterogeneity in self 
renewal and differentiation potential among the most primitive hemopoietic stem 
cells (i.e. CFU-S; Worton et a!, !969a; Schofield and Lajtha, 1973; Micklem et 
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al, 1975; Rosendaal et al 1976, 1979; Hodgson and Bradley, 1979; see also 
Chapter 1). The organization of hemopoietic stem cells is further discussed in 
Chapter 8. 
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Conclusions 
1. Day-8 and day-12 CFU-S from normal bone marrow differ in the density of 
H-2K antigens. 
2. Day-12 CFU-S are Thy-! positive and day-8 CFU-S are Thy-! positive or 
Thy-1 negative 
3. Day-8 CFU-5 incorporate relatively much rhodamine 123, while day-12 CFU-S 
show a variable uptake of rhodamine 123 
4. Day-8 and day-12 CFU-S have the same sedimentation velocity. 
5. Day-12 CFU-S regenerate in vivo earlier than the day-8 CFU-S after 
treatment with 5-FU. 
6. The day-12 CFU-S or its precursor, the pre-CFU-S, in FUBM is one of the 
targets of SAF as measured by the production of day-12 CFU-S after 
stimulation with SAF. 
7. The appearance and disappearance of day-8 CFU-S in in vitro cultures of 
FUBM in relation to that of the day-12 CFU-S suggests that the day-12 
CFU-S is the precursor of the day-8 CFU-5. 
8. The presence of day-12 CFU-S in fractions of NBM does not accurately 
predict the radioprotective capacity. This indicates that day-12 CFU-S 
is a functionally heterogenous stem cell population or that 
radioprotection is mediated via another stem cell, the pre-CFU-s. 
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Chapter 5 
THE LATE APPEARING SPLEEN COLONY FORMING UNIT (DAY-12 CFU-S) 
IN RELATION TO THYMOCYTE PRECURSORS 
Introduction 
Repopulation of a thymus after lethal irradiation and bone marrow 
transplantation has been studied for more than twenty years. It is well known 
that precursors of thymocytes exist in the bone marrow (Harris, et al., 1964; 
Kadish and Basch, 1976 and Boersma et al., 1981a, 1982).. Boersma reported a 
linear relationship between the number of bone marrow cells transplanted and the 
number of donor cells present in the thymus at 14 days after transplantation 
(Boersma, 1982). He showed that the number of donor type thymocytes present in 
a regenerating thymus is a quantitative measure of the number of thymus 
precursors in normal bone marrow suspensions. 
The thymocyte precursor cells have been characterized as follows: They have 
a low density, an intermediate sedimentation velocity and are relatively 
cortisone resistant (Basch and Kadish, 1977 and Boersma et al., 1982). 
Prothymocytes have further been reported to be Thy-1 negative and to share 
antigens present on brain tissue (Basch and Kadish 1977; Boersma et al., 1981b). 
The sensitivity to in vitro gamma irradiation of prothymocytes (Do=0.92 Gy) was 
significantly higher than that of the CFU-S (Do=1.22 Gy)(Boersma eta!., !981b). 
From these data it appears that the prothymocyte shares several characteristics 
with ·the CFU-S which was usually ·measured at 9-10 days after transplantation, 
but that there are also differences between the two cell types. Separation of 
the CFU-S and the prothymocyte has however not yet been accomplished. 
This Chapter describes experiments that determine the number of thymocyte 
precursors and CFU-S in: normal, unseparated bone marrow cells and in fractions 
from NBM differing in the density of cell membrane bound class I H-2 antigens. 
In other experiments the thymus repopulating capacity of BM fractions differing 
in the uptake of rhodamine 123 and of BM pretreated in vivo with 5-fluorouracil 
(FUBM) is investigated. 
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Fig. 5.1 Thymus repopulation after transplantation of 106 normal C3AK F1 BM 
cells into lethally irradiated C3H recipients. Each dot represents the mean 
value of groups of three to four mice. A. Number of donor thymocytes versus 
the time after BMT. B. Number of donor thymocytes per CFU-5 transplanted 
versus the time after BMT. 
Thymus repopulation by normal bone marrow cells 
Most of the thymus repopulation data by normal bone marrow cells that were 
performed in 1981-1984 were pooled and analyzed (see Chapter 2 for details about 
the CFU-S- and prothymocyte assay). Fig. 5.1A shows the appearance of donor 
thymocytes after irradiation and bone marrow transplantation. Each point 
of three C3H represents 
that were 
the mean number of donor thymocytes from 
transplanted with 106 C3HxAKR FI (C3AK) 
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groups mice 
nucleated bone marrow cells. 
The average day- I 0 CFU-S content of these bone marrow cells was 204±40 CFU-S 
per 106 nucleated cells. The average ratio of day-12 CFU-S/day-8 CFU-S in C3AK 
Fl bone marrow cells was 1.10±0.15. Donor thymocytes were detectable by day 14 
after bone marrow transplantation after which a swift increase was apparent. At 
day 22-24 the thymus was fully repopulated. Fig: S.IB shows thymus repopulation 
by normal bone marrow cells expressed as the number of donor type thymocytes per 
day-10 CFU-S transplanted. 
Thymus repopulation by fractionated bone marrow cells 
Sorting of H-2K labeled hemopoietic progenitors from mouse bone marrow 
Bone marrow cell were incubated with biotinylated anti-H-2K MCA and avidin/ 
FITC and separated on a fluorescence activated cell sorter. The incubation 
and sorting procedure are described in Chapter 2. The density of H-2K mole-
cules on day-8 and day-12 CFU-S from C3H mice was described in Chapter 4. 
In the thymus regenerating experiments we used C3AK donor mice. C3AK mice 
have a higher mean density of H-2K molecules (Bauman et al, 1985). The CF'...i-S 
were initially assayed at day 10 only. The recovery of such CFU-S in the 
brightly fluorescent fraction ranged from 89 to 104 % (see also Chapter 2). 
This indicates that virtually all day-10 CFU-S from C3AK F1 mice are present 
among the cells with the highest density of H-2K antigens. Later experiments in 
which the day-8 and day-12 CFU-S were determined showed that two third of 
day-S CFU-S were recovered from a fraction staining less intense with anti-H-2K, 
while the most density stained cells were relatively enriched in day-12 CFU-S. 
The mean day-12/day-8 CFU-s ratio of this fraction was 2.02±0.39. These results 
are in agreement with those described in the previous Chapter in which C3H mice 
were used. 
Determination of the density of H-2K antigens on thymocyte precursors 
Concomitantly with the CFU-S assay, the thymus repopulating capacity of the 
sorted cell suspensions was assayed. Fig. 5.2 gives a summary of the results 
with untreated BM cells, with cells incubated with anti-H-2K and with brightly 
H-2K-positive bone marrow cells (4% of total cells). The results are expressed 
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Fig. 5.2 A. Number of donor cells in the thymus versus the time after BMT per 
106 NBM cells (111; 236 day-10 CFU-5),. per 106 BM cells treated with anti-H-2K 
(o; 112 day-10 CFU-5) and by a brightly fluoresceing fraction sorted from 10 6 
anti-H-2K labeled BM cells (~; 99 day-10 CFU-5). All BM cells were run through 
a light activated cell sorter. B. Number of donor cells in the thymus per 
day-10 CFU-S transplanted versus the time after BMT. NBM, H-2K-treated and 
H-2K-positive BM contained 19.9±6.3, 10.2±5.0 and 8.4±1.1 day-10 CFU-S, resp. 
The regression lines were calculated from the means of the obtained data. Each 
bar represents one standard deviation. The correlation coefficients were 0.95 
with 5 degrees of freedom for normal bone marrow cells, 0.99 with 3 degrees of 
freedom for anti-H-2K-treated bone marrow cells, and 0.99 with 3 degrees of 
freedom for brightly anti-H-2K-positive bone marrow cells in the FLS-PLS window 
(see also Chapter 2). Comparison of the regression lines of NBM and anti-H-2K 
treated BM showed that they were parallel (intercept Y-axis p=0.027;slope 
p=0.13). The regression line of brightly anti-H-2K-positive BM was parallel 
with that of NBM (intercept Y-axis p=0.027; slope p=0.40) and different from 
that of H-2K-treated BM (intercept Y-axis p<0.001; slope p<0.01). 
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as donor cells per day-10 CFU-S injected.. This makes a comparison of the three 
groups possible, since different numbers of CFU-S were injected in each 
experiment. The treatment of BM cells with anti-H-2K caused a reduction to 40 % 
of the number of CFU-S.. Thymus regeneration by anti-H-2K treated BM cells 
expressed per number of cells injected was delayed when compared to that by 
untreated BM cells (Fig.. 5 .. 2A).. Accordingly, thymus regeneration when 
expressed per day-12 CFU-S transplanted by anti-H-2K treated BM was similar when 
compared to that by untreated BM cells (Fig. 5 .. 2B).. This indicates that the 
treatment with anti-H-2K MCA affects CFU-S and the thymocyte precursor cells to 
the same extent. The brightly labeled H-2K-positive bone marrow cells showed a 
delay in thymus repopulation when compared with unsorted anti-H-2K-labeled bone 
marrow cells {Fig. 5.2B). This highly H-2K-positive bone marrow graft 
contained the same absolute number of CFU-5 as that of unsorted H-2K-labeled 
bone marrow cells. Comparison of the regression lines of H-2K positive bone 
marrow cells with sorted, but unseparated~ anti-H-2K labeled bone marrow cells 
shows that they are not parallel (p<O.Ol) and that the intercepts with the 
Y -axis are different (p<O .. OOl). We conclude from these results that the 
H-2K-bright bone marrow cells, which are enriched in CFU-S (Chapter 3), are 
depleted in prothymocytes (Fig. 5 .. 2) .. 
Animals receiving the CFU-S poor-fraction (about 11 % of total nucleated 
cells) in the cell sorting experiments described above died from radiation 
exposure before thymus repopulation could be determined. Therefore, the 
prothymocyte assay was altered slightly by coinjection of a small dose of 
syngeneic bone marrow cells into the recipient (5x104 cells per animal). Fig .. 
5 .. 3 shows the results of a representative experiment (out of 3).. The dim H-2K 
positive cells gave rise to a significant progeny of donor-derived cells in the 
thymus. These cells appeared relatively early during repopulation (day 15) and 
disappeared after 24 days (Fig. 5.3).. From this pattern it is concluded that 
prothymocytes have -fewer H-2K antigens on their cell surface than do day-10 
CFU-S.. The committed progenitor cells or prothymocytes, apparently, are present 
in the bone marrow.. They migrate to the thymus and give rise to relatively 
early and transient thymus repopulation. After transplantation of NBM this 
transient repopulation then must be overtaken by the swift increase due to 
prothymocytes produced by the grafted stem cells.. The presence of fewer H-2K 
antigens on the prothymocyte also explains the somewhat higher early thymus 
repopulation after anti-H-2K treatment in comparison with NBM as well as the 
absence of this early thymus repopulation by sorted H-2K brightly positive BM. 
83 
antl-H-lK l<:~beled 6M 
' 
v bright anti-H-2K positive 
1 /' ..... /• '? -.. dull anti-H-2K po:>ltlve yo : ~· / 
" / 
v •••••••• j 
time after transplantation ( day l 
Fig. 5.3 Thymus repopulation by BM cells treated with anti-H2K-biotin, and 
avidin-FITC { o), by sorted cells brightly positive for H-2K ( 'il) and by cells 
intermediately positive for H-2K ( x). Thymus repopulation is expressed as the 
number of donor thymocytes produced by 10 6 9M cells or by a fraction sorted 
from 106 BM cells. The numbers of day-10 CFU-5 in these grafts were 100, 89, 
and 20, respectively. 
Thymus repopulation by purified stem cells 
CFU-S were shown to have the following characteristics: They have a low 
density (Worton et al., 1969b; Bol et al., 1977; Visser and Bol, 1981) and they 
contain a large number of receptors for wheat germ agglutinin (Visser and Bol, 
1981). CFU-S scatter laser light relatively strong when measured at low angles, 
but relatively weakly when measured perpendicular from the direction of the 
laser beam (van den Engh et al. 1979). CFU-S were also shown to stain with 
antibodies directed against class I H-2 antigens (Russell and van den Engh, 
1979; Chapters 2 and 4). Visser et a!. (1984) combined these methodologies 
which resulted in an enrichment of day-12 CFU-S with a factor of about 135 
(range, 90-230). The purity of these cell suspensions ranged from 35-110% when 
an f-factor of ·10 % is taken into consideration. Morphological analysis by 
electron microscopy indicated that the purified cell suspension contains two 
cell types: 43-59 % of the cells resemble the "candidate stem cell" which was 
described by van Bekkum et al (1971), while 24-43 % have somewhat more cytoplasm 
and deeper nuclear indentations (Visser et al, 1984). The spleen colony data 
indicated that the average ratio of day-12 CFU-S/day-8 CFU-S is 4.2 in these 
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Table 5.1 
CFU-S content of bone marrow cells after density separation and 
fluorescence activated cell sorting. 
Experiment 
I 
II 
III 
IV 
v 
VI 
VII 
VIII 
5 
CFU-S/10 purified cells 
Day 8 
4250 
1500 
1360 
2750 
1110 
1580 
2560 
1160 
2000±1000 
Day 12 
8070 
2380 
2480 
2660 
2320 
4390 
5640 
1440 
3680±2100 
The isolation procedure is described in Chapter 2. 150-250 purified cells 
derived from C3AK mice were transplanted for the CFU-S assay. Unseparated bone 
marrow cells contained 20.4±4.0 day-10 CFU-S per 105 transplanted cells. 
sorted suspensions {in NBM this ratio was 1.2; Visser et al., 1984). The two 
cell types, discerned by electron microscopy, do not to correlate with the 
day-12 and day-8 spleen colony data. 
The method described above appeared to give the highest enrichment of CFU-S 
from normal bone marrow cells and to result in cell suspensions that resembles 
pure pluripotent hemopoietic stem cells best with the presently available 
techniques. Purified stem cells derived from C3AK mice were prepared as 
described by Visser et al {1984) {see Chapter 2 for more technical details) and 
they were tested for thymus repopulating ability. Table 5.1 gives the spleen 
colony data that were obtained in the thymus repopulation experiments with 
enriched hemopoietic stem cells. An average of 2000±1000 day-8 CFU-S and 
3680±2100 day-12 CFU-S per 105 nucleated cells were obtained. Compared to 
normal bone marrow a 100 fold enrichment of day-8 CFU-S and a 180 fold 
enrichment of day-12 CFU-S was observed. These results, similar to those of 
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Fig. 5.4 Thymus repopulation by purified C3AK stem cells. See Chapter 2 for 
the isolation procedure. anti-H-2K treated, unseparated 8M cells (o), purified 
stem cells ( a ) • The recipients of both groups received similar numbers of 
day-12 CFU-S. The dots with arrows represent values calculated from the number 
of thymocytes and the detection limit (1%) of the flow cytometric assay. In 
these cases no donor thymocytes were observed. 
Visser et al (1984) show that both day-8 and day-12 CFU-S were enriched in the 
purified cell suspension, but that the recovery of day-8 CFU-S was lower. 
Similar data were obtained with C3H mice (Chapter 4). 
Thymus repopulation by purified stem cells was tested by injection of low 
density, WGA+ and H-2K+ C3AK bone marrow cells into lethally irradiated 
recipients. At various days after transplantation animals were sacrificed and 
the thymuses were removed. The number of donor cells per thymus was determined 
as described in Chapter 2. The results are expressed as the number of donor 
cells per day-12 CFU-S (Fig. 5,4). Fig. SA shows that purified stem cells 
gave a thymus repopulation that is delayed when compared to that by unseparated, 
anti-H-2K treated bone marrow cells. This delay was similar to that observed 
between brightly H-2K-positive, sorted cells and unseparated, anti-H-2K treated 
cells as was shown in Fig. 5.2) and indicates that the cell, responsible for 
early thymus regeneration, the prothymocyte, is depleted from the brightly H-2K 
positive BM cell fraction. 
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Fig. 5.5 Fluorescence intensity distributions of various cell types incubated 
with biotinylated anti-H-2K and avidin/FITC. The thin lines are fluorescence 
distributions of cells incubated with avidin/FITC only. 
Staining of hemopoietic and lymphatic tissues with anti-H-2K 
The expression of H-2K among thymocytes and T cells varies widely (e.g. 
Winn, 1969). In order to determine the changes in the density of H-2K antigens 
from pluripotent hemopoietic stem cells to mature T cells the fluorescence 
intensity after incubation with anti-H-2K MCA was measured. C3AK Fl cells from 
four tissues were incubated with biotinylated anti-H-2K monoclonal antibody 
(MCA), washed and incubated with avidin/FITC as described in Chapter 2. 
Fluorescence distributions of anti-H-2K treated cells are shown in Fig. 5.5. 
Almost all nucleated bone marrow cells had the H-2K determinant on their cell 
membranes, although in variable density. The fluorescence distribution of C3AK 
Fl bone marrow (Fig. 5.5A) had the same shape as that of C3H BM (Fig. 4.1A). 
Most thymocytes are weakly labeled, with the exception of about 20 percent, 
which had a medium to high fluorescence intensity (Fig. 5.5B). Spleen cells 
and mesenteric lymph node cells stained very brightly with this monoclonal 
antibody. There was clearly no evidence of an H-2K negative subpopulation in 
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these tissues. These results are in agreement with results reported in the 
literature (e.g. Winn, 1969). 
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Fig. 5.6 Thymus repopulation by BM sorted on the uptake of rhodamine 123. 
C3AK F1 BM cells were labeled with rhodamine 123 as described in Chapter 2. 
Lethally irradiated C3H mice received BM cells sorted from 10 6 BM cells. Rh+ 
BM contained 0 day-S CFU-S and 1 0 day-12 CFU-S per 1 oS cells. Rh++ BM 
contained 15.6 day-S CFU-S and 11.2 day-12 CFU-S. Each point represents the 
mean value of four mice. 
Thymus repopulation by BM fractions differing in the uptake of rhodamine 123 
In the previous Chapter it was shown that day-8 CFU-S take up a high amount 
of Rhl23, while day-12 CFU-S are heterogenously labeled. It was further shown 
that the capacity for radioprotection after lethally irradiation is 
predominantly present in the weakly labeled fraction which contained only day-12 
CFU-S. In other experiments the thymus repopulating ability of weakly (Rh+) and 
brightly (Rh++) labeled fractions was assessed. This is shown in Fig. 5.6. 
The Rh++ cells repopulated the thymus similar to NBM, but the Rh+ fraction 
repopulated the thymus with a delay of about four days. This delay was similar 
to that observed with the H-2K bright BM cells and the purified stem cells. 
These results indicate that the cell responsible for early thymus regeneration 
(the prothymocyte) differs from the Rh+ day-12 CFU-S, but that prothymocytes and 
day-8 CFU-s incorporate a similar amount of rhodamine 123. 
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Table 5.2 
DFU-5 content of bone marrow cells after 5-FU treatment 
day-S 
5 
Treatment CFU-5/10 BM CFU-5/femur 
normal bone marrow 16.7 ± 4.0 3106 ± 55 
day-4 FUBM 15.5 ± 6.7 434 ± 33 
day-12 
5 
CFU-5/10 BM CFU-5/femur 
14.8 ± 7.2 3124 ± 177 
89.1 ± 11.1 2495 ± 112 
FUBM was obtained as described in Chapter 2. The total number of nucleated 
cells per femur was decreased from 18.6x106 in normal femora to 2.8x106 in 5-FU 
treated mice. The data represent the average of 4 experiments. 
Bone marrow from mice pretreated with 5-FU (FUBM) 
As a source of day-12 CFU-S we used murine bone marrow cells four days after 
injection of 5-FU (Hodgson and Bradley, 1979). The delayed appearance of spleen 
colonies from these cells has been suggested to result from transient toxicity 
of the drug to CFU-S (Rosendaal et al., 1981). Rosendaal distinguished however 
between the toxicity to early and late colony formers~ the latter being less 
affected (Rosendaal et al., 1981). The remaining day-12 CFU-S have been shown 
to repopulate the hemopoietic system at a higher rate than do CFU-S from normal 
BM (Hodgson and Bradley, 1979; Ross et a!, 1982). The day-12 CFU-S present in 
bone marrow after treatment with 5-FU or HU have also been shown to have a 
higher rate of self renewal than those in normal bone marrow (Hodgson and 
Bradley, 1979; Roosendaal et al., 1979). These results indicate that the 
surviving CFU-S do not suffer from any detectable toxicity. We have therefore 
considered the 5-FU treated cells as representative for day-12 CFU-S which are 
present in normal bone marrow. Table 5.2 shows the effect of 5-FU on the 
presence of CFU-8. The frequency of day-8 CFU-S is normal at 4 days after 5-FU. 
Due to the decrease in the total number of nucleated cells per femur, the total 
number of day-8 CFU-S was 14 % of normal. The total number of day-12 CFU-S per 
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Fig. 5.7 Thymus repopulation by FUBM. Lethally irradiated mice received 106 
NBM (11) 7 or graded numbers of 5-FUBM (5x105 (o) 7 z.Sx105 (o), 1.25x105 
( v). NBM contained 166, 172 and 232 day-S, -10 and -12 CFU-5, resp. FUBM 
contained 230, 760, and 1000 day-8,-10 and -12 CFU-S per 106 cells, 
respectively. Each point represents the mean value of three to four mice • 
. 
• 
" '" 
32 
time <~fter trJnspl<~ntation ( day ) 
Fig. 5.8 Thymus repopulation by FUBM. Thymus repopulation per day-12 CFU-5 
transplanted. See Fig. 5.7 for details. 
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femur was 80 % of normal after treatment with 5-FU and the concentration of 
day-12 CFU-S was 6 times that in normal bone marrow cells. 
Thymus repopulation by FUBM 
The bone marrow cells remaining after in vivo treatment with 5-FU (day-12 
CFU-5) were tested for thymus repopulating ability. Fig. 5 .. 7 shows the 
relationship between the number of cells transplanted and the number of 
thymocytes at different days after transplantation. Mice injected with FUBM 
showed diminished thymus repopulation at 15 days after transplantation. After 
injection of high numbers of nucleated cells, containing large numbers of CFU-S, 
thymus repopulation is still less than that of normal bone marrow (Fig. 5 .. 7). 
In other experiments even larger numbers of 5-FUBM were transplanted, but at the 
saturating dose thymus repopulation was still less than that of NBM (data not 
shown). Since we wanted to determine the thymus repopulation in relation to the 
day-12 CFU-S, the thymus repopulation was expressed per day-12 CFU-S 
transplanted. This is shown in Fig. 5.8. A delay of three to five days is 
apparent in the early repopulation period. This difference disappears rapidly 
due to a higher growth rate in the thymuses injected with FUBM. These results 
indicate that the prothymocyte is sensitive to 5-FU. 
Comparison of thymus repopulation by NBM, purified stem cells, FUBM and SAFBM 
In order to compare thymus regeneration by different cell suspensions, the 
dose-response relationship (i.e. the number of CFU-S transplanted versus the 
number of donor derived thymocytes) was determined at several days after BMT .. 
The curves are shown in Fig. 5 .. 9. The lines indicate that the number of donor 
derived thymocytes depends log linear on the number of day-12 CFU-S {and also 
the total number of cells) transplanted. The regression lines from these data 
were determined and the values at a dose of 200 and 500 transplanted CFU-S were 
calculated. These doses were within the range of most experiments (except for 
those of 500 CFU-S with the purified stern cells which is omitted in Fig. lOB). 
The values are presented versus the time after BMT in Fig.. 5.1 OA and B. 
Differences in thymus repopulating ability of the various cell suspensions is 
reflected by a different onset of thymus repopulation. 
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Fig. 5.9 Thymus repopulation by NBM, purified stem cells, FUBM and SAFBM. 
Dose-response relationship between the number of CFU-S transplanted and the 
number of donor thymocytes present at the indicated days. 
The delay in thymus repopulation between NBM and purified stem 
cells and FUBM disappears during the early repopulation phase. The delay in 
thymus repopulation between NBM and SAFBM (either per day-6 CFU-S or per day-12 
CFU-S) is much more pronounced. This is about ten days. 
Discussion 
In the experiments that are described in this Chapter two biological assays 
are applied to the same cell supensions: The spleen colony assay and the thymus 
repopulation assay (Till and McCulloch, 1961; Kadish and Basch, 1976). The 
CFU-S assay measures a heterogenous population of cells that produces spleen 
colonies at different times after transplantation (Hodgson and Bradley, 1979; 
Magli et al., 1982; Harris et al., 1984; Visser et al., 1984). In Chapter 3 it 
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Fig. 5.10 Comparison of thymus repopulation by the various BM sources. The 
curves were constructed from the dose response curves presented in Fig. 5.9. 
A. At a dose of 200 day-12 CFU-5 in NBM (•), purified stem cells (•), 5-FUBM (o) 
and SAFBM (~) or day-6-8 CFU-S in SAFBM (v). B .At a dose of 500 CFU-5, see A 
for characters. 
was described that BM cell populations enriched in day-8 CFU-S (SAFBM) showed a 
dimished capacity to repopulate the thymus, indicating that these day-8 CFU-S 
had no longer thymus repopulating ability. The experiments described in this 
chapter were performed in order to evaluate the thymus repopulating capacity of 
day-12 CFU-S in enriched cell suspensions. 
The results can be summarized as follows: Thymus repopulation by normal bone 
marrow cells is, with Thy-1.1 as a marker, detectable at 14-15 days after 
transplantation after which a rapid growth could be observed (Figs. 5.1A and 
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Table 5.3 
Presence of day-S CFU-5, day-12 CFU-5 and prothymocytes in cell suspensions 
Delay in thymus regeneration 
Cell suspension Day-8 CFU-5 Day-12 CFU-5 
absence of prothymocytes 
----------
------------- -------------
-----------------------------
normal BM 0.9 1 .o 
bright H-2K pes. 0.5 1 .o 3-4 days 
purified stem 0.5 1 .o 3-4 days 
cells 
dull H-2K pes. 4.0 1 .o none 
day-4 FUBM 0.2 1 .o 4 days 
Rh123+ 0.3 1 .o 4 days 
Rh123++ 1 .4 1 .0 none 
5AFBM 3.0 1 .0 6 days 
Summary of the content of day-S CFU-S, day-12 CFU-5 and prothymocytes in various 
BM cell suspensions. The presence of prothymocytes is indicated by the absence 
of a delay in thymus regeneration. The data are derived from experiments 
described in Figs. 3.6, 4.4, 5.1, 5.2, 5.3, 5.4, 5.6, and 5.8 and Tables 3.1, 
4.1, 4.4, 5.1 and 5.2. 
B). This is in agreement with results obtained by others (Kadish and Basch, 
1976; Boersma et al., 198la). Bone marrow cells were separated in fractions 
differing in the content of class I H-2 antigens. All day-12 CFU-S, at least 90 
% of the day-1 0 CFU-S and 35 % of the day-8 CFU-S were present in 4-5 % of 
bone marrow cells selected for FLS, PLS and high fluorescence intensity after 
labeling with anti-H-2K and avidin/FITC (see also Chapter 4). Thymus 
repopulation by this fraction was delayed 3-4 days when compared to labeled, 
unseparated bone marrow cells (Fig. 5.2B). Relatively large numbers of day-8 
CFU-S (65 %) and low numbers of day-10 CFU-S (10 %), but virtually no day-12 
CFU-S were present in the weakly H-2K positive fraction. This fraction gave 
rise to transient progeny between 14 and 24 days after irradiation and 
transplantation (Fig. 5.3). Purified stem cells were prepared as described in 
Chapter 2. The last step also separates cells on fluorescence intensity after 
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labeling with anti-H-2K. The average enrichment of day-8 CFU-S was 100 fold, 
whereas day-12 CFU-S were enriched 180 times. Thymus repopulation by these 
highly enriched bone marrow stem cells was, on a per CFU-S basis, similar to 
that by bone marrow 
anti-H-2K only (Fig. 
cells that were separated on fluorescence intensity with 
5.4). Both these cell suspensions showed a delay in 
thymus repopulation of 3-4 days. 
Early thymus regeneration is mediated with BM cells that label brightly with 
Rhl23 (Fig. 5.6). This fraction contains most day-8 CFU-S and part of the 
day-12 CFU-S. These results are consistent with the separation experiments in 
which anti-H-2K was used. In both cases early thymus repopulation is correlated 
with day-8 CFU-S, but not with day-12 CFU-S. Three to four days delayed thymus 
repopulation is correlated with the presence of day-12 CFU-s. 
FUBM contains a preponderance of CFU-S that produce spleen colonies late 
after transplantation (Hodgson and Bradley, 1979; Table 5.2). Several committed 
progenitors with restricted differentiation capacity have been reported to be 
sensitive to the cytotoxic action of the drug (day-8 CFU-S, BFU-E, GM-CFU-1 and 
GM-CFU-2)(Fig. 4. 7 and Table 5.2; Hodgson and Bradley, 1979; Suda et a!, 1983). 
Thymus repopulation is delayed several days, indicating that prothymocytes are 
also killed by 5-FU. The delay in thymus regeneration disappears rapidly with 
time (Figs. 5.7-5.10). The similarities between FUBM, H-2K bright BM cells, 
purified stem cells and weakly Rh!23 labeled BM cells suggests that delayed 
thymus repopulation in these preparation is caused by the absence of the 
prothymocyte. This suggests that the thymus repopulation stems following 
transplantation of these cell suspensions is effectuated not by prothymocytes 
present in the graft, but by prothymocytes that derive from grafted pluripotent 
stem cells. 
These results can be interpreted as follows (Fig. 5.11). Pluripotent stem 
cells, present in BM fractions enriched in day-12 CFU-s, give rise to spleen 
colonies late after transplantation. Thymus repopulation by PHSC is delayed 
several days when compared to that by NBM. This indicates that PHSC (part of 
the day-12 CFU-5 or the pre-CFU-S, see Chapter 4) first have to produce 
prothymocytes in the bone marrow. Directly grafted prothymocytes are 
responsible for the early thymus repopulation. They are present in NBM, in bone 
marrow fractions staining intermediately dense with anti-H-2K and bright with 
Rhl23 (Table 5.3). They are absent from FUBM, SAFBM, BM cells weakly labeled 
with Rhl23 and from brightly H-2K-positive bone marrow cells (purified stem 
cells) (Table 5.3). The thymic progeny of the prothymocytes contained in the BM 
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Fig. 5.11 Proposed model of early hemopoietic differentiation. See text for 
details. 
graft is relatively small and is gradually replaced by the progeny of 
prothymocytes that are produced by PHSC in the bone marrow. In this model it is 
postulated, that the CFU-S that produces early spleen colonies (day 6-8) have 
lost the differentiation potential for the T cell lineage and can no longer give 
rise to prothymocytes (see also Chapter 3, SAFBM). 
If this model is correct, then prothymocytes, although identifiable and 
separable from day-12 CFU-S have limited proliferative and few self renewing 
capacity. The literature supports that such characteristics belong to the 
prothymocyte: Transplantation of thymus suspensions from mice irradiated and 
bone marrow transplanted 2 days previously, resulted in the appearance of low 
numbers of donor cells with little proliferative activity. Donor cells were 
absent 18 days after the transplantation (Boersma, 1982). Similar results were 
obtained after transplantation of normal thymocytes (Takada and Takada, 1973; 
Boersma, 1982). 
The changes in H-2K expression during T -cell development are interesting. 
The PHSC have a higher density than do prothymocytes (Fig. 5.3) and most 
thymocytes contain barely detectable H-2K antigens (Fig. 5.5). Those with a 
"mature" phenotype do express again high levels levels of H-2K antigens (Ceredig 
et al., 1982a). Phenotypic characterization of thymocytes leaving the thymus 
showed that all migrating cells are brightly H-2K-positive, compared with 20-50% 
H-2K positive cells in the thymus (Scollay et a!., 1980). Peripheral T cells, 
that are smaller than CFU-S have a fluorescence intensity comparable to that of 
the CFU-S (Fig. S.SC and SD). The density of H-2K on these cells must 
therefore be higher as compared with the CFU-S. H-2K expression, therefore, 
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Fig. 5.12 Density of H-2K antigens on increasingly mature T cells. See text for 
explanation. 
decreases early during T cell differentiation (CFU-S -.prothymocyte ..... cortical 
thymocyte) and is increased again in cells with a 'mature'phenotype (medullary 
thymocyte -migrating thymocyte -.peripheral T cell (Fig. 5.12). Reexpression 
of H-2K on immature thymocytes also occurs after in vitro stimulation with 
factors that are probaly derived from macrophages (Beller et al.~ 1977; Di 
Sabato et al., 1979; Abbott, et al., 1981). Why only a minority of the 
thymocytes (re)express H-2K antigens and leave the thymus as mature cells 
remains to be elucidated. 
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Conclusions 
l. Day-10 to 12 CFU-S and prothymocytes differ in the density of H-2K proteins 
2. Although day-8 CFU-S and prothymocytes are different cells, they have a 
similar density of H-2K proteins and a similar uptake of rhodamine 123. 
3. fUBM is depleted of prothymocytes. 
4. Thymus repopulation stems from prothymocytes contained in the graft and from 
prothymocytes produced by grafted PHSC. Prothymocytes are present in a 
fraction staining intermediately with anti-H-2K and brightly with rhodamine 
123. They cause early thymus repopulation. Pluripotent stem cells are 
present in a fraction densely labeled with anti-H-2K, in a fraction weakly 
labeled with rhodamine 123 and in fUBM. PHSC cause a delayed thymus 
repopulation, probably via in vivo generation of prothyrnocytes in the BM. 
5. Prothymocytes have limited proliferative and no self renewing properties 
6. The expression of H-2K molecules is high in PHSC, is less in prothymocytes, 
is very low in cortical thymocytes and is again high in mature T cells. 
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Chapter 6 
HOMING OF BONE MARROW CELLS INTO THE THYMUS 
Introduction 
Several methods, determining the presence of thymocyte precursors in cell 
suspensions were reviewed in Chapter 1. Most are indirect measurements because 
they determine the progeny of the precursor cell. Boersma ( 1982) extrapolated 
thymus repopulation data to the day of transplantation. Assuming that 
prothymocytes arrive in the thymus shortly after irradiation, it was calculated 
that there are about 300 prothymocytes per 106 BM cells. One method, which 
counts the number of cells that arrive in the thymus after transplantation of 
supravitally stained cell suspensions into lethally irradiated mice, has been 
used as an assay of prothymocytes (Lepault and Weissman, 1981; Lepault et a!, 
1983). This assay, if specific for thymocyte precursor cells, should be a 
valuable tool for the study of the very first differentiation step from 
thymocyte precursor cell to thymocyte. These studies suggested that the BM 
contains more thymus seeking cells than do spleen, mesenteric lymph nodes and 
thymus. The frequency of these cells was found to be about 1 in 1000 nucleated 
BM cells transplanted (Lepault and Weissman, 1981). Determination of the 
phenotype of the immigrated cells revealed that 1/4-1/3 of these cells express 
markers of mature B and T lymphocytes and macrophages. It was, however, not 
determined whether the thymic immigrants are also thymocyte precursors. 
Therefore, experiments were performed with the intention to relate the number of 
thymic immigrants to thymus regeneration. The entry of BM cells into the thymus 
three hours after BMT of mice which were irradiated 3 hours, 1 day or 4 days 
before BMT was determined by using fluorescent labeling techniques and chromium 
51 labeled cells. The light scatter characteristics of the thymus immigrants 
was compared to that of the thymocyte precursor cells. The entry of cells into 
the thymus from BM cells depleted of thymocyte precursors (FUBM or purified stem 
cells; see Chapter 5) was compared to that by NBM. The first two BM suspensions 
showed a delay in thymus regeneration of 3-4 days which is indicative for a 
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Fig. 6.1 A. Fluorescence of NBM labeled with Hoechst 33342 NBM was labeled 
with Hoechst 33342 as described in Chapter 2. The cells were analyzed on a 
light activated cell sorter with the laser in UV mode (351-364run). B. 
Fluorescence of BM cells four days after injection of 150 mg per kg 5-FU (i.v.) 
and labeled with Hoechst 33342. 
depletion of prothymocytes (Chapter 5). One would expect very low numbers of 
thymus seeking cells from these cell suspensions. 
Homing of BM. cells labeled with Hoechst 33342 
Homing experiments with fluorescein-isothiocyanate (FITC) labeled BM cells 
and analysis of cell suspensions by flow cytometry showed that there was a high 
background fluorescence in thymus cell suspensions. Other supravital dyes were 
tested and Hoechst 33342 was selected. Normal BM cells were labeled with 
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Fig. 6.2 A. Forward light scatter of the fluoresceing cells. B. Dotplot of 
thymocytes from mice irradiated at -Sh and transplanted with 30x106 Hoechst 
33342 labeled NBM at -3h. 10 6 events are shown. For comparison the FLS of NBM 
(C) and the 'blast' (D) population containing the prothymocytes are shown. 
Hoechst 33342 as described by Baines and Visser (1983). This supravital dye 
binds to DNA. The fluorescence distribution of these cells is shown in Fig. 
6.1A. Due to the bright fluorescence of the labeled cells, transplanted cells 
could easily be recognized among unlabeled cells of the recipient as shown in 
Fig. 6.2B. After transplantation of BM cells incubated with Hoechst 33342 into 
preirradiated mice (-3h) a linear relationship was observed between the number 
of cells transplanted and the frequency of donor cells in the spleen, bone 
marrow and thymus (Fig. 6.3A). The small deviation from linearity after 
transplantation of relatively low numbers of BM cells, with respect to thymus 
homing, may be due to the selective homing of BM lymphocytes, which comprise 
most thymic immigrants, to other organs (Yoshida and Osmond, 1978). At three 
hours after BMT 10-15 % of the injected cells could be recovered from the both 
the spleen and the bone marrow. However, very few, i.e. less then 0.1 % of the 
injected cells, could be recovered from the thymus. 
From these experiments it was concluded that the number of donor cells 
recovered from the spleen, BM or thymus, is linear with the number of BM cells 
transplanted. 
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Fig. 6.3 A. Relationship between the number of Hoechst 33342 labeled BM cells 
transplanted and the frequency of labeled cells in the BM (•), spleen (o) and 
thymus{~) at 3h after BMT. Note that the scales for the different organs are 
different. B. Relationship between the time after transplantation of 21x106 
Hoechst 33342 labeled NBM and the frequency of labeled cells in the BM ( • ) , 
spleen {a) and thymus (~). 
The appearance of BM cells in the three organs in relation to the time after 
transplantation is 'shown in Fig. 6.38. Transplanted cells appeared very soon 
in the spleen and the thymus after BMT and there was a tendency to a decrease in 
frequency in the subsequent hours. A somewhat later appearance of transplanted 
cells was evident in the bone marrow. 
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Table 6.1 
Number of thymus seeking BM cells 
Time between 
irradiation 
and BJYJT 
2-3h 
1d 
4d 
Total nucleated 
cells per thymus 
6 
X 10 
85 ±7 
14.4±1.1 
1 .2±0.2 
Number of donor cells per organ 
per 106 cells transplanted 
from 
NBM FUBM 
1200±400 NO 
795±140 314/480 
19±5 NO 
8M cells were labeled with Hoechst 33342 as described in Chapter 2. 15-30x106 
nucleated BM cells were injected into mice that were preirradiated at the times 
indicated. The frequency of transplanted cells and the total number of 
nucleated cells was determined at three hours after BMT. From this, the 
recovery per organ per 10 6 injected cells was calculated. The data are derived 
from 5 experiments. In each experiment five mice were used per point. Two 
experiments with FUSM are shown. The data are corrected for background 
fluorescence, which ranged from 100-400 events per 106 analyzed cells. Values± 
1 standard deviation are shown. ND=not done. 
Number of NBM cells homing to the thymus 
Bone marrow cells ( 15-30xl 06) were transplanted into mice that were lethally 
irradiated at 2-3 hours, 1 day or 4 days before transplantation. The frequency 
of transplanted cells in the thymus at three hours after transplantation was 
determined by counting the number of fluoresceing cells among 2x105-106 
thymocytes in a flow cytometer. The total recovery per thymus was calculated 
from the frequency of labeled cells and from the total number of nucleated cells 
per thymus. Table 6.1 shows that early after irradiation relatively large 
numbers of injected cells could be recovered from the thymus. When recipient 
mice are irradiated 1 day before BMT lower numbers of injected cells are 
recovered and with a four day interval a very small part of the inoculum could 
be detected. Concominant with this decreased seeding fraction of labeled BM 
cells there was a 70-fold decline in the number of nucleated cells in the thymus 
during the first four days post-irradiation (Table 6.1). 
103 
Analysis of the forward light scatter intensity of the fluoresceing cells (a 
measure of cell size, see also Chapter 2) showed that the majority of the 
labeled cells are small (Fig. 6.2). They have the size of lymphocytes. 
Sorting experiments have shown that virtually all thymocyte precursor cells can 
be recovered from the large 'blast' population (e.g. the exps. described in 
Fig. 5.2-5.4, see also Chapter 2). 
These experiments show that, apart from the number of BM cells injected, the 
recovery of donor cells from the thymus is also dependent on the interval 
between lethal irradiation and BMT. 
Homing of FUBM labeled with Hoechst 33342 
In two experiments BM cells from mice treated four days previously with 5-FU 
were labeled with Hoechst 33342 and injected into mice that were irradiated one 
day before transplantation. Fig. 6.16 shows the fluorescence distribution of 
FUBM prior to injection. The unstained cells (channel number I 00) were 
erythroid cells which are very abundant in FUBM. The nucleated cells had a 
bimodal fluorescence distribution, which was due to the large fraction of cells 
in S - and G-2/M phase: the right peak (channel number 180) represents cells 
with about twice the fluorescence intensity (=2nDNA) when compared to that of 
the left peak (Go/Gl, channel number 195). The number of FUBM derived cells 
that appeared in the thymus is shown in Table 6.1. Per 106 cells transplanted 
314-480 cells could be recovered from the thymus (irradiated one day before 
BMT). This is half of that observed after injection of normal BM cells.. 
Extrapolation of the thymus repopulation data by FUBM (Fig. 5. 7) to the day of 
BMT, showed that 0.4 per 106 injected BM cells seeded into the thymus (95 % 
range: 0.06-2.5). Extrapolation of thymus repopulation data by NBM (Fig. 
5.1A), resulted in 460 BM cells per 106 injected BM cells at the day of BMT. 
The extrapolation data are compatible with the notion that FUBM is devoid of 
committed thymocyte precursor cells which was indicated by the delayed thymus 
regeneration by FUBM (Chapter 5). However, the large discrepancy between the 
direct homing assay and the functional, but indirect repopulation assay, 
strongly suggests that the FUBM derived cells present in the thymus early after 
BMT are not thymocyte precursor cells. 
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Table 6.2 
51 
Homing of Chromium and Hoechst 33342 labeled purified stem cells 
Organ 
Femur 
Spleen 
Liver 
Kidney 
Thymus 
Recovered specific radioactivity 
per organ (% of injected) 
Exp. I Exp. II 
---------------- -----------------
1.0±0.9 1 .8±1 .. 2 
5.5±2.6 12.2±2 .. 6 
27.7±10 16.9±3.4 
3.0±1 .8 1 0.4±2 .. 2 
-1.4±1.9 0.07±0.8 
Recovery of Hoechst 33342 
labeled cells per thymus 
(% of injected cells) 
10 
0.13 I 0.10 
Purified stem cells were isolated and labeled with 51 Cr or Hoechst 33342 as 
described in Chapter 2. In exp I there were 0 day-8 CFU-S and 4 day-12 CFU-5 
per 100 cells and in exp II there were 4.4 day-S CFU-5 and 7.7 day-12 CFU-5 per 
100 cells injected. The recipients received 5100, 1700 or 570 cells in exp I 
ard 6400, 2100 or 710 cells in exp II at one day after lethal irradiation. At 
three hours after BMT the recipients were killed, the organs were removed and 
the radioactivity per organ was determined. Each datum represents the mean 
value obtained from 9 mice ± 1 standard deviation and is corrected for 
background. The total recovery was 42±6 %. One femur comprises about 6 % of 
the total BM compartment (Smith and Clayton, 1970). The calculated total 
recovery is then 52±6 %. The radioactivity of faeces and urine at 3 h after 
grafting was negligible, but after 24 h 20- 44 % of total injected radioactivity 
could be recovered from filter paper on which the urine was disposed. Lethally 
irradiated mice also received 4000 or 5000 Hoechst 33342 purified stem cells. 
After three hours the recipients were killed, the thymus was removed, frozen and 
cut in 16~m thick sections. The slides were examined by fluorescence microscopy 
and the number of Hoechst labeled cells in the thymus was counted (less than 5 
labeled cells were present). In both experiments the thymuses from three mice 
were counted. 
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Homing of purified stem cells labeled with Hoechst 33342 and Cr 
Hemopoietic stem cells purified by density separation and light-activated 
cell sorting for both a high density of WGA receptors and H-2K antigens were 
shown to be enriehed in day-12 CFU-S (Visser et a!, 1984; Chapter 5). In the 
previous chapter it was described that the onset of thymus regeneration by such 
purified stem cells as well as FUBM are both similarly delayed by 3 to 4 days, 
despite the presence of large numbers of CFU-S. Comparison of the seeding of 
FUBM and purified stem cells into the thymus at three hours after 
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transplantation may help answering the question whether these seeded cells are 
involved in thymus repopulation. 
Purified stem cells were isolated and labeled with Hoechst 33342 or 51 Cr as 
described in Chapter 2. When Hoechst 33342 labeled cells were used, thymuses of 
recipient mice were carefully removed, frozen and the total organ was cut in 16 
J.lffi thick sections. The slides were examined by fluorescence microscopy and the 
number of fluoresceing cells per organ was scored. Very few (i.e. less than 5) 
fluoresceing cells were present per thymus after injection of 4000-5000 purified 
stem cells (Table 6.2). In other organs with a larger seeding fraction {e.g. 
the spleen) fluoresceing cells could easily be scored {data not shown). 
570-6400 purified stem cells, labeled with 51cr were also injected into 
preirradiated (-3h) mice. Three hours later several organs were removed and the 
radioactivity per organ was determined (see also Chapter 2). Table 6.2 shows 
the results of two experiments. The recovery of radioactivity in the spleen and 
BM is in the same range as that of CFU-S that are recovered in a 
retransplantation assay {Visser and Eliason, 1983). In the thymus no 
radioactivity above that of untransplanted, irradiated controls was observed. 
Titration experiments showed that the detection limit of this assay is about 50 
cells. These measurements indicate that purified stem cells do not home to the 
thymus in significant numbers. FUBM, in contrast, which is also depleted of 
prothymocytes, is a much richer source of thymus immigrants. 
Discussion 
The experiments described in this Chapter were performed in order to relate 
the presence of transplanted cells in the thymus to that of thymocyte 
progenitors. The extrapolated curve of NBM in Fig. 5.1 leads to a seeding of 
400±200 thymocyte precursor cells in the thymus early after BMT. Instead, 
1200±400 donor cells were observed in the thymus at 3 h after BMT (Table 7.1). 
It has been shown that thymus repopulation by donor cells is not related to the 
time between irradiation and BMT (Boersma, 1982). Therefore, from the 
extrapolated curVe in Fig. 5.1 400±200 prothymocytes would be expected to be 
present at 3 h after BMT in the thymus of mice that were irradiated 4 days 
previously. However, only 19±12 donor cells were observed per thymus per 106 
transplanted cells if the irradiation was given 4 days earlier. This has also 
been reported by Varlet et al, {1982). These two inconsistencies indicate that 
106 
most thymic immigrants consist of other cells than prothymocytes. The low 
number of thymic immigrants observed in mice that were irradiated 4 days earlier 
suggests that the prothymocyte enter the thymus later than 3 h after BMT. In 
addition, this indicates that extrapolation of the thymus repopulation data to a 
time early after BMT may lead to an erronous outcome. 
Extrapolation of the thymus regeneration data suggests that there exists a 
1000 fold difference in the number of donor cell in the thymus early after BMT 
between NBM and FUBM. In the direct homing assay there is only a two fold 
difference in the number of donor cells in the thymus from NBM and FUBM. This 
indicates that the migration of donor cells to the thymus early after BMT is not 
related to the repopulation of the thymus by the donor stern cells and progenitor 
cells. 
Light scatter measurements indicated that the size of most of the thymic 
immigrants is less than that of thymocyte precursor cells in the BM (Fig. 6.2). 
The FLS distribution is in agreement with the observation that a significant 
fraction of the seeded cells are mature lymphocytes and macrophages (Lepault 
and Weissman, 1981). 
Comparison of the results with FUBM and purified stern cells also showed 
inconsistencies with regard to thymus repopulation and thymus homing. These 
cell suspensions showed a similar, delayed thymus repopulation kinetics which is 
characteristic for a depletion of prothymocytes (Chapter 5). Thymus 
repopulation by these cell suspensions is closely related to the number of 
grafted day-12 CFU-S. Less than 0.13 % of labeled (Hoechst 33342 or 51 Cr) 
purified stem cells could be detected in the thymus at 3 h after BMT (in the 
direct homing assay: 2 to 4 cells per 4000 to 5000 injected purified stem 
cells). This is in agreement with earlier observations that CFU-S do not home 
to the thymus (Boersma, 1982). 310 to 480 per 106 (i.e. 0.03 to 0.05 %) FUBM 
cells transplanted into lethally irradiated recipients seeded into the thymus. 
However, the concentration of day-12 CFU-S (day-12 CFU-S) in FUBM was less than 
that of the purified stem cells (Chapter 5). In order to obtain similar thymus 
repopulation kinetics as by purified stem cells more cells had to be 
transplanted. This indicates that the number of cells that have entered the 
thymus 3 hours a"fter BMT is not correlated with the number of transplanted 
day-12 CFU-S and thus with thymus repopulation, but with the total number of 
cells transplanted. These results confirm the previous conclusion that early 
immigrants are not prothyrnocytes. 
Because the direct homing assay measures cells that appear to be unrelated 
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to thymocyte precursors, experiments were designed to determine functionally 
the time of entry of thymocyte precursors. These are described in the 
next Chapter. 
Conclusion 
The majority of BM cells that are present in the thymus early after irradiation 
are not thymocyte precursors. 
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Chapter 7 
THE ARRIVAL OF THYMOCYTE PRECURSORS IN THE THYMUS AFTER 
BONE MARROW TRANSPLANTATION 
Introduction 
In the previous Chapter it was described that the number of transplanted BM 
cells that were present in the thymus at 3 h after irradiation is not related to 
thymus repopulation kinetics. The earliest donor BM derived thymocytes can be 
detected around 8-12 days by various methods applied to thymus cell suspensions 
(Kadish and Basch, 1976; Sturman, 1977; Boersma et al, 1981; Ceredig and 
MacDonald, 1982; Sharrow et al, 1983; Hirokawa et al, 1985). In one report 
donor thymocytes were detected as early as 6 days after BMT (Boersma et al, 
1982). Thus, thymocyte precursor cells must enter the thymus before the sixth 
day after BMT. 
So far all investigators determined the appearance of the progeny of the 
thymocyte precursor. These results do not provide sufficient information on the 
time of entrance of thymocyte precursors.. Determination of the time after BMT 
that precursor cells, committed to the T cell lineage (prothymocytes) enter the 
thymus is important for the study of the earliest differentiation events in the 
T cell lineage. If the time at which prothymocytes enter the thymus were known, 
it would become possible to characterize these cells more closely, to define 
their port of entry and to study the first differentiation steps. 
In this Chapter attempts to determine the time of entry of thymocyte 
precursors are described. They employ procedures involving two irradiations 
(Fig. 7.1). C3H mice were lethally irradiated and transplanted with C3AK BM 
cells. At various times after the BMT, mice were reirradiated on the thymus. 
Thymus repopulation was determined subsequently between 15 and 35 days after the 
BMT. If prothymocytes entered the thymus before reirradiation of the thymu~ 
thymus repopulation should be delayed when compared to that of mice that were 
not reirradiated. By varying the interval between BMT and the second 
irradiation it should be possible to determine when precursor cells begin to 
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Fig. ?.1 Outline of the reirradiation experiments. See text for explanation 
enter the thymus. In a second set of experiments lethally irradiated and BM 
transplanted mice were reirradiated with or without thymus shielding at various 
times after BMT. When prothymocytes are present in the thymus at the time of 
reirradiation, thymus repopulation can be expected to start earlier in mice 
which were shielded on the thymus than in those which were not shielded. 
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Fig. 7.2 Relationship between the dose of the second irradiation and thymus 
repopulation at 22 days after BMT. Lethally irradiated and BM transplanted mice 
were reirradiated on day 4 with various doses of X rays (see Chapter 2). At 22 
days after BMT the number of donor thymocytes was determined. 
Preliminary experiments 
In order to determine the appropiate dose for the second irradiation, mice 
were lethally irradiated, transplanted with 10 6 C3AK BM cells and whole body 
reirradiated (TBI) at day 4 with increasing doses of 6 MV X rays. The number of 
donor type thymocytes was determined 22 days later. Without reirradiation, the 
thymus is regenerated at this time (Fig. 5.1). Fig. 7.2 shows the 
relationship between the dose of the second irradiation and the number of donor 
type thymocytes. The maximum dose of irradiation that is tolerated was 5 Gy, 
which caused a reduction of the number of donor type thymocytes at day 22 by a 
factor of 1000. Reirradiation with 6 Gy caused some mortality and all mice 
reirradiated with 7 Gy died in the second week after the first irradiation. 
Therefor~ a radiation dose of 5 Gy was selected for reirradiation. 
The effectiveness of thymus shielding with a leaden pole te'=I2 mm; 10 em 
high) was tested by counting the total number of thymocytes at various times 
after 5 Gy whole body irradiation of normal mice with or without thymus 
Ill 
thymus 
shielding 
(30x35 mm] 
100 ..0. •• "'0-...D 
time after Irradiation ( day l 
Fig. 7.3 Effectivenes of thymus shielding. C3H mice were irradiated with 5 Gy 
whole body irradiation (o) or irradiated and shielded on the thymus with a bar 
of 12 mm diameter (o) or with a block of 3x3.5 em (o). 
shielding. Two days after whole body irradiation virtually all thymocytes were 
eliminated (Fig. 7.3). Thymus repopulation started 7 days after the 
irradiation and the thymus was repopulated at about 16 days after TBI (Fig. 
7.3). Thymus shielding resulted in much less reduction in the number of 
thymocytes than that following whole body irradiation (Fig. 7.3). At four days 
after irradiation with thymus shielding a 35-65 % decrease in the number of 
thymocytes was observed and the thymus had a normal cellularity as early as 7 
days after irradiation. The shielded thymuses showed focal necrosis that was 
present throughout the thymus (data not shown). Flow cytometric analysis of 
thymocytes from mice that were irradiated with thymus shielding showed no 
difference in cell size, and in the density distribution of Thy-1, H-2K and Ly-2 
antigens when compared to normal thymocytes (data not shown). These results 
indicated that thymus shielding with a circular field of 12 mm in diameter was 
partially protective. It caused a 35 to 65 % reduction in the number of 
thymocytes but there appeared to be no selective advantage for any of the 
thymocyte subpopulations. With the use of a larger shield (3.5 em x 3.0 em, 10 
em high) and irradiation of normal mice with 5 Gy, no decrease in the number of 
thymocytes was observed. (Fig. 7.3). This indicate that some radiation was 
delivered under the circular shield (.0'=12 mm). 
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The fraction of the delivered dose under the shielded area C«= 12mm) was 
measured and found to be about 10 % (see Chapter 2). Thus, 0.5 Gy was delivered 
under the shielded area. The sensitivity of prothymocytes to in vivo gamma 
irradiation has been determined previously (Do=0.85 Gy; Boersma, 1982). From 
his data it can be calculated that after an exposure to 0.5 Gy, 50 % of the 
precursor cells should be viable according to in the thymus repopulation assay. 
The sensitivity of the thymus repopulation assay was determined by Boersma 
(1982). He calculated that a two fold difference in the number of thymocyte 
precursors in a BM transplant caused a significant delay of 1 day in thymus 
repopulation kinetics. Therefore, the results of the thymus shielding 
experiments have to be corrected for the death of 50 % of the prothymocytes or 
in terms of thymus repopulation corrected for a 1 day delay. Although the 
correction could have been circumvented with the use of a larger shield, it was 
considered better to use the smallest possible shielding area, because this 
allows for more complete elimination of prothymocytes in the extrathymic sites. 
Thymus repopulation after lethal irradiation,. bone marrow transplantation and a 
second irradiation on the thymic area only 
Reirradiation of the thymus after lethal irradiation and BMT has the 
advantage that it does not affect the bone marrow and the spleen. It should 
kill the thymocyte precursors that are present in the thymus which results in a 
delayed thymus repopulation. Fig. 7A shows the means of three experiments in 
which lethally irradiated and BM transplanted mice were reirradiated on the 
thymus 1 hour before BMT or 1 h or 1, 2, 3 or 4 days after BMT. The mice that 
were reirradiated on the thymus at 1 h and 1 d after BMT contained similar 
numbers of donor thymocytes at all times post BMT as the control mice (not 
reirradiated mice and mice reirradiated 1 h before BMT). The observation that 
reirradiation at these times does not affect thymus repopulation indicates that 
thymus precursor cells are absent from the thymus until 1 day post BMT. The 
number of donor thymocytes at 14 to 19 days post BMT in the mice reirradiated on 
the thymus 2 to 4 days after BMT was significantly lower than control values 
(day 14: p<O.OI; day 18: p<O.OI; day 19: p<O.OS). This indicates that 
significant numbers of thymocytes start to enter the thymus from the second day 
after BMT onwards. 
The results of one experiment are shown in detail in Table 7.1. The table 
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Fig. 7.4 Thymus repopulation by mice reirradiated on the thymus. Lethally 
irradiated and BM transplanted mice were reirradiated on the thymus 1 h before 
BMT (o), or 1 h (.6.), 1 d (o), 2 d (•), 3d (A) and 4 d (•) after sm.-
represents thymus repopulation after total body irradiation at day 4. Thymus 
repopulation was determined as described in Chapter 2.. The mean results of 3 
experiments are shown. The Wilcoxon-Mann-Whitney test was used to disprove the 
zero-hypothesis that the data at day 14 to 19 of the groups reirradiated at 2, 3 
and 4 days after BMT have the same frequency distribution as the control values: 
day 14 p 0.01; day 18: p 0.01; day 19: p 0 .. 05 .. The test showed that at these 
time points the groups reirradiated 2, 3, and 4 days after BMT differed 
significantly from non-reirradiated controls. The W-M-W test could not be 
applied to the results at day 21 for reirradiation at 4 days after BMT, because 
this value represented the mean of only two determinations. 
Thymus repopulation by mice that were lethally irradiated (Leth. irr.), 
transplanted with 106 BM cells and reirradiated on the thymus (Thymus irr.) 1 h 
before and 1 h, 1 d, 2 d, 3 d, 4 d and 7 d after BMT.. At the times indicated 
the recipients were killed and the number of donor derived thymocytes was 
determined as described in Chapter 2. The Wilcoxon-Mann-Whitney test was used 
for the analysis of a significant difference between the data at day 15 to 19 of 
the groups of mice reirradiated at 2, 4 and 7 days after BMT and the ones that 
were reirradiated earlier or those that received no reirradiation. *: p 0.05; 
£:p 0 .. 01 .. 
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Table 7.1 
------
Thymus repopulation in lethally irradiated, bone marrow transplanted mice 
that were reirradiated on the thymus only 
Treatment Day of assay Number of donor % Number of donor 
after BMT and host cells Donor cell per thymus 
per thymus x1 D 6 cells x1o6 
--------------- -----------
------------- --------
-------------------
Leth. irr. (Oh) 15 32 0.32 
8MT (3h) 17 57.2 11 7.4 
19 43 65 28.0 
21 49 88 43.1 
24 71 96 68.2 
Leth. irr. {Oh) 15 1.54 10 0.15 
Thymus irr.(2h) 17 11.6 65 7.5 
BMT (3h) 19 21 .9 91 20.0 
21 41 .5 90 37.4 
24 63 97 61.1 
Leth. irr. (Oh) 15 5.6 5 0.28 
8MT (3h) 17 9.6 40 3.8 
Thymus irr.(4h) 19 22.2 91 20.2 
21 45 95 42.8 
24 48 98 47 
Leth. irr. (Oh) 15 1 .9 30 0.57 
8MT (3h) 17 10.9 52 5.7 
Thymus irr.(1d) 19 18.3 84 15.4 
21 34 92 31.3 
24 62 95 58.9 
Leth. irr .. (Oh) 15 0.25 10 0.025 £ 
8MT (3h) 17 8.8 18 1 .6 • 
Thymus irr. ( 2d) 19 9.9 81 8.0 • 
21 15.6 91 14.2 • 
24 33 96 31.7 
Leth. irr. (Oh) 15 0.36 4 0.014 £ 
8MT (3h) 17 3.6 0.036 * 
Thymus irr .. ( 4d) 19 2.3 18 0.41 • 
21 0.8 81 0.64 • 
24 3.0 93 2.8 
Leth. irr. (Oh) 15 0.44 5 0.022 £ 
8MT (3h) 17 5.5 0.055 * 
Thymus irr .. (7d) 19 17 .. 6 73 12.8 • 
21 26.2 85 22.3 
24 54.6 97 53 
---------------------------------------
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Fig. 7.5 Thymus repopulation in mice transplanted 3 days (A), 2 days (B) or 
immediately after lethal irradiation (C) with 10 6 C3AK BM cells. The recipients 
were reirradiated on the fourth day with 5.0 Gy with (o) or without (•) thymus 
shielding or were not reirradiated (- ) • 
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lists part of the data incorporated in Fig. 7.4: a delay in thymus repopulation 
occured in the groups that were reirradiated on the thymus at days 2 and 4. 
However, reirradiation of the thymus at 7 days after BMT caused less delay in 
thymus generation as compared to that at 4 days after BMT. This may be related 
to the presence of larger numbers of intrathymic precursors cells at day 7 after 
BMT (see section on intrathymic precursor cells). 
Thymus repopulation after lethal irradiation, bone marrow transplantation and a 
second irradiation with or without thymus shielding 
The kinetics of thymus repopulation after lethal irradiation, grafting of 
106BM cells on day 1 and 5 Gy total body reirradiation on day 4 is shown in 
Fig. 7.5A. The first donor thymocytes can be detected between 25 and 30 days 
after BMT. This is more than 10 days later than in mice that were not 
reirradiated. Boersma et al (1981a) showed that a 10 day delay in thymus 
repopulation corresponds to an, at least 200 fold difference in the number of BM 
cells transplanted. This is in accordance with the results in Fig. 7.2 and 
indicates that very few thymocyte precursor cells are left in the body after the 
second irradiation. 
Lethally irradiated mice were transplanted after 1 h, 2 and 3 days with 10 6 
BM cells and reirradiated with or without thymus shielding on the fourth day. 
The mice that were reirradiated with the thymus shielded at one day after BMT 
showed no difference in thymus repopulation when compared to mice that were 
reirradiated without thymus shielding (Fig. 7.5A). The mice that were 
reirradiated with thymus shielding 2 and 4 days after BMT showed an enhanced 
thymus repopulation as compared to mice that were reirradiated without thymus 
shielding (Fig. 7.58 and C). These results are in accordance with those 
reported in the previous paragraph in showing that one day after BMT thymocyte 
precursor are absent from the thymus and that they are present at two and four 
days after BMT. 
Presence of thyffiocyte precursors in the bone marrow shortly after bone marrow 
transplantation 
The absence of migration of prothymocytes into the thymus during the first 
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Fig. 7.6 Thymus repopulation by BM cells which were obtained from lethally 
irradiated C3H mice transplanted with 30x106 C3AK 8M cells. At 24 (o) and 36 h 
(•) after BMT BM cells were collected from the femura and tibiae and injected 
into lethally irradiated C3H recipients. Thymus repopulation is expressed per 
day-12 CFU-5 transplanted and compared to that by NBM which is represented by 
the shaded area (see Fig. 5.18). 
day post BMT would suggest that prothymocytes, delivered with the BM graft, home 
elsewhere.. The most obvious site is the bone marrow. In order to test this 
hypothesis BM was obtained from lethally irradiated C3H mice at 24 and 36 hours 
after grafting of 3x!O 7 normal C3AK BM cells and tested for thymus repopulating 
ability. It was found (Fig. 7.6) that between 13 and 16 days post BMT there 
was a higher number of donor derived cells than after injection of NBM (compare 
with Fig. S.IB). These data are in agreement with the hypothesis that at 24 to 
36 hours after transplantation, the BM contains a relative abundance of 
prothymocytes. The decline in donor cells observed thereafter probably reflects 
the time required for the production of prothymocytes by pluripotent stem cells. 
Intrathymic thymocyte precursors 
It is well known from thymus regeneration studies that after lethal 
irradiation, the thymus first involutes, but that between 7 and 21 days many 
host derived thymocytes appear, reaching maximum values 13 to 15 days after 
irradiation. (Kadish and Basch, 1975; Boersma et al, 198la; Ceredig et al, 
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Fig. 7.7 Thymus repopulation in regenerating mice that received 5 Gy total body 
irradiation at various times after BMT. At 24 days after BMT the number of 
donor thymocytes was determined as described in Chapter 2. 
1982). The experiments in which the thymus was reirradiated showed that host 
thymus repopulation can be abolished by reirradiation of the thymus with a dose 
of 5 Gy (Table 7.1: the difference between the first and third columns}. From 
this observation it can be concluded that the host derived thymocytes stem from 
intrathymic precursor cells and that the precursor cells, which survived 9.0 Gy, 
were killed when an additional dose of 5 Gy was given to the thymus. 
In the experiments in which mice were reirradiated with thymus shielding, 
control groups received a total body reirradiation. Thymus repopulation was 
determined in these groups also. It was found that prolonging the interval 
between BMT and reirradiation to 10 days led to an increase in the number of 
donor cells at 24 days after BMT. A further increase of the interval between 
BMT and reirradiation led to a progressive decline in the thymus repopulation at 
day 24. This decline is due to the shorter interval between reirradiation and 
determination of thymus cellularity, which is insufficient for full repopulation 
(I 0 and 7 days respectively). 
The increase in the number of donor cells after reirradiation at 6 or 10 
days after BMT can be explained as follows: Reirradiation at any time after BMT 
kills the same fraction of PHSC in the bone marrow compartment. This cannot 
cause a difference in the number of thymocytes at 24 days or later. The 
result~ therefore7 indicate that the difference in thymus repopulation between 
the groups that were reirradiated at 2 or 10 days after BMT is caused by the 
development of another compartment of thymocyte precursors after the second day 
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Fig. 7.8 A. Thymus repopulation of lethally irradiated C3H mice injected with 
106 C3AK F1 BM (•) cells or 106 FUBM (x). Regression lines were calculated from 
the data points during the rapid growth phase. 95 % confidence limits for the 
regression lines are shown. The doubling times were 30.4 h (normal BM) and 18.4 
h (FUBM). B. Thymus repopulation of lethally irradiated mice injected with 106 
BM cells (----) • The doubling time changes from less than 18 h at the 
initiation of repopulation to 30 h around 16 days after BMT. The dotted line 
represents thymus repopulation after 5 Gy whole body reirradiation at day 10. * 
represent the measurements. The symbols with arrows represent values calculated 
from the number of thymocytes and the detection limit (1 %) of the flow 
cytometric assay. In these cases no donor thymocytes were observed. The 
difference between the two curves at day 10 corresponds with a 
Do=500/(ln(5/1000)/ln0.37)=0.94 Gy. 
after BMT. These precursor cells are different from the PHSC. Reirradiation of 
the thymus only at 7 days after BMT also caused less delay in thymus 
regeneration when compared to reirradiation of the thymus at day 4. (Table 7.1, 
last column). This indicates that the other compartment of thymocyte precursor 
cells is located in the thymus. 
There are few data on the development of donor precursor cells in the 
thymus. In the previous Chapter it was shown that the number of BM cells in the 
thymus at 3 h after BMT is not related to thymus repopulation kinetics and the 
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reirradiation experiments, described in this Chapter show that thymus 
repopulation starts from the second day onwards. Furthermore, repopulation of 
the thymus by donor cells is usually measured when more than 106 donor (Thy-1.1 
positive) cells are present in the thymus. At this time it can be expected that 
the measured growth rate of the total thymocyte population is less than at the 
initiation of the repopulation. The decreasing growth rate with time is 
probably due to a progressive increase in cell loss, i.e. death of cortical 
thymocytes (see also Fig. 5.3). Log-linear regression analysis of data 
obtained after transplantation of normal BM cells, therefore, describes thymus 
repopulation erronously during the first two weeks after BMT {Fig. 7.8A). The 
doubling time of intrathymic thymocyte precursor cells during the first two 
weeks after BMT must be less than measured during the third week for the total 
donor thymocyte population {30 hours). 
Thymus repopulation after injection of FUBM or purified stem cells is faster 
than after injection of normal BM cells (Figs. 5.10 and Fig. 7.8A). Thymus 
repopulation by the first two cell populations stems from pluripotent stem cells 
but not from prothymocytes. Since there is a difference in the growth rate 
between thymocytes derived from prothymocytes and those derived from PHSC (Fig. 
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5.3), as measured between 16 and 21 days, it is assumed that the doubling time 
of the thymocyte population after injection of FUBM (18 hours) reflects the 
initial doubling time of the intrathymic precursor population more closely. 
In Fig. 7.8B thymus repopulation by donor cells is presented with a 
doubling time of 30 hours when more than 10 6 donor cells are present in the 
thymus. In the early repopulation phas~ the assumed shorter doubling time of 
18 hours is depicted. With this repopulation kinetics the higher number of 
donor thymocytes after whole body reirradiation at day 10 as compared to that at 
day 2 (Fig. 7. 7) can be explained: At day 2 there are few precursor cells in 
the thymus. Reirradiation results in the death of virtually all cells. After 
reirradiation at day 10, however, a substantial number survive which results in 
a higher number of thymocytes at day 24. This is represented by the dotted 
line. From the difference between the two curves a Do of the precursor cell 
population can be calculated: 0.94 Gy (see legend Fig. 7.8B). 
The host intrathymic precursor cells have been reported to be radioresistant 
(Kadish and Bascb, 1975; Sato and Sakka, 1969; Sharp and Watkins, 1981). The 
high Do values calculated by these authors were obtained either by measuring the 
surviving fraction of nucleated cells, which could have been cells other than 
thymocytes or their precursors, or by determination of the repopulation of the 
thymus. When the latter method is used one has to know the doubling time of the 
precursor cell population during the irradiation. However, this cannot be 
determined accurately at the present time and therefore the doubling time of the 
total thymocyte population was used to estimate the Do value of the thymocyte 
precursor cell. The same argument used above applies to host thymocyte 
regeneration; The doubling time of the total thymocyte population is probably 
longer than that of the precursor cell population. When it is assumed that a 
doubling time of 18 hours corresponds with that of the precursor cells, the 
following Do can be calculated. After lethal irradiation there are 31(±4)x10 6 
thymocytes at day 15. Lethal irradiation immediately followed by irradiation of 
the thymus with 5 Gy results in only 8.l(±8)xl05 thymocytes at 15 days. With a 
doubling time of 30 h the Do of the thymocyte precursor is 137 rad and with a 
doubling time of 18 h the Do is 90 rad. These calculations argue against the 
presence of radioresistant precursor cells in the thymus. 
Discussion 
The experiments presented in this Chapter can be summarized as follows: 
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Thymus shielding with a leaden pole of 12 mm diameter was partially protective 
(Fig. 7.3). It was calculated that about SO % of the thymocyte precursor cells 
located in the thymus survived reirradiation with thymus shielding. 
Reirradiation of the thymus at 1 hour and 1 day after BMT did not change the 
kinetics of thymus repopulation, while reirradiation at 2 to 4 days caused a 
delay in thymus repopulation (Fig. 7.4; Table 7.1). It was concluded that 
thymocyte precursor cells begin to enter the thymus on the second day post BMT .. 
The experiments in which the mice were reirradiated with thymus shielding 
confirmed this conclusion: reirradiation with thymus shielding at 1 day after 
BMT did not show an enhanced thymus repopulation when compared to that after 
reirradiation without thymus shielding (Fig. SA). However, reirradiation with 
thymus shielding at a later time after BMT did show an earlier onset of thymus 
repopulation, indicating that thymocyte precursor cells were entering the thymus 
by that time. These results show that all thymocytes are derived from precursor 
cells that do not home directly to the thymus, in contrast to the direct homing 
of BM cells to the thymus as suggested by the experiments of Lepault and 
Weissman (1981). 
The period of 8-12 days between BMT and the appearance of the first donor 
derived thymocytes represents both the time necessary for migration and the time 
needed for differentiation and proliferation. Since prothymocytes begin to 
enter the thymus on the second day post grafting (Fig. 7.4), 2 days is probably 
the minimum time necessary for migration into the thymus. This leaves 6 to 10 
days for differentiation and proliferation before significant numbers of donor 
cell can be detected.. In a recent publication it was shown that after 
intrathymic (i.t .. ) injection of !OSBM cells it took 14 days before donor 
derived cells could be detected (Goldschneider et al, 1986). Dose-response 
curves (the number of donor thymocytes at 17 days after grafting versus the 
number of BM cells injected; Goldschneider et al, 1986) indicated that after 
i.t. injection of saturating numbers of BM cells, significant numbers of donor 
thymocytes may be detected as soon as 8 days after i.t. injection.. This is 
within the range estimated from the data obtained after intravenous BMT.. It has 
been suggested that the proliferation of host-derived thymocyte precursors may 
inhibit the proliferetion of the donor cells until the wave of host cells is 
completed (Greiner et al, 1984). The reirradiation experiments exclude this 
possibility because reirradiation Virtually abolishes host repopulation, while 
donor thymus repopulation is unaffected (Fig. 7.4 and Table 7.1). These 
results indicate that the 6 to 10 days between the immigration of prothymocytes 
123 
and the detection of thymocytes is only required for differentiation and 
proliferation of the precursor cells. 
In the experiments in which BM cells obtained from mice 24 to 36 hours after 
lethal irradiation and BMT were retransplanted into lethally irradiated 
recipients, a biphasic thymus repopulation was observed: Between 13 and 16 days 
there were more donor thymocytes as compared to injection of normal BM cells. 
This was followed by a decline after which the rapid growth phase started. 
These results suggest that the BM soon after BMT contains many prothymocytes as 
compared to the day-12 CFU-S. The dip in the thymus repopulation curve 
indicates that during the early repopulation phase there occurs already a 
considerable loss of thymocytes. This strengthens the notion that the doubling 
time of the precursor population must be less than that of the total population. 
The dip also indicates that it takes several days before host type prothymocytes 
are produced from PHSC in the bone marrow. 
Intrathymic thymocyte precursor cells, the progeny of prothymocytes in the 
thymus, were found to produce very few thymocytes after irradiation with 14 Gy. 
Sine~ it is quite likely that the doubling time of these precursor cells, early 
after irradiation and BMT, is higher than that of the total thymocyte population 
it could be calculated that they have a Do which is close to or somewhat less 
than 0.9 Gy. The CFU-S (Do=1.01 Gy), prothymocyte (Do=0.85)(Boersma, 1982) and 
most peripheral lymphocytes (Do=O.S0-1.20 Gy; Sharp and Watkins, 1981) have a 
similar radiosensitivity. This indicates that the intrathymic precursor cells 
are not radioresistant precursor cells in contrast to previous reports by others 
(Sato and Sakka, 1969; Kadish and Basch, 1975; Sharp and Watkins, 1981; Boersma, 
1982; Ceredig and MacDonald, 1982; Sharrow et a!, 1983). 
The donor derived thymocyte precursor cells in the thymus could be detected 
to be present in relatively large numbers at day 10 after BMT. In the results 
section it was calculated that these cells have a Do which is at most 0.94 Gy. 
The repopulation kinetics (the precursor cells give rise to maximal numbers of 
thymocytes 14-16 days later) and the Do values (host type cells: 0.9 Gy; donor 
type cells: 0.94 Gy) suggest that the two cell types are similar. 
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Conclusions 
1. The first prothymocytes enter the thymus on the second day after BMT and 
continue to do so at the third and fourth day. 
2. The precursor cells of host thymocytes are present in the thymus, but 
they are not radioresistant cells. Their Do is calculated as approximately 
0.9 Gy. 
3. Donor derived intrathymic thymocyte precursor cells are present in 
relatively large numbers at 10 days after BMT as indicated by the survival 
of significant numbers after irradiation with 5 Gy. They have a calculated 
Do of 0.94 Gy. 
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Chapter 8 
GENERAL DISCUSSION 
Organization of hemopoietic stem cells 
The day-12 CFU-S 
The day-12 CFU-S, the hemopoietic stem cell that produces spleen colonies 
around day 12 after lethal irradiation, was found to coenrich with cells capable 
of protecting mice from hemopoietic death following lethal irradiation (Visser 
et al, 1984). This suggests that the day-12 CFU-S in the enriched cell 
suspension are pluripotent hemopoietic stem cells. However, not all cell 
populations, containing day-12 CFU-S, protected lethally irradiated mice to the 
same extent. For instance, strongly Rhl23 labeled BM cells protected lethally 
irradiated mice less than weakly labeled Rh123 BM cells, expressed day-12 
CFU-S (Fig. 4.5). This indicates either that a subpopulation of day-12 CFU-S 
(weakly Rhl23+) is the cell responsible for radioprotection or that the 
radioprotective cells are different from the day-12 CFU-S, but coenrich with 
these cells in many purification procedures. Strong evidence for the notion of 
qualitative differences between the two BM fractions obtained after separation 
on Rh 123 fluorescence comes from Bertoncello et al. (1985). They showed that 
the weakly Rh123 labeled fraction contained 38 % of the day-13 CFU-S, but also 
92 % of the precursor cells that can give rise to CFU-C2 at 13 days after BMT 
(a measure of marrow repopulating ability) and 77 % of the platelet precursors 
(platelet repopulating ability). In contrast, the brightly Rhl23 labeled cells 
contained 62 % of the day-13 CFU-S, but only 8 % marrow repopulating ability 
and only 23 % platelet repopulating ability. These results are in agreement 
with those presented in this thesis, which indicate that the hemopoietic stem 
cells in the fraction weakly labeled with Rh123 are qualitatively different from 
those that incorporate more Rh123. 
The uptake of Rh123 is higher in cycling than in non-cycling cells (Cohen et 
al, 1981; Darzynkiewicz et al, 1981; James and Bohman, 1981). Rh123 is a 
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supravital dye which accumulates exclusively in mitochondria. Therefore it can 
be concluded that the number of mitochondria per cell type increases during the 
cell cycle. Day-7-9 CFU-s from NBM are all contained within the fraction 
brightly labeled with Rhl23, but only 10 % of these cells are cycling (Visser et 
al, 1977; Johnson and Nicola, 1984; Chertkov and Drize, 1984). The high uptake 
of Rh!23 by day-8 CFU-S as compared to the other BM cells must therefore be 
caused by other factors than an active cell cycle. It has been reported that 
putative hemopoietic stem cells have a low content of mitochondria (van Bekkum 
et al, 1971). This suggests that the number of mitochondria as well as the 
Rh123 uptake increases with the differentiation of hemopoietic stem cells. 
Culture of BM cells in the presence of SAF (IL-3), which causes stem cell 
proliferation, resulted in a diminished capacity, per day-12 CFU-s, to protect 
mice from the development of bone marrow failure (Fig. 3.4B). Microscopical 
examination of the day-12 spleen colonies from SAFBM revealed that one third of 
the spleen colonies were desintegrating colonies which contained many (mature) 
erythroid cells. NBM produced only few of these desintegrating spleen colonies 
(Table 3.2). These observations indicate that the day-12 CFU-S of SAFBM 
produces higher numbers of differentiated stem cells as compared to the day-12 
CFU-s of NBM and that therefore the day-12 CFU-S of SAFBM and NBM are 
different stem cells. As to the nature of the more differentiated stem cells 
produced in SAFBM, it is likely that they belong to the population of erythroid 
burst- forming units (BFU-E). 
An important conclusion from these experiments is that the number of day-12 
CFU-S in a BM graft, which has been subject to separation procedures or in vitro 
culture, is not representative for the capacity to protect lethally irradiated 
mice. This indicates that either day-12 CFU-S are a heterogenous population or 
that there is yet another, more immature cell, the pre-CFU-S that is responsible 
for survival after lethal irradiation. In other studies a discrepancy between 
the number of day-12 CFU-S injected and the number of progenitor cells derived 
from the graft was also observed: day-! FUBM, per day-12 CFU-S injected, gave 
rise to at least 5 times more day-12 CFU-S in the spleens and 10 times more 
day-10 CFU-S in the femur when compared to NBM (Hodgson and Bradley, 1979). 
A similar difference between the number of injected day-12 CFU-S from FUBM 
and NBM was observed for the number of megakaryocytes in the spleen (Jones et 
a!, 1980). These results led Hodgson and Bradley (1979) to propose that there 
exists a pre-CFU-S in the BM whose offspring can produce day-12 and day-8 
CFU-S. An in Vitro colony was described, the HPP-CFC (high proliferative 
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Table 8.1 
Characteristics of day-12 CFU-S, day-8 CFU-S and prothymocytes 
Characteristic Day-12 CFU-S Day-8 CFU-S Prothymocyte 
--------------------------- ------------
-----------
-----------
1. Presence in NBM ++ ++ ++ 
2. Presence in FUBM + 
3. Presence in SAFBM + +++ 
4. Presence in early RBM + + ++ 
5. Presence in day-7 RBM + + 
6. Presence in long-term BM N.D. + 
cultures 
7. Presence in spleen + + 
8. Presence in fetal liver + + ± 
9. Sensitivity to in vitro 1 .20 1 .01 0.85 
gamma irradiation (Do) 
10.Density of H-2K antigens ++ + + 
11.Density of Thy-1 antigens + +I- + 
12.Uptake of Rhodamine 123 +-- ++ ++ ++ 
Derived from 1.: Fig. 5.1, Table 3.1; 2: Fig. 5.7 and 5.8, Table 5.2; 3: Fig. 
3.5 and 3.6, Table 3.2; 4: Fig. 7.6; 5-8: Boersma, 1982; 9: Boersma, 1982, 
Visser, personal communication; 10: Figs. 4.1, 5.1-5.4, Tables 4.1 and 5.1; 11: 
Figs. 4.2 and 4.3, Table 4.3; 12: Figs. 4.4 and 5.6, Table 4.4. Early RBM is 
regenerating BM from mice injected 1 to 2 days previously with 20 to 30x106 BM 
cells. 
potential-colony forming cells), whose presence in a BM graft corresponded more 
closely with the ability of a BM graft to generate progenitor cells in the femur 
of a recipient mouse at 13 days post-BMT (marrow repopulating ability) (Bradley 
et a!, 1980) than the number of CFU..S in that graft. The HPP-CFC can 
be stimulated by growth factors derived from human placenta conditioned medium 
(HPCM) and pregnant mouse uterus extract (PMUE=M-CSF) and is resistant to 
the cytotoxic action of 5-FU (Bradley et a!, 1980; Baines et a!, 1981). Other 
studies indicate that the growth factor present in HPCM is probably identical to 
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Fig. 8.1 A. Relationship of early hemopoietic stem cells. 8. Relative content 
of hemopoietic stem cells in the BM cell suspensions used in this study. 
a stimulator derived from a human bladder carcinoma line, called hemopoietin-I 
(Bartelmez and Stanley, 1985). This factor was shown to act on a more primitive 
cell than the one stimulated by IL-3 (SAF)(Bartelmez and Stanley, 1985; 
Bartelmez et al, 1985)-
Fig. 8.1 depicts one of the likely relationships of the pre-CFU-S, the 
day-12 CFU-S and the day-8 CFU-S. The relative number of these stem cells in 
NBM, FUBM and SAFBM and in BM cells fractionated on their Rhl23 content is 
also shown. FUBM is relatively enriched in the pre-CFU-S and contains less 
mature hemopoietic stem cells as compared to NBM. SAFBM, on the other han~ 
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Fig. 8.2 Relationship of early hemopoietic stem cells based on the results of 
this study. Responsiveness to hemopoietin-1 is derived from Bartelmez et al, 
1985. 
contains less pre-CFU-S and is enriched in day-8 CFU-S. Rh!23+ BM cells 
resemble FUBM and the composition of Rhl23++ BM cells is similar to that of 
SAFBM in that the cells have a lower proportion of pre-CFU-S. The lower 
radioprotective capacity of SAFBM and Rhl23++ BM must be due to the relative 
absence of the pre-CFU-S. The higher marrow repopulating capacity of FUBM is 
ascribed to a relative excess of pre-CFU-S as compared to NBM. This model is 
also consistent with the observation that after serial transplantation of BM 
cells, there is a decrease in the radioprotective capacity per cru ... s 
transplanted (Ross et al, 1982). Preliminary experiments from our laboratory 
also indicate that larger numbers of day-12 CFU-S obtained from mice after the 
second retransplantation are required for long-term survival when compared to 
NBM (Mulder and Platenburg, unpublished results). 
As stated above bone marrow cells purified by density separation and light 
activating cell sorting for a high binding of WGA-FITC and anti-H-2K are 
enriched for both day-12 CFU-S (130±30 fold) and radioprotective capacity 
(180±70 fo!d)(Visser et a!, 1984). Electron microscopy identified two, slightly 
different, cell types in the purified cell population (Visser et a!, !984). The 
presence of the day-12 CFU-S and a radioprotective cell as two separate 
morphological entities in the purified cell fraction is therefore possible. 
Since day-12 CFU-S and the PHSC must be closely related, it is likely that these 
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cells copurify in many separation procedures. With the use of Rh123 it may be 
possible to obtain separation between day-12 CFU-S and the PHSC in the purified 
stem cell suspension and to correlate these cells with one of the two 
morphological cell types. These experiments are in progress. 
Day-8 and day-12 CFU-$ 
Day-8 and day-12 CFU-8 have been reported to differ in the density of 
membrane bound Qa-2 antigenic determinants (Harris et al, 1984) and in the 
uptake of the supravital DNA dye Hoechst 33342 (Baines and Visser, 1983). 
Day-12 CFU-S bind more anti-Qa-2 and incorporate less Hoecbst 33342 than do 
day-8 CFU-S. Other differences that are described in this thesis can be 
summarized as follows (see also Table 8.1): Day-12 CFU-8 contain many class 
H-2 molecules (Fig. 4.1) and are weakly positive for the Thy-! antigen (Fig. 
4.2). As mentioned above the Rhl23 uptake by day-12 CFU-S is heterogenous 
(Fig. 4.4). Day-8 CFU-8, in contrast, contain less H-2K molecules on their cell 
membrane and part of the day-8 CFU-$ are Thy-! negative. Day-8 CFU-S take up 
relatively high amounts of Rhl23 in their mitochondria. These results show that 
day-8 and day-12 CFU-S belong to distinct cell populations 
Functional differences between cell populations differing in the content of 
day-8 and day-12 CFU-8 were describe<i The experiments in which BM cells were 
separated on the uptake of Rhl23 showed that radioprotection was predominantly 
present in the weakly labeled fraction.. This fraction contained only day-12 
CFU-S (Table 4.4 and Fig. 4.5). The day-8 CFU-S are therefore not important 
for radioprotection after lethal irradiation.. Similarly, culturing of BM cells 
in the presence of SAF(=IL-3) (SAFBM) caused a 3-fold increase in the number of 
day-8 CFU-S and a maintenance of the number of day-12 CFU-S (Table 3.2). 
Despite its ability to produce day-8 CFU-8, SAFBM showed a diminished 
radioprotective capacity when compared to fresh BM (Figs.. 3.2-3.4}. In another 
functional assay: thymus repopulation, SAFBM, containing large numbers of day-8 
CFU-S, was less .effective than day-12 CFU-S from NBM or FUBM (Figs. 3.5, 3.6, 
5.4, 5. 7 and 5.9). These results show that day-8 CFU-S have less properties 
ascribed to pluripotent hemopoietic stem cells than the day-12 CFU-S and 
suggests that the day-8 CFU-S is a more differentiated stem cell. 
The most plausible relationship between day-8 and day-12 CFU-S is, that 
day-12 CFU-S produce day-8 CFU-S. Indirect results in support of this notion 
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Fig. 8.3 Model describing the relationship between the pre-CFU-5, the day-12 
CFU-5, the day-8 CFU-5 and the prothymocyte. 
was obtained with BM from mice, injected with 5-FU. Day-8 CFU-S are more 
sensitive to 5-FU than the day-12 CFU..S. The day-12/day-8 CFU..S ratio is 24 
one day after 5-FU injection as compared to 1 in NBM (van Zant, 1984). After 
treatment of mice with 5-FU, day-12 CFU-S recovered before the day-8 CFU-S in 
vivo (Fig. 4.7). A similar pattern of both proliferation and loss of day-12 
and day-S CFU-S has been obtained in SAF containing cultures of BM cells of 5-FU 
treated .mice. The day-12 CFU-S kinetics was always a few days ahead of that of 
the day-8 CFU-S. 
From these results it is concluded that day-8 CFU-S are not pluripotent 
hemopoietic stem cells and may suggest that day-12 CFU-S produce day-8 CFU-S 
(Fig. 8.2). The differentiation from day-12 CFU-S to day-8 CFU-S is associated 
with a loss of H-2K determinants and possibly with a loss of Thy-1 antigens. 
Prothymocytes 
Prothymocytes, the committed precursor cells of thymocytes show several 
similarities with day-8 and day-12 CFU-S, but are clearly different from them. 
This is summarized in Table 8.1. Day-12 CFU-S and day-8 CFU-S were present in 
most hemopoietic cell suspensions, although the ratio of the two CFU-S varied 
widely (see also Table 5.3). Prothymocytes, whose presence was measured by the 
ability to induce early thymus regeneration were absent from several of these 
cell suspensions, like day-1-4 FUBM, SAFBM, day-7 RBM, and spleen (Boersma, 
1982; Boersma, 1983b; Table 8.1). In regenerating BM early after BMT (I day), 
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there is a relative excess of prothymocytes when compared to the day-12 CFU-S 
(Fig. 7.6). These results indicate that prothymocytes, day-8 and day-12 CFU-S 
are present in different proportions in the various cell populations. 
Day-8 CFU-S and prothymocytes had a similar density of class I H-2 antigens 
and showed a similar uptake of Rh!23 (Figs. 4.1, 4.4, 5.3 and 5.6). Thymus 
repopulation capacity, however, was confined to Thy-1.1 positive cells (data not 
shown; Basch and Berman, 1982), while about 40% of the day-8 CFU-S were negative 
for Thy-!.! (Fig. 4.2). SAFBM, enriched in day-8 CFU-S (Table 3.1) is 
severely depleted in thymus repopulating capacity (Fig. 3.5 and 3.6}. From 
these data it is concluded that the day-8 CFU-S and the prothymocyte are 
different cell types and that day-8 CFU-S do not differentiate into 
prothymocytes. 
Day-12 CFU-5 and prothymocytes differed in the density of class I H-2 
antigens (Figs. 4.1, 5.2-5.4). Only a fraction of the day-12 CFU-S, but all 
prothymocytes incorporated relatively much Rhl23 (Fig. 5.6). Day-12 CFU-5 and 
prothymocytes are, thus, different cells (see also Table 8.1). The question 
remains whether the day-12 CFU-S or the pre-CFU-5 (or both) are the precursors 
of prothymocytes. Two possible differentiation pathways are shown in fig. 
8.3. Since a separation between pre-CFU-S and day-12 CFU-5 (and an absence of 
prothymocytes) has not yet been obtained, it is not yet possible to discriminate 
between these options (Fig. 8.3). 
The entry of the prothymocyte into the thymus 
Prothymocytes travel from the BM to the thymus by an unknown mechanism .. 
For instance, it is not known whether the prothymocytes receive a stimulus 
before their exit from the BM. Experiments in which the thymus could receive 
precursor cells from two different sources of BM cells (e.g. after parabiosis 
or in mixed BM chimeras) showed that there was a high variability in the ratio 
of descendents from the two BM sources with time and also between the two 
thymus lobes (Harris et al, 1964; Wallis et al, 1975; Ezine et al, 1984). From 
these studies it was concluded that few prothymocytes enter the thymus during 
steady state conditions. Another, equally likely, explanation for the high 
variability in the ratio of descendants is that the progeny of the precursor 
cells is transiently present in the thymus and that a few weeks later the thymus 
may contain thymocytes that are derived from other prothymocytes. This is 
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supported by the high turnover of thymocytes (Metcalf, 1966; Shortrnan and 
Jackson, 1974; McPhee et al, 1979; Scollay et al, 1980). Furthermore, the 
thymus (normal or 2 days regenerating) contains thymocyte precursor cells that 
can give rise to only a limited and transient progeny in the thymus (Boersma, 
1982). These experiments show that a continous inflow of precursor cells is 
necessary for the maintenance of thymus cellularity. In recent experiments the 
phenotype of the thymocyte population, responsible for the early and transient 
thymus repopulation was determined: low Ly-1 positive and Ly-2 and L3T4 negative 
(Mathieson and Fowlkes, 1984; Fowlkes et al, 1985). 
When do the prothymocytes enter the thymus after BMT? Homing experiments 
have shown that BM cells labeled with a supravital fluoresceing dye can be 
recovered from the thymus as early as three hours after lethal irradiation and 
BMT (Lepault and Weissman, 1981). The experiments described in Chapter 6 
(Figs. 6.2 and 6.3 and Table 6.1) are in agreement with this. However, several 
observations argue against the notion that these cells have anything to do with 
repopulation of the thymus. Firstly, most of the immigrant cells were smaller 
than the prothyrnocyte (Fig. 6.2). Secondly, a longer interval between lethal 
irradiation and BMT, which does not influence thymus repopulation kinetics (i.e. 
thymus repopulation starts at the same time after BMT; Boersma, 1982), caused a 
decrease in the number of BM cells that could be obtained at 3 h after BMT from 
the thymus {Table 6.1). Thirdly, extrapolation of the thymus repopulation data 
after injection of FUBM, indicated that 1 000-times less 
the thymus at the day of grafting than with NBM (Fig. 
precursor cells entered 
7.8), while in our direct 
homing experiments only 2-times fewer FUBM derived cells entered the thymus at 
3 h post-BMT. Therefore the definition of prothyrnocytes does not apply to the 
unidentified BM cells that enter the thymus immediately after grafting. At 
present it has to be assumed that entrance into the thymus is not an exclusive 
property of prothymocytes. 
The experiments in which regenerating mice were reirradiated on the thymus 
only (Fig. 7.4 and Table 7.1) or reirradiated with thymus shielding (Fig. 7.5) 
showed that prothymocytes are absent from the thymus until the second day after 
BMT. Two days after BMT the presence of prothymocytes in the thymus could be 
demonstrated with both reirradiation procedures. These results show that 
prothymocytes enter the thymus from the second day onwards and indicate that 
the prothymocyte first migrates to another site before transfer to the thymus. 
Evidence was presented that this primary homing site is the bone marrow: It was 
shown that soon after BMT (24-36 hours) prothymocytes can be recovered from 
135 
the BM. 
Intrathymic thymocyte precursor cells 
After their entry in the thymus, the prothymocyte differentiates and 
becomes part of the intrathymic pool of proliferating thymocyte precursor 
cells. Due to the production of host thymocytes after lethal irradiation, it 
has been argued that the thymus contains radioresistant thymocyte precursors 
(Kadish and Basch, 1975; Boersma et a!, 1981a; Ceredig and MacDonald, 1982; 
Sharrow et al, 1983). However, reirradiation (5 Gy) of the thymus 2 h after a 
TBI (9 Gy) Gy, results in a strong reduction in the number of host derived 
thymocytes (Table 7.1). Assuming that the precursor cells have a shorter 
doubling time early after irradiation than the total thymocyte population 12 
to 15 days later it could be calculated that these precursor cells are not 
radioresistant and have a Do of approximately 0.9 Gy. 
6 to 10 days after BMT relatively large numbers of these intrathymic 
progenitor cells must already be present in the thymus. Their presence was 
observed by a dimished delay in thymus regeneration when the thymus is 
reirradiated at or later than 6 days after BMT (Table 7.1 and Fig 7.7). 
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SUMMARY 
The presence of hemopoietic stem cells in cell suspensions can be 
determined by a variety of in vivo or in vitro techniques. The spleen colony 
assay, the 30 day survival and the thymus repopulation assay are in vivo 
assays. In addition, there are a multitude of in vitro tests, using different 
hemopoietic growth factors (or combinations of growth factors). The 
difficulty with these rests is that it is largely unknown to which extent they 
measure similar cell types. This makes it impossible to determine the 
differentiation pathways of the various lineages exactly and to define where a 
lineage deviates from the others. In order to obtain a clearer insight in the 
organization of hemopoietic stem cells a variety of BM cell suspensions or 
fractions thereof were applied to the three in vivo assays. From the results 
it could be estimated to which extent different stem cells were measured in 
these assays and what the differences between the stem cells were. These 
experiment are described in Chapter 3, 4 and 5. 
The spleen colony assay measures a proportion of the stem cells (colony 
forming unit-spleen; CFU-S) injected into lethally irradiated mice as discrete 
nodules which consist of hemopoietic cells from several lineages. They appear 
on the surface of the spleen between 6 and 14 days after BMT (colonies counted 
at 8 days after BMT are derived from day-8 CFU-S and those present at twelve 
days from day-12 CFU-S, etc.). The CFU-S assay has long been regarded as an 
assay of pluripotent hemopoietic stem cells (PHSC, the least mature 
hemopoietic stem cell). However, it was found that CFU-S are a heterogenous 
cell population and that day-S and day-12 CFU-s are different cells. Cell 
populations enriched in day-8 CFU-S can be obtained by culture of BM cells in 
the presence of stem cell activating factor (SAF, which is identical to IL-3) 
(Chapter 3). The day-S CFU-S in these cultures could be produced by self 
renewal of day-8 CFU-S or by differentiation from less mature cells. In order 
to test the hypothesis that day-12 CFU-S give rise to day-8 CFU-S, experiments 
were performed with BM cells obtained from mice treated with 5-fluorouracil 
(5-FU; FUBM). 5-FU kills predominantly cycling cells. Shortly after 5-FU 
injection very few day-8 CFU-S survived as compared to the day-12 CFU-S. The 
kinetics of regeneration of day-12 CFU-S was several days ahead of that of the 
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day-8 CFU-S. This suggests that the day-12 CFU-S is an earlier cell type than 
the day-8 CFU-S. A similar pattern of proliferation of day-12 and day-8 CFU-S 
has been obtained in SAF containing cultures of FUBM. The generation of 
day-12 CFU-S was always a few days ahead of that of the day-S CFU-S. These 
results suggest that the day-12 CFU-S is one of the targets of SAF and that 
stimulation with SAF leads to differentation of day-12 CFU-S into day-8 
CFU-S (Chapter 4). 
Several BM suspensions or fractions thereof where tested for the ability to 
protect lethally irradiated mice for 30 days. It was found that after culture 
of BM cells with SAF there is a loss of protective capacity, despite the 
production of day-8 CFU-S. Day-8 CFU-S, therefore, do not represent pluripotent 
hemopoietic stem cells (Chapter 3). A completely different technique allowed 
the separation of day-12 CFU-S from normal BM cells containing day-8 CFU-S and 
a fraction of the day-12 CFU-S: BM cells were labeled with rhodamine 123 
(Rh123), a fluoresceing dye which accumulates exclusively in mitochondria of 
living cells. The cells were subsequently separated on fluorescence intensity 
with a cell sorter. Two third of the day-12 CFU-S and all day-8 CFU-S were 
brightly labeled with Rh123, while one third of the day-12 CFU-S was recovered 
from the weakly labeled fraction. Radioprotection, expressed per day-12 CFU-s 
transplanted was predominantly mediated by the weakly labeled fraction. The 
diminished protective capacity of the brightly fluoresceing fraction, containing 
the day-8 CFU-S, agrees with the loss of protective capacity by SAFBM. The 
difference in 30 day survival per transplanted day-12 CFU-S also shows that the 
day-12 CFU-S present in the weakly labeled fraction differ from those in the 
brightly labeled fraction or that another earlier stem cell, the pre-CFU-S, is 
also present in this fraction (Chapter 4). 
Thymus repopulation after lethal irradiation and BMT was found to be caused 
by, at least two cell types: a progenitor cell committed to the T lineage (the 
prothymocyte) and the pluripotent hemopoietic stem cell. Prothymocytes cause 
transient thymus repopulation between 15 and 21 days after BMT. PHSC show 
thymus repopulation which is 3 to 4 days delayed (Chapter 5). Prothymocytes 
differ from the day-12 CFU-S in the expression of class I H-2 antigens, from the 
cell responsible for radioprotection in the ability to incorporate Rh123 
(Chapter 5) and from the day-8 CFU-S in the expression of Thy-1 antigens 
(Chapter 4). In addition, BM cells cultured with SAF, which contain large 
numbers of day-8 CFU-S, show a profound loss of thymus repopulating ability. 
These results indicate that prothymocytes do not derive from day-8 CFU-5. This 
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is in agreement with the very low radioprotective capacity of day-8 CFU-S. The 
prothymocyte, therefore, 
the pre-CfU-S (see fig. 
stems from either the day-12 CFU-S or its predecessor, 
8.5). 
The experiments described in Chapters 3-5 show that infrequent cells like 
hemopoietic stern cells can be dissected into subpopulations with the aid of 
fluorescence activated cell sorting, monoclonal antibodies and fluorescent dyes. 
The relationship between these cells could subsequently be studied with the use 
of in vivo assays. Further studies at the single cells and molecular level 
should reveal the processes that govern these differentiation processes. 
Comparison of these events with those in malignant cells should enhance our 
understanding of neoplasms and may give us a clue to their treatment. 
Bone marrow cells injected into lethaUy irradiated recipients seed into 
many organs. It has been claimed by others that the BM cells that appear at 3 h 
after BMT in the thymus represent prothymocytes. In Chapter 6 it is shown that 
this is not the case. Using fluoresceing cell suspensions of different 
composition, it appeared that the number of thymus immigrants at 3 h after BMT 
related more closely to the total number of cells injected than with the ability 
to repopulate the thymus. Moreover, the thymic immigrants were smaller than the 
prothyrnocytes in the BM. This was determined by analysis of the laser light 
scatter of prothyrnocytes and thymus immigrants. Therefore, the assay which 
determines the number of cells that appear in the thymus shortly after BMT 
cannot be used for quantification of thymocyte progenitor cells. 
In Chapter 7 a series of experiments is reported which elucidated the exact 
time of entry of prothymocytes into the thymus following grafting of BM cells. 
For this purpose the recipient mice were reirradiated at various intervals after 
BM transplantation on the whole body, with or without thymus shielding or 
reirradiated on the thymus only. Thymus repopulation was used as a functional 
assay for the prothymocyte. All reirradiation designs resulted in the same 
conclusion, i.e. that during the first 24 hours there is no entry of 
prothymocytes in the thymus. For instance, reirradiation of the thymus at 1 day 
after BMT did not affect thymus regeneration, but reirradiation at later times 
(until 4 days post BMT), caused a delay in thymus repopulation. The later the 
reirradiation the more delay in thymus repopulation. From these results it was 
concluded that prothymocytes enter the thymus from the second day post grafting 
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onwards. 
A wave of host thymocytes is present in mice during the second and third 
week after lethal irradiation and BMT. Reirradiation of the thymus in 
regenerating mice abolished this host repopulation, indicating that the 
precursor cells of host thymocytes are located in the thymus, but that they are 
not radioresistant cells as was reported previously by several authors. It was 
calculated that the radiosensitivity of the host intrathymic thymocyte precursor 
cells was similar to that of the CFU-S (Chapter 7). 
The reirradiation experiments indicated that after the first week post-BMT 
the donor BM also had produced significant numbers of intrathymic thymocyte 
precursor cells which gave rise to cortical type thymocytes 14 days later. It 
was discussed that it is likely that the doubling time of the thymocyte 
precursor cell population is less than that of the total thymocyte population 
(e.g. due to loss of cortical thymocytes and exhaustion of precursor cells). 
Therefore, it was assumed that the doubling time of these precursor cells is 
close to the initial thymus regeneration following injection of FUBM or purified 
stem cells, which was considerably faster than after injection of normal BM 
cells (18.4 h vs. 30.4 h). From the thymus repopulation data obtained in the 
reirradiation experiments and a doubling time of 18 h for the thymocyte 
precursor population a Do of 0.94 Gy could be calculated. The similarity in 
thymus regeneration kinetics (i.e. 14 days after their presence in the thymus 
they give rise to thymocytes) and in radiosensitivity suggests that these donor 
and host intrathymic precursor cells represent similar cell types, which have 
the same radiosensitivity as other lymphoid cells. 
The experiments described in Chapters 6 and 7 may help the study of the very 
first differentiation steps of prothymocytes in the thymus. Prothymocytes enter 
the thymus on and after the second day after BMT. In this period the thymus 
contains, due to the irradiation, very few nucleated cells. With the present 
separation and detection techniques it should be possible to follow the changes 
that occur to the relatively synchronized population of prothymocytes in the 
subsequent days. 
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SAMENVATTING 
Hemopoietische cellen onstaan door differentiatie en proliferatie uit 
onrijpe voorlopercellen. Deze voorlopercellen, stamcellen, kunnen door middel 
van diverse in vivo en in vitro testen worden bestudeerd.. De miltkolonie test, 
de bepaling van overleving na letale bestraling en beenmergtransplantatie 
(BMT), en de thymus repopulatie test zijn methoden om stamcellen in vivo te 
meten. Helaas is het onduidelijk of, en in welke mate, de verschillende 
testsystemen verschillende stamcellen meten. Hierdoor is het onmogelijk om te 
bepalen waar de splitsing tussen twee differentiatielijnen, bijvoorbeeld van 
granulocyten en lym focyten, is ontstaan. De scheiding tussen de cell en die zich 
in de richting van thymocyten en T cellen ontwikkelen en die van de andere 
differentiatiereeksen vormt het eerste deel van dit proefschrift. Hiervoor 
werden diverse soorten en/of fracties van beenmerg cellen (BM) getest op de drie 
bovengenoemde in vivo meetmethoden. Uit de resultaten kon worden geschat in 
welke mate verschillende stamcellen bijdragen tot de drie in vivo testen en 
welke verschillen er tussen de stamcellen bestaan. 
In de miltkolonie test worden stamcellen gemeten, die, na injectie in letaal 
bestraalde dieren, een kolonie vormen die op het oppervlak van de milt zichtbaar 
is.. Een kolonie is een kloon en de stamcel wordt "colony forming unit-spleen" 
(CFU-S) genoemd. De kolonies, bestaande uit cellen van diverse differentiatie-
lijnen, worden 6 tot 14 dagen na BMT macroscopisch zichtbaar. Miltkolonies 
welke op de achtste en twaalfde dag aanwezig zijn worden per definitie gevormd 
uit respectievelijk dag-8 en dag-12 CFU-S. Slechts het deel van de geinJiceerde 
stamcellen dat in de milt verschijnt vormt kolonies. De miltkolonie test is 
lange tijd beschouwd als een techniek waarmee de meest onrijpe stamcellen 
(pluripotente hemopoietische stamcellen; PHSC) quantitatief kunnen worden 
bepaald. De CFU-s populatie bleek echter uit een heterogene groep cellen te 
bestaan, want dag-8 en dag-12 CFU-S zijn verschillende cellen. 
De relatie tussen de dag-8 en dag-12 CFU-s werd onderzocht met BM van 
muizen welke van te voren waren ingespoten met 5-fluorouracil (5-FU; FUBM). 
5-FU doodt voornamelijk delende cellen. Dag-12 CFU-S zijn minder gevoelig voor 
5-FU dan de dag-8 CFU-S en dag-12 CFU-S regenereren eerder dan de dag-8 CFU-5. 
Dit suggereert dat de dag-12 CFU-S een onrijpere eel is dan de dag-8 CFU-S. In 
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andere experimenten werd normaal BM en FUBM gekweekt met een stamcel 
activerende factor (SAF, hetgeen identiek is aan interleukine-3). Deze 
substantie zet stamcellen aan tot deling. Kweek van normaal BM met SAF 
veroorzaakt een relatieve toename van de dag-8 CFU-S t.o.v. de dag-12 CFU-S 
(Hoofdstuk 3). Na stimulatie van FUBM, hetgeen aanvankelijk geen dag-8 CFU-S 
bevatte, met SAF werd eerst een toename van de dag-12 CFU-S gevonden. Dit 
celtype verdween vervolgens langzaam uit de kweken. De groei van de dag-8 CFU-8 
in vitro was, evenals in vivo, enkele dagen vertraagd t.o.v. de dag-12 CFU-S. 
Zij waren echter langer aanwezig in de kweken dan de dag-12 CFU-S (Hoofdstuk 3). 
Deze resultaten geven aan dat de dag-12 CFU -s gevoelig is voor de werking van 
SAF en dat dag-8 CFU-S de nakome!ing kunnen zijn van de dag-12 CFU-S. 
Twee verschillen in de aanwezigheid van membraanantigenen op de dag-12 en 
de dag-8 CFU-S zijn beschreven in Hoofdstuk 4. Op de dag-8 CFU.S zijn minder 
klasse I H-2 antigenen aanwezig dan op de dag-12 CFU-S. Bovendien zijn aile 
dag-12 CFU-S positief voor bet Thy-1 antigen, terwijl ongeveer 50 % van de dag-8 
CFU-S geen Thy-1 bevatten. In Hoofdstuk 4 zijn eveneens scheidingsproeven met 
rhodamine 123 (Rhl23) beschreven. Deze fluorescerende stof wordt opgenomen in 
de mitochondria van levende cellen. Na scheiding van de gekleurde cellen op 
basis van fluorescentie werd gevonden dat aile dag-8 CFU-S en tweederde van de 
dag-12 CFU.S re1atief vee! rhodamine 123 opnemen. Eenderde van de dag-12 CFU-S 
nemmt echter weining Rhl23 op (Hoofdstuk 4). Met behulp van een licht 
geactiveerde cellensorteerder konden dag-8 en dag-12 CFU-S op bovengenoemde 
karakteristieken worden gescheiden. Deze resultaten steunen eerdere 
bevindingen,. waarin verschillen tussen de dag-8 en dag-12 CFU-S werden 
aangetoond. 
Diverse BM suspensies of BM fracties werden getest op bet vermogen om 
letaal bestraalde dieren te beschermen tegen bet ontstaan van een 
beenmergsyndroom. BM, gekweekt in de aanwezigheid van SAF en dus rijk aan 
dag-8 CFU-5, beschermde Ietaal bestraalde dieren minder goed dan het 
oorspronkelijke BM. Hieruit blijkt dat de dag-8 CFU-5 in deze kweken niet de 
pluripotente stamcel vertegenwoordigt (Hoofdstuk 3). Met behulp van de reeds 
hierboven beschreven scheiding op basis van rhodarnine123 opnarne kon hetzelfde 
worden aaFigetoond: De zwak met Rh123 gekleurde BM cellen,. welke vrijwel geen 
dag-8 CFU-s bevatten,. bleken letaal bestraalde muizen aanzienlijk beter te 
beschermen dan de sterk fluorescerende BM fractie. Overleving na letale 
bestraling, uitgedrukt per getransplanteerde dag-12 CFU-8, was eveneens minder 
na transplantatie van de sterk fluorescerende fractie dan van de zwak 
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fluoreseerende BM-populatie. Deze resultaten duiden erop dat of de dag-12 CFU-S 
een heterogene populatie is, waarvan sleehts een deel het onstaan van een 
stralingsziekte kan voorkomen, of dat de zwak met Rhl23 gekleurde fractie nog 
een andere stamcel bevat die deze ziekte voorkomt, de pre-CFU-S {Hoofdstuk 4). 
Repopulatie van de thymus na letale bestraling en beenmergtransplantatie 
wordt veroorzaakt door, tenminste twee, stamcellen: een voorlopercel, beperkt 
tot de T eel reeks (de prothymocyt), en de pluripotente hemopoietische stamcel. 
De thymus wordt door de prothymocyt tijdelijk (tussen 15 en 21 dagen na BMT} 
gerepopuleerd. Pluripotente stamcellen veroorzaken echter een permanente 
thymusrepopulatie, die 3 tot 4 dagen na de repopulatie door de prothymocyt 
begint. Prothymocyten versehillen van de dag-12 CFU-S in de dichtheid van 
klasse I H-2 antigenen op de celmembraam, van de eel die bescherming biedt na 
Ietale bestraling in de opname van Rh123, en van een deel van de dag-8 CFU-S in 
de dichtheid van bet Thy-1 antigeen op de eelmembraan (Hoofdstukken 4 en 5). 
Bovendien werd gevonden dat BM, gekweekt met SAF en waarin zich veel dag-8 
CFU-S bevinden, de thymus aanzienlijk minder goed repopuleert (Hoofstuk 3). 
Deze resultaten wijzen erop dat de dag-8 CFU-S niet een voorlopercel is van de 
prothymocyt en steunen de hypothese dat de prothymocyt is ontstaan uit de dag-12 
CFU-S of een nag vroegere voorlopereel, de pre-CFU-S. 
De experimenten beschreven in de Hoofdstukken 3-5 tonen aan dat weinig 
voorkomende eellen, zeals de hemopoietische stamcellen, kunnen worden 
onderverdeeld in subpopulaties met behulp van de licht geactiveerde cellen-
sorteerder, monoclonale antiliehamen en fluoreseerende kleurstoffen. De relatie 
tussen deze subpopulaties kon vervolgens worden bestudeerd met behulp van in 
vivo testen. Verder onderzoek met teehnieken waarby een eel kan worden 
bestudeerd op moleculair niveau zijn nodig om de differerentiatiestappen tussen 
de diverse stamcellen te bestuderen. Vergelijking van deze ontwikkelingsstappen 
tussen normale en maligne cellen kan ons begrip van maligniteit verhelderen en 
mogelijk nieuwe therapeutisehe gezichtspunten aan het licht brengen. 
Beenmergcellen~ getransplanteerd in een letaal bestraalde muis, komen in 
vele organen terecht. Men heeft beweerd dat de BM cellen, die zich 3 uur na BMT 
in de thymus bevinden, prothymocyten zijn. De experimenten beschreven in 
Hoofdstuk 6 tonen aan dat deze Stelling niet klopt. Met behulp van diverse 
suspensies van fluorescerende BM cellen bleek het aantal thymus immigranten 
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beter te correleren met bet totaal aantal ingespoten cellen dan met het thymus 
repopulerend vermogen. Verder bleek o.a. dat de thymusimmigranten kleiner 
waren dan de prothymocyt. De voorwaartse verstrooiing van laserlicht, welke 
toeneemt bij grotere cellen, van de thymusimmigrant was namelijk minder dan dat 
van de prothymocyt. Een test, waarin het aantal BM cellen, dat kort na 
bestraling in de thymus verschijnt, wordt bepaald, kan dus niet gebruikt worden 
om bet aantal thymusvoorlopercellen te bepalen. 
In Hoofdstuk 7 staat beschreven op welk tijdstip na letale bestraling en BM 
transplantatie de prothymocyten in de thymus verschijnen. Hiervoor werden 
ontvanger muizen op verschillende tijdstippen na BM-transplantatie herbestraald 
op de thymus of op bet hele lichaam met of zonder afscherming van de thymus. 
De aanwezigheid van prothymocyten in de thymus werd gemeten als repopulatie van 
dethymus. Herbestraling van de thymus I dag na BMT beinvloedde de thymus-
repopulatie niet. Herbestraling op latere tijdstippen leidde echter tot een 
toenenende vertraging van de thymusrepopulatie. Hieruit blijkt dat op de eerste 
dag na BMT de prothymocyt nog niet in de thymus aanwezig is en dat vanaf de 
tweede dag prothymocyten in de thymus komen. 
Een golf van thymocyten, afkomstig van de ontvanger, wordt gevormd gedurende 
de tweede en derde week na letale bestraling en BMT. Herbestraling van de 
thymus voorkomt dit en toont aan dat deze voorlopercellen zich reeds in de 
thymus bevinden. Deze intrathymische voorlopercellen zijn beschreven als 
radioresistente cellen. Het niet verschijnen van de thymocyten uit ontvanger 
voorlopercellen na herbestraling van de thymus is bier niet mee in 
overeenstemming. 
De herbestralingsproeven lieten verder zien dat een week na BMT aanzienlijke 
aantallen donorvoorlopercellen in de thymus aanwezig zijn. Er werd bediscus-
sieerd dat de verdubbelingstijd van deze voorlopercellen sneller moet zijn dan 
dat van de totale thymocytenpopulatie, welke pas een week later kan worden 
gemeten. Op dat tijdstip treedt nl. reeds verdwijning van thymocyten op en 
uitputting van de eerste golf van prothymocyten. Herbestraling van de thymus op 
zeven dagen na BMT leidt tot een vertraging in thymus repopulatie. Uit de 
meetgeg~vens kon voor de gastheer en de donorvoorlopercel een bestralingsgevoel-
igheid met een Do van, respectievelijk 0.90 and 0.94 Gy worden berekend. Deze 
waarden zijn vrijwel eender aan die van de hemopoietische stamcel, de 
prothymocyt en de meeste lymphocyten. Deze resultaten bestrijden de opvatting 
in de literatuur waarin radioresistente voorlopercellen zijn beschreven. 
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De experimenten beschreven in de Hoofdstukken 6 en 7 kunnen bydragen tot 
de studie van de eerste differentiatiestappen van de prothymocyt in de thymus. 
Prothymocyten verschijnen vanaf de eerste dag na BMT in de thymus. Op dit 
tijdstip bevat de thymus, als gevolg van de letale bestraling zeer weinig kern-
houdende cellen. Het moet mogelijk zijn om de min of meer gesynchroniseerde 
populatie van prothymocyten met de huidige celscheidings - en detectietechnieken 
te bestuderen. 
145 

ACKNOWLEDGEMENTS 
The work described in this thesis could not have been accomplished without 
the support and inspiration present in the Radiobiological Institute. I am 
especially indebted to Prof.Dr.O.W. van Bekkum for making the facilities of the 
Institute available to me and for his lively interest in the present work. 
I am grateful for the stimulating discussions with Or. G.J. van den Engh 
and copromoter Dr. J.W.M. Visser. Both friends always had helpful sugges-
tions when experimental data were inconsistent. They showed me the tricks of 
fluorescence activated cell sorting wherafter many difficulties could be sorted 
rut. 
Of great value for the present study was the presence of my predecessor and 
prothymologist Dr. W.J.A. Boersma at the Institute for Experimental Geronto-
logy. The lenghthy discussions on the fine details of thymus repopulation have 
attributed much to my understanding of thymopoiesis. 
A large number of persons within and around the flow cytometry group helped 
with the experiments and the interpretation thereof. I like to mention Dr. 
J.G.J. Bauman, whose ideas did not suffer from any dogma; Drs. P. de Vries, H 
Herweyer, A.C.M. Martens, W-R, Gerritsen and P.M. Hoogerbrugge. Mrs. M.G.C. 
Hogeweg-Platenburg and later also Miss M.C. Mostert were most helpful with the 
technical details of the experiments and telling me the whereabouts of 
laboratory equipment after the many removals. 
I enjoyed the help and the songs during the lengthy sorting experiments by 
Ing. W. Stokdijk. 
I am grateful to Dr. J. Zoetelief and his coworkers for devicing and 
assisting in the reirradiation protocol. 
Finally, the realisation of this thesis and of several manuscripts was 
greatly dependent on the help of Mrs. M. van der Sman-Poot, Mr. J.Ph de Kler, 
Mr. E.J. van der Reyden and Mr. T. Glaudemans. 
147 

LITERATURE 
Abbott, J., Doyle, P.J., Ngiam, K. and Olson, C.L. (1981) Ontogeny of murine T lymphocytes. 
I. Maturation of thymocytes induced in vitro by tumor necrosis factor-positive serum (TNF) 
Cell.Immunol. 57:237-250 
Abramson, S., Miller, R.G. and Phillips, R.A. (1977) The identification in adult bone marrow 
of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J.Exp.Med. 
145:1567-1579 
Acute, 0 and Reinherz, E.L. (1985) The human T cell receptor. New.Engl.J.Med 313:1100-1111 
Allison, J.P., Macintyre, 8.W. and Block, D. 
T-lymphoma defined with monoclonal antibody. 
Ash, P., Loutit, J.F. and Townsend, K.M.S. 
stem cells. Nature 283:669-670 
(1982) Tumor specific antigen and murine 
J.Immunol. 129:2293-2300 
(1980) Osteoclasts derived from haematopoietic 
Auchincloss, H., Ozato, Jr. and Sachs, O.H. (1982) A monoclonal antibody against unusual 
Thy-1 determinants. J.Immunol. 128:1584-1589 
Bach, J.F. and Oardenne, M. (1973) Studies and characteristics on thymus products. II. 
Demonstration and characterization of a circulating thymic hormone. J.Immunol. 25:353-366 
Baines, P., Sol, S.J.L., Rosendaal, M. (1981) Characterization of a developmentally early 
macrophage progenitor found in normal mouse bone marrow. Brit.J.Haematol. 48:147-153 
Baines, P. and Visser, J.W.M. (1983) Analysis 
by Ho33342 fluorescence-activated cell sorting. 
and separation of mouse bone marrow stem cells 
Exp.Hematol. 11:701-708 
Barnes, o.w.H., Ford, C.E. and Loutit, J.F. (1959) Greffes en serie de moelle osseuse 
homologue chez des souris irradies. Sang 30:762-765 
Barnes, o.w.H., Evans, E.P., Ford, C.E. and West, B.J. (1968) Spleen colonies in Mice: 
Karyotypic evidence of multiple colonies from single cells. Nature 219:518-520 
Bartelmez, S.H., Sacca, R. and Stanley, R.E. (1985) Lineage specific receptors used to 
identify a growth factor for developmentally early hemopoietic cells: Assay of hemopoietin-2. 
J.Cell. Physic!. 122:363-369 
8artelmez, S.H. and Stanly, R.E. (1985) Synergism between hemopoietic growth factors (HGFs) 
detected by their effects on cells bearin receptors for a lineage specific HGF: Assay of 
hemopoietin-1. J.Cell.Physiol. 122:370-378 
Basch, R.S. and Stetson,.C.A. (1962) Quantitative studies on histocompatibility antigens of 
the mouse. Transpl. 1:469-480 
Basch, R.S. and Kadish, J.L. (1977) Hematopoietic thymocyte precursors. I. Properties of 
the precursors. J.Exp.Med. 145:405-419 
Basch, R.S. and Berman, J.W. (1982) Thy-1 determinants are present on many murine 
hematopoietic cells other than T cells. Eur.J.Immunol. 12:359-364 
149 
Bauman, J.G.J, Mulder, A.H. and van den Engh, G.J. {1985) Effect of surface labeling on 
spleen colony formation: Comparison of the indirect immunofluorescence and the biotin-avidin 
methods Exp.Hematol. 13:760-767 
Becker, A.J., McCulloch, E.A. and Till, J.E. (1963) Cytological demonstration of the clonal 
nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197:452-454 
van Bekkum, D.W. and Vas, 0. {1957) Immunological aspects of homo and hetereologous bone 
marrow transplantation in irradiated animals. J. Cell.Comp. Physiol. 50:136-156 
van Bekkum, D.W. and Weyzen, W.W.H. (1961) Serial transfer of isologous and homologous 
hematopoietic cells in irradiated hosts. Pathol.Biol. 9:888-893 
van Bekkum, D.W. and de Vries, M.J. (1967) Radiation Chimeras. Logos Press/Academic Press. 
New York London 
van Bekkum, D.w., van Noord, M.J., Maat, B. and Dicke, K.A. (1971) Attempts at identification 
of hemopoietic stem cells in the mouse. Blood 38:547-558 
van Bekkum, D.W., Boersma, W.J.A., Eliason, J.F. and Knaan, S. (1984) The role of 
prothymocytes in radiation induced leukemogenesis in C5781Rij mice. Leuk.Res. 8:461-471 
van Bekkum, O.W., Visser, J.W.M., Castagnola, C., Boersma, W.J.A., Sol, S.J.L., van den Engh, 
G.J. and Wagemaker, G. (1983) Properties of purified hemopoietic stem cells. Haemopoietic 
stem cells, Alfred Benzon Symposium 18 Editors: Sv-Aa. Killman, E.P. Cronkite and G.N. 
Muller-Berat, Munksgaard, Copenhagen. 17-28 
Beller, O.I. and Unanue, E.R. (1977) Thymic macrophages modulate one stage of T cell 
differentiation in vitro. J.Immunol. 121:1861-1864 
Bertoncello, I., Hodgson, G.S., Bradley, T.R. (1985) Multiparameter analysis of transplantable 
hemopoietic stem cell: I. The separation and enrichment of stem cells homing to marrow and 
spleen on the basis of Rhodamine-123 fluorescence. Exp.Hematol. 13:999-1006 
Bevan, P.J. and Fink, P.J. (1978) The influence of thymus H-2 antigens on the specificity of 
maturing killer and helper cells. Immunol.Rev. 42:3-19 
von Boehmer, H., Hudson, L. and Sprent, J. (1975) Collaboration of histoincompatible T and 8 
lymphocytes using cells from tetraparental bone marrow chimeras. J.Exp.Med- 142:989-997 
von Boehmer, H. and Haas, W. (1980) H-2 restricted cytolytic and noncytolytic T cell clones: 
Isolation, specificity and functional analysis. Immunol.Rev. 54:27-56 
von Boehmer, H. and Schubiger, K. 
histocompatibility complex antigens 
14:1048-1052 
(1984) Thymocytes appear to ignore class I major 
expressed on thymus epithelial cell. Eur.J.Immunol. 
Boersma, w., Betel, T., Daculsi, R. and van der Westen, G. (1981a) Post-irradiation thymocyte 
regeneration after bone marrow transplantation. I. Regeneration and quantification of 
thymocyte progenitor cells in the bone marrow. Cell Tissue Kinet. 14:179-196 
Boersma, W.J.A., Oaculsi. R. and van der Westen. G. (1981b) Post-irradiation thymocyte 
regeneration after bone marrow transplantation. II. Physical characteristics of thymocyte 
progenitor cells. Cell Tissue Kinet. 14:197-201 
!50 
Boersma, W.J.A. (1982) Characterization of mouse prothymocytes. Thesis. Erasmus University, 
Rotterdam. 
Boersma, W.J.A., Kokenberg, E., van der Westen, G. and Haaijman, J.J. (1982) Post-irradiation 
thymocyte regeneration after bone marrow transplantation. III Intrathymic differentiation and 
development of thymocyte subpopulations. Eur.J.Immunol. 12:615-619 
Boersma, W.J.A. (1983) Prothymocytes in fetal liver. Thymus 5:419-428 
Boettiger, D., Anderson, S. and Dexter, T.M. (1984) Effect of src infection on long-term 
marrow cultures. Increased self-renewal of hemopoetic progenitor cells without leukemia. Cell 
36:763-773 
Boggs, S.S. and Boggs, O.R. (1973) Cell-cycling characteristics of exogenous spleen 
colony-fOrming units. J.Lab.Clin.Med. 82:740-753 
Boggs, D.R., Saxe, D.F. and Boggs, S.S. (1984) Aging and hematopoiesis. II The ability of 
bone marrow cells from young and aged mice to cure and maintain cure in W/Wv. Transplantation 
37,300-306 
Sol, S. (1982) The recognition of early developmental stages in haemopoiesis. Thesis. 
Erasmus University Rotterdam, The Netherlands 
Sol, S., Visser, J., Williams, N. and van den Engh (1977) Physical characterization of 
haemopoietic progenitor cells by equilibrium density centrifugation. In: Bloemendal, H. ed. 
Cell Separation Methods. Elsevier/North-Holland Biomedical Press, Amsterdam, 39 
Boniver, J., Decleve, A., Dailey, M.D., Honsik, C., Lieberman, M., and Kaplan, H.S. (1981) 
Macrophage and lymphocyte-depleted thymus reticuloepithelial cell cultures: establishment and 
functional influence on T-lymphocyte maturation, c-type virus expression and lymphomatous 
transformation in vitro. Thymus 2:193-213 
Born, W. and Wekerle, H. 
thymocytes react with I-A 
Eur.J.Immunol. 12:51-59 
Bouwens, L and Wisse, E. 
3:23-31 
(1982) Lymphostromal interactions in the thymus: medullary 
determinants on autochthonous thymic stimulator cells. 
(1980) On the origin of the Kupffer cell. Kupffer Cell Bull. 
Botnick, L.E., Hannon, E.C. and Hellman, S. 
compartment and its proliferative potential. 
(1979) Nature of hemopoietic stem cell 
Blood Cells 5:195-210 
Boyse, E.A., Miyazawa, M., Aoki, T. and Old, L.J. (1968) Ly-A and Ly-8: Two systems of 
lymphocyte isoantigens in the mouse. Proc.Roy.Soc.(London) B 170:175-193 
Bradley, T.R., Hodgson, G.O. and Bertoncello. I. (1980) Characteristics of primitive 
macrophage progenitor cells with high proliferation potential: Relationship to cells with 
marrow repopulating ability in 5-fluorouracil treated mouse bone marrow. In: Experimental 
Hematology Today 1980. Eds.. Baum, S.J., Ledney, G.O. and van Bekkum, O.W •• S.Karger 
Bradley, S.M., Kruisbeek, A.M. and Singer, A. (1982) Cytotoxic T lymphocyte responses in 
allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the 
self-repertoire of Ia restricted T cells but not H-2K/D resyricted T cells. J.Exp.Med. 
156:1650-1664 
!51 
Britz, J.S., Jason, J.~., Ptak, J.~., Janeway, C.A. and Gershon (1984) Distinctive 
immunological properties of cultured murine epithelial cells. Clin.Immuno.Immunopathol. 
30:227-232 
Bruce, W.R., Meeker, B.E. and Valeriote, F.A. (1966) Comparison of the sensitivity of normal 
and hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents 
administered in vivo. J.Natl.Can.Inst. 37:233-245 
Brumby, ~. and Metcalf, D. (1967) Migration of cells to the thymus demonstrated by 
parabiosis. Proc.Soc.Exp.Biol.Med. 124:99-1D3 
Cantor, H. and Boyse, E.A. (1975) Functional subclasses of T lymphocytes bearing different Ly 
antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative 
process independent of antigen. J.Exp.Med. 141:1376-1389 
Cantor, H. and Weissman, I.L. (19?6) Development and function of subpopulations of thymocytes 
and T lymphocytes Prog.Allergy 20:1-64 
Castagnola, C., Visser, J., Boersma, W. and van Bekkum O.W. (1981) Purification of rat 
pluripotent stem cells hemopoietic stem cells. Stem cells 1:250-260 
Ceredig, R. and MacDonald, H.R. (1982) Phenotypic and functional properties of murine 
thymocytes. II. Quantification of host - and donor-derived cytolytic T lymphocyte precursors 
in regenerating bone marrow chimeras. J.Immunol. 128: 14-620 
Ceredig, R., Glasebrook, A.L. and MacDonald (1982a) Phenotypic and functional properties of 
murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells 
are all contained with a subpopulation of "mature" thymocytes as analyzed by monoclonal 
antibodies and flow microfuorometry. J.Exp.Med. 155:358-379 
Ceredig, R., Jenkinson, E.J., MacDonald, H.R. and Owen J.J.T. (1982b) Development of 
cytolytic T lymphocyte precursors in organ-cultured mouse embryonic thymus rudiments. 
J.Exp.Med. 155:617-622 
Ceredig, R., Sekaly, R.P. and ~acDonald, H.R. (1983a) Differentiation in vitro of Lyt 2+ 
thymocytes from Lyt 2- precursors. Nature 303:248-250 
Ceredig, R., MacDonald, H.R. and Jenkinson, E.J. (1983b) Flow microfluorometric analysis of 
mouse thymus development in vivo and in vitro. Eur. J. Immunol. 13:185-190 
Ceredig, R., Dialynas, D.P., Fitch, F.W. and ~acDonald, H.R. (1983c) Precursors ofT cell 
growth factor producing cells in the thymus: Ontogeny, frequency, and quantitative recovery in 
a subpopulation of phenotypically mature thymocytes defined by monoclonal antibody GK-1.5. 
J.Exp.Med. 158:1654-16?1 
Ceredig, R. and Schreyer, M. (1984) Immunohistochemical localization of host and 
donor-derived cells in the regenerating thymus of radiation bone marrow chimeras. Thymus 
6:15-26 
Ceredig, R.~ Lowenthal, J.W., Nabholtz, M. and MacDonald, H.R. (1985) Expression of 
interleukin-2 receptors as a differentiation marker on inthrathymic stem cells. Nature 
314:98-100 
!52 
Chen, W-F., Scollay, R., Clark-Lewis, I. and Shortman, K. (1983a) The size of functional 
T-lymphocytes pools within thymic medullary and cortical cell subsets. Thymus 5: 179-195 
Chen, W-F., Scollay, R. and Shortman, K. (1983b) The Ly phenotype of functional medullary 
thymocytes. Thymus 5:197-207 
Chertkov, J.L. and Drize, N.J. (1984) Cells forming spleen colonies at 7 or 11 days after 
injection have different proliferation rates. Cell Tissue Kinet. 17:247-252 
Ching, L-M. and Miller, R.G. (1980) Characterization of in vitro T lymphocyte colonies from 
normal mouse spleen cells: colonies containing cytotoxic lymphocyte precursors. J.Immunol 
124:696-701 
Ching, L-M. and Miller, R.G. (1981) Generation of cytotoxic T-lymphocyte precursor cells in 
T-cell colonies grown in vitro. Nature 289:802-804 
Ching, L-M. and Miller, R.G. (1982) Development of cytotoxic T lymphocyte precursor cells in 
T cell colonies grown in vitro. J.Immunol. 129:2345-2351 
Claesson M.H., Rodger, M.S., Johnson, G.R., Whittingham, S. and Metcalf, D. (1977a) Colony 
formation by human T lymphocytes in agar medium. Clin.exp.Immunol. 28:526-534 
Claesson M.H., Whittingham, S., Rodger, M.S. and Burgess, A.W. (1977b) Colony growth of human 
T lymphocytes in agar: effect of a soluble factor from adherent cells. Eur.J.Immunol. 
7:608-612 
Cohen, J. and Fairchild, S.S. (1979) Thymic control of proliferation of T cell precursors in 
bone marrow. Proc.Natl.Acad.Sci.USA 76:6587-6590 
Cohen, R.L., Muirhead, K.A., Gill, J.E., Waggoner, A.S. and Horan, P.K. (1981) A cyanine dye 
distinguishes between cycling and non-cycling fibroblasts. Nature 290:593-595 
Coligan, J.E., Kindt, T.J., Uehara, H., Martinko, J. and Nathanson, S.G. (1981) Nature 
291:35-39 
Curry, J.L. and Trentin, J.J. {1967) Hemopoietic spleen colony studies. I. Growth and 
differentiation. Develapmental.Biol. 15:395 
Darzynkiewicz, z., Staiano-Coico, L. and Melamed, M.R. (1981) Increased mitochondrial uptake 
of rhodamine 123 during lymphocyte stimulation. Proc.Natl.Acad.Sci.USA 78:2383-2387 
Dexter, T.M., Scott, D. and Teich, N.M. (1977) Infection of bone marrow cells in vitro with 
FLV: Effects on stem cell proliferation, differentiation and leukemogenic capacity. Cell 
12•355-364 
Dexter, T.M., Allen, T.O., Scott, D. and Teich, N.M. (1979} Isolation and characterisation of 
a bipotential haemopoeitic cell line. Nature 277:471-474 
Dialynas, D.P., Loken, M.R., Glasebrook, A.L. and Fitch, F.W. (1981) Lyt-2-/Lyt-3- variants 
of a cloned cytolytic T cell line lack an antigen receptor functional in cytolysis. J.Exp.Med. 
153:595-604 
Dialynas, D.P., Wilde O.B., Marrack, P., Pierres, A., Wall, K.A., Havran, W., Otten, G., Loken, 
M.R., Pierres, M., Kappler, J. and Fitch, F.W. (1983) Characterization of the murine 
antigenic determinant, designated L3T4a by functional T cell clones appears to correlate with 
!53 
class II MHC antigen-reactivity. Immunol.Rev. 74:29-56 
Dicke, K. A., Platenburg, M.G.C. and van Bekkum, D.W. (1971). Colony formation in agar: in 
vitro assays of haemopoietic stem cells. Cell Tissue Kinet. 4:463-477 
DiSabato, G., Moraes, E.K. and Altin, M. (1981) Effect of thymocyte-stimulating 
factor-containing supernatants on the surface antigens of murine thymocytes. Cell.Immunol. 
44:252-
Doherty, P.C., Blanden, R.V. and Zinkernagel, R.M. (1976) Specificity of virus-immune 
effector T cells for H-2K or H-2D compatible interactions: Implications for H-antigen 
diversity. Transpl.Rev 29:89-124 
Dorssers, L., Burger, H. and Wagemaker, G.(1984) Identity of murine stem cell activating 
factor (SAF) and interleukin-3 (IL-3) and common specificity for pluripotent hemopoietic stem 
cells. abstr. Exp.Hematol. 12:357 
Le Douarin, N. and Jotereau, F.V. (1975) Tracing of cells of the avian thymus through 
embryonic life in the interspecific chimeras. J.Exp.Med. 142:17-40 
Dulbecco, R., Bologna, M. and Unger, M (1979) Role of the Thy-1 antigen in the in vitro 
differentiation of a rat mammary cell line. Proc.Natl. Acad.Sci.USA 78:1848-1852 
Dumenil, 0., Lauret, E. and Frindel, E. (1984) Effects of various treatments of CFU-S seeding 
efficiency in mice. Exp.Hematol. 12:749-752 
Duplan, J.F. (1970) Radiosensitivity of the hemopoietic colony-forming cells of the mouse. 
On: Haemopoietic cellular proliferation. F. Strohman, jr. (ed.), New York, 189. 
Eckner, R.J., Hettrick, K.L., Greenberger, J.S. and Bennet, M. (1982) Extended self-renewal 
capacity of pluripotent hemopoietic stem cells: Association with persistent Friend Spleen 
Focus-Forming virus. Cell 31:731-738 
van den Engh, G.J. (1976) Early events in haemopoietic cell differentiation. Thesis, State 
University, Leiden. 
van den Engh, G.J., Visser, J. and Trask, 8. (1979) Identification of CFU-5 by scatter 
measurements on a light activated cell sorter. Exp.Hematol.Today. Baum, S.J., Ledney, G.O. 
(eds.). Springer.Verlag. New York, Heidelberg, Berlin, p. 19 
van Ewijk, W., 5oest, P.L. and van den Engh, (1981) Fluorescence analysis and anatomic 
distribution of mouse T lymphocyte subsets defined by monoclonal antibodies to the antigens 
Thy-1, Lyt-1, Lyt-2, and T-200. J.Immunol. 127:2594-2604 
van Ewijk, W., Jenkinson, E.J. and Owen, J.J.T. (1982) Detection of Thy-1, T-200, Lyt-1 and 
Lyt-2-bearing cells in the developing lymphoid organs of the mouse embryo in vivo and in vitro. 
Eur.J.Immunol. 12:262-271 
Ezine, S., Weissman, I.L. and Rouse, R.V. (1984) Bone marrow cells give rise to distinct 
clones within the thymus. Nature 309:629-631 
Fathman, C.G., Small, M., Herzenberg, L.A. and Weissman, I.L. (1975) Thymus cell maturation. 
II. Oifferentiatiom of three "mature" subclasses in vivo. Cell.Immunol. 15:109-128 
Fink, P.J. and Bevan, M.J. (1981) Influence of H-2 antigen expression on killer T cell 
specificity, differentiation, and induction. Proc.Natl.Acad.Sci.USA 78:6401-6405 
!54 
Fink, P.J., Weissman, I.L., Kaplan, H.S. 
murine stromal cell-associated thymocytes. 
and Kyewski, B.A. (1984) The immune competence of 
J.Immunol. 132:2266-2272 
Fontaine-Perus, J.C., Calman, J.C., Kaplan, F.M. and Le Douarin, N.M. 
10-day mouse embryo thymic rudiment by lymphocyte precursors in vitro. 
126:2310-2316 
( 1981 ) Seeding of the 
J .Immunol .. 
Ford, C.E., Hamerton, J.L., Barnes, O.W.H. Loutit, J.F. (1956) Cytological identification of 
radiation chimeras. Nature 177:452-454 
Ford, C.E. and Micklem, H.S. (1963) The thymus and lymph-node in radiation chimaeras. The 
Lancet i: 359 
Ford, C.E., Micklem, H.S., Evans, E.P., Gray, J.G. and Ogden, D.A.. (1968) The inflow of bone 
marrow cells to the thymus: studies with part-body irradiated mice injected with 
chromosome-marked bone marrow and subjected to antigenic stimulation. Ann .. N.Y.Acad.Sci. 
283-296 
Fowlkes, B.J. (1984) Characterization and differentiation of thymic lymphocytes in the mouse. 
Thesis. George Washington University Graduate School of Arts and Science, Washington, D.C. 
Fowlkes, B.J., Edison, L., Mathieson, B.J. and Chused, T.M. (1985) Early T Lymphocytes. 
Differentiation in vivo of adult intrathymic precursor cells. J.Exp.Med. 162:802-822 
Fred, S.S. and Smith, W.W. (1968) Induced changes in transplantability of haemopoietic colony 
forming cells. Proc.Soc.Exp.Biol.Med. 128:364-366 
Frelinger, J.G., Hood, L., Hill, S. and Frelinger, J.A. (1979) Mouse epidermal Ia molecules 
have a bone marrow origin. Nature 282:321-324 
Frindel, E., Dumenil, D. and Sainteny, F. (1980) Role of pluripoietins in murine bone marrow 
stem cell differentiation. Leuk.Res. 4:287-299 
van Furth, R. (1980) Monocyte origin of Kupffer cells. Blood Cells 6:87-90 
Garland, J.M. and Crompton, S. (1983) A preliminary report: Preparations containing 
Interleukin-3 (IL-3) promote proliferation of multipotential stem cells (CFU-5) in the mouse. 
Exp.Hematol. 11 :757-761 
Gengozian, N. and Makinodan T. (1957) Mortality of mice as affected by variation of the X-ray 
dose and number of rrucleated rat bone marrow cells injected. Cancer Res. 17:970-975 
Gengozian, N., Ursa, I.S., Congdon, C.C., Conger, A.D. and Makinodan,T. (1957) Thymus 
specificity in lethally irradiated mice treated with rat bone marrow. Proc Soc Exp Biol Med 
96:714-720 
Gidali, J., Feher, I. and Antal, S. (1974) Some properties of the circulating hemopoietic 
stem cells. Blood 43:573-580 
Glimcher, L.H., Kruisbeek, A.M., Paul, W.E. and Green, I. 
transformed thymic epithelial cell line. Scand.J.Immunol. 
(1983) Functional activity of a 
17:1-11 
Goldschneider, r., Metcalf, o., Battye, F. and Mandel, T. (1980) Analysis of rat hemopoietic 
cells on the fluorescence-activated cell sorter. I. Isolation of pluripotent hemopoietic stem 
cells and granulocyte-macrophage progenitor cells. J.Exp.Med. 152:419-437 
!55 
Goldschneider, I., Ahmed, A., Bellum, F.J. and Goldstein, A.L. (1981) Induction of terminal 
deoxynucleotidyl transferase and Lyt antigens with thymosin: Identification of multiple subsets 
of prothymocytes in mouse bone marrow and spleen. Proc.Natl.Acad.Sci.USA 78:2469-2473 
Goldschneider, I., Shortman, K., McPhee, D., Linthicum, S., Mitchell, G., Battye, F. and 
Bellum, F.J. (1982) Identification of subsets of proliferating low Thy 1 cells in thymus 
cortex and medulla. Cell.Immunol. 69:59-69 
Goldschneider, I., Komschlies, K.L. and Greiner, D.L. (1986) Studies of thymocytopoiesis in 
rats and mice. I. Kinetics of appearance of thymocytes using a intrathymic adoptive transfer 
assay for thymocyte precursors. J.Exp.Med. 163:1-17 
Goldstein, G., Scheid, M.P., Hammerling, U., Boyse, E.A., Schlesinger, D.H. and Niall, H.D. 
(1975) Isolation of a polypeptide that has lymphocyte differentiating properties and is 
probably represented universally in living cells. Proc.Natl.Acad.Sci.USA 72:11-15 
Gaube de Laforest, and Rozenszajn (1984) Meeting report on T-cell colony growth in semisolid 
media: significance and possible applications. Int.J.Cell Clan. 2:47-66 
Greenberger, J.S., Hoffman, N., Lieberman, M., Botnick, L.E., Sakakeeny, M.A. and Eckner R.J. 
(1983) Pool size of pluripotential hematopoietic stem cells increased in continuous bone marrow 
culture by Friend Spleen Focus-Forming Virus. J.Natl.Canc.Inst. 70:323-331 
Greenstein, J.L., Kappler, J., Marrack, P. and Burakoff, S.J. (1983) The role of the L3T4 in 
recognition of Ia by a cytotoxic, H-20-specific T cell hybridoma. J.Exp.Med. 159:1213-1224 
Gregory, C.J., McCulloch, E.A. 
colonies: effect of normal and 
and Till, J.E. (1975) Transient erythropoietic spleen 
genetically anemic W/Wv mice. J.Cell.Physiol. 86:1-8 
Greiner, O.L., Goldschneider,I. and Barton R.W. (1982) Identification of thymocyte 
progenitors in hemopoietic tissues of the rat. II. Enrichment of functional prothymocytes on 
the fluorescence activated cell sorter. J.Exp.Med. 156:1448 
Greiner, O.L., Goldschneider, I. and Lubaroff, O.M. 
progenitors in hemopoietic tissues of the rat. I. 
regeneration. Thymus 6:181-199 
(1984) Identification of thymocyte 
A quantitative assay system for thymocyte 
Hara, H. and Ogawa, M. {1978) Murine hemopoietic colonies in culture containing normoblasts, 
macrophages, and megakaryocytes. Am.J .Hematol. 4:23-34 
Harris, J.E., Ford, C.E., Barnes, O.W.H. and Evans, E.P. {1964) Evidence from parabiosis for 
an afferent stream of cells. Nature 201:886-887 
Harris, R.A., Hogarth, P.M., Wadeson, L.J., Collins, P., McKenzie, I.F.c. and Penington, O.G. 
(1984) An antigenic difference between cells forming early and late haematopoietic spleen 
colonies (CFU-5). Nature 307:638-641 
Harris, R.A., Sandrin, M.S., Sutton, V.R., Hogarth, P.M., McKenzie, I.F.C. and Penington, O.G. 
(1985) Variable expression of Qa-m7, Qa-m8, and Qa-m9 antigenic determinants on primitive 
hemopoietic precursors. J .Cell.Physiol. 123:451-458 
Harrison, D.E. and Astle, C.M. (1982) Loss of stem cell repopulating ability upon 
transplantation. Effects of donor age, cell number and transplantation procedure. J. Exp. 
Med. 156:1767-1779 
!56 
Harrison, D.E. 
stem cells. J. 
(1983) Long-term erythropoietic repopulating ability of old, young and fetal 
Exp. Med. 157:1496-1504 
Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J. (1983) The major histocompatibility 
complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. 
J.Exp.Med. 157:1149-1169 
Hedrick, S.M., Cohen, O.I., Nielsen, E.A. and Davis, M.M. (1984a) Isolation of eDNA clones 
encoding T-cell specific membrane-associated proteins. Nature 308:149-153 
Hedrick, S.M., Nielsen, E.A., Kavaler, J., Cohen, I. and Davis, M.M. (1984b) Sequence 
relationsips between putative T-cell receptor polypeptides and immunoglobulins. Nature 
308:153-158 
Hedrick, S.M., Germain, R.N., Bevan, M.J., Dorf, M., Engel., I., Fink, P., Gascoigne, N., 
Heber-Katz, E., Kapp, J., Kaufmann, Y., Kaye, J., Melchers, F., Pierce, c., Schwartz, R.H., 
Sorensen, C., Taniguchi, M. and Davis, M.M. (1985) Rearrangement and transcription of a 
T-cell receptor b-chain gene in different T-cell subsets. Proc.Natl.Acad.Sci.USA 82:531-535 
Hellman, S., Botnick, L.E., Hannon, E.C. and Vigneulle, R.M. (1978) Proliferative capacity of 
murine hematopoietic stem cells. Proc.Natl.Acad.Sci.USA 75:490-494 
Hirakawa, K., Sado, T., Kubo, S., Kamisaku, H., Hitomi, K. and Utsuyama, M. (1985) 
Intrathymic T cell differentiation in radiation bone marrow chimeras and its role in T cell 
anigration to the spleen. An immunohistochemical study. J.Immunol. 1354:3615-3624 
Hodes, R.J., Hathcock, K.S. and Singer, A. (1980) Major histocompatibility complex-restricted 
self recognition. A monoclonal anti-1-Aik reagent blocks helper T cell recognition of self 
major histocompatibility complex determinants. J.Exp.Med. 152:1779-1794 
Hodgson, G.$. and Bradley, T.R. (1979) Properties of haemopoietic stem cells surviving 
5-Fluorouracil treatment: Evidence for a pre-CFU-S cell. Nature 281:381-382 
Hodgson, G.S. and Bradley, T.R. (1984) In vivo kinetic status of hemopoietic stem and 
progenitor cells as inferred from labeling with bromodeoxyuridine. Exp.Hematol. 12:683-687 
Hogarth, P.M., Crewther, P.E. and McKenzie, L.F.C. (1982) Description of a Qa-2 like 
alloantigen (Qa-m2). Eur.J.Immunol. 12:374-379 
Hollander; N., Pillemer, E. and Weissman, I.L. (1981) Effects of antibodies on T cell 
functions: Augmentation by anti-Lyt-1 as opposed to inhibition by anti-Lyt-2. 
Proc.Natl.Acad.Sci.USA 78:1148-1151 
Hopper, K. and Shortman, K. (1976) The differentiation of T-Lymphocytes. III. The behaviour 
of subpopulations of mouse thymus cells in short-term cell culture. Cell.Immunol. 27:256-273 
Hopper, K., Ryder, A. and Shortman, K. (1978) The differentiation ofT lymphocytes. IV. Net 
increase in low cells, maintenance of biological activity and death of high cells during 
short-term culture af mouse thymocytes. Exp.Cell Biol. 46:31 
Houben-defresne, M-P., Varlet, A. and Boniver, J. (1984) Thymic nurse cells and thymic 
repopulation after whole body sublethal irradiation in mice. Thymus 6:324-333 
Huiskamp, R. and van Ewijk, w. (1985) Repopulation of the mouse thymus after sublethal 
fission neutron irradiation I. Sequential appearance of thymocyte subpopulations. J.Immunol. 
134:2161-2169 
157 
Humphries7 R.K., Eaves, A.C. and Eaves, C.J. (1981) Self-renewal of hemopoietic stem cells 
during mixed colony formation in vitro. Proc.Natl.Acad.Sci.USA 78:3629-3633 
Hunig, T. 
hypothesis. 
and Bevan 7 M.J. (1981) Specificity ofT-cell clones illustrates altered self 
Nature 294:460-462 
Hwang, w.s., Ho, T.Y., Luk 7 S.C. and Simon, G.T. (1974) Ultrastructure of the rat thymus. A 
transmission, scanning electron microscope, and morphometric study. Lab.Invest. 31:473-487 
Ihle, J.N., Pepersack, L. and Rebar, L. (1981) Regulation ofT cell differentiation: in vitro 
induction of 20 alpha hydroxysteroid dehydrogenase in splenic lymphocytes is mediated by a 
unique lymphokine. J.Immunol. 126:2164-
James, T.W. and Bohman, R. (1981) Proliferation of mitochondria during the cell cycle of the 
human cell line (HL-60). J.Cell.Biol. 89:256-260 
Jason, J.M. and Janeway, C.A. (1984) In vitro cultivation of nonlymphoid thymic cells: 
morphological and immunological characterization. Clin.Immunol.Immunopathol. 30:214-226 
Jensenius, J.C. and Williams, A.F. (1982) The T lymphocyte antigen receptor- paradigm lost. 
Nature 300:583-588 
Johnson, G.R. (1980) Colony formation in aga~ by adult bone marrow multipotential hemopoietic 
cells. J.Cell.Physiol. 103:371-383 
Johnson, G.R. and Nicola, N.A. (1984) Characterization of two populations of CFU-S 
fractionated from mouse fetal liver by fluorescence-activated cell sorting. J.Cell.Physiol. 
116:45-52 
Johnson, L.V., Marcia, M.L., Walsh, M.L. and Chen, L.8. (1980) Localization of mitochondria 
in living cells with rhodamine 123 Proc.Soc.Natl.Acad.Sci.USA 77:990-994 
Johnson, M.H. and Edidin, M. (1972} H-2 antigens on mouse spermatozoa. Transpl. 14:781-766 
Jones, B.C., Radley, J.M., Bradley, T.R. and Hodgson, G.S. (1980) Enhanced megakaryocyte 
repopulating ability of stem cells surviving 5-Fluorouracil treatment. Exp.Hematol. 8:61-64 
Janes-Villeneuve, E., Rusthoven, J.J., Miller, R.G. and Phillips, R.A. (1980) Differentiation 
of Thy-1 bearing cells from progenitors in long-term bone marrow cultures. J.Immunol. 
124:597-601 
Jotereau, F.V. and Le Douarin, N.M. {1962) Demonstration of a cycle renewal of the lymphoid 
precursor cells in the quail thymus during embryonic and perinatal life. J.Immunol 
129:1869-1877 
Kadish, J.L. and Basch, R.S. (1975) Thymus regeneration after lethal irradiation: Evidence 
for an intra-thymic radioresistant T cell precursor. J.Immunol. 114:452-458 
Kadish, J.L. and Basch, R.S. (1976) Hematopoietic thymocyte precursors. I. Assay and 
kinetics of the appearance of progeny. J.Exp.Med 143:1082-1099 
Kamarck, M.E. and Gottlieb, P.O. {1977) Expression of thymocyte surface alloantigens in the 
fetal mouse thymus in vivo and in organ culture. J.Immunol 119:407-415 
!58 
Kappler, J. and Marrack, P. (1977} The role of H-2 linked genes in helper T-cell function. 
I. In vitro expression in B-cells of immune response genes controlling helper T-cell activity. 
J.Exp.Med. 146:1748-1764 
Kappler, J., Kubo, R., Haskins, K., White, J. and Marrack, P. (1983b) The mouse T cell 
receptor: comparison of MHC-restricted receptors on two T cell hybridomas. Cell 34:727-737 
Kappler, J., Kubo, R., Haskins, K., Hannum, C., Marrack, P., Pigeon, M., Mcintyre, 8., Allison, 
J. and Trowbridge, I. (1983a) The major histocompatibility complex-restricted antigen 
receptor on T cells in mouse and man: Identification of constant and variable peptides. Cell 
35,295-302 
Kast, W.M., de Waal, L.P. and Melief, C.J.M. (1984) Thymus dictates major histocompatibility 
complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells 
but not of class I MHC-restricted T cells. J.Exp.Med. 160:1752-1766 
Katz, D.H., Homoaka, J. and Benacerraf, B. (1973} Cell interactions between histoincompatible 
T and 8 lymphocytes. II. Failure of physiologic cooperative interactions between T and 8 
lymphocytes from allogeneic donor strains in humoral response to hapten-protein conjugates. 
J.Exp.Med. 137:1405-
Katz, D.H., Skidmore, B.J., Katz, L.R., Bogowitz, C.A. {1978) Adaptive differentiation of 
murine lymphocytes. I. Both T and 8 lymphocytes differentiating in a F1 - parental chimeras 
manifest preferential cooperative activity for partner lymphocytes derived from the same 
parental type corresponding to the chimeric host. J.Exp.Med. 148:727-745 
Keller, G. and Phillips, R.A. (1982) Detection in vitro of a unique multipotent progenitor. 
J.Cell.Physiol. 1:31-36 
Keller., G., Holmes, W. and Miller, R.A. 
hemopoietic blast cell colonies in vitro. 
(1984) Clonal generation of multipotent and unipotent 
J.Cell.Physiol. 12D:29-35 
Kisielow, P., Hirst, J.A., Shiku, H., Beverley, P.C.L., Hoffman, M., Boyse, E.A. and Oettgen, 
H.F. (1975 ). Ly antigens as markers for functionally distinct subpopulations of 
thymus-derived lymphocytes of the mouse. Nature 253:219-220 
Kisielow, P., Leiserson, w. and Boehmer, H. (1984) Differentiation of thymocytes in fetal 
organ culture: analysis of phenotypic changes accompanying the appearance of cytolytic and 
interleukin-2 producing cells. J.Immunol. 133:1117-1123 
Kitamura, Y., Shimada, M., Hatanaka, K .. and Miyano (1977) Development of mast cells from 
grafted bone marrow cells in irradiated mice. Nature 268:442-443. 
Kitamura, Y., Yokoyama, M., Matsuda, H., Ohno, T., Mori, K.J. {1981) Spleen colony-forming 
cell as a common precursor for tissue mast cells and granulocytes Nature 291:159-160 
Klein, B., Caraux, J., Thierry, C., Gauci, L .. , Causse, A. and Serrou, B. (1981) Human 
T-lymphocyte colonies: generation of colonies in different lymphocyte subpopulations. 
Immunology 43:39-45 
Klein, 8., Caraux, J., Thomas, P. and Gaube de LaForest (1982) Nature and mechanisms of action 
of co-operating cells controlling human T-colony formation. Immunology 45:265-271 
Klein, J. {1975) Biology of the Mouse Histocompatibility-2 Complex. Springer-Verlag, Berlin, 
Heidelberg, New York 
!59 
Klein, J. Gotze, 0., Hammerling, G.H. and Lemke, H. (1979) Nomenclature for H-2 and Ia 
antigens define by monoclonal antibodies. Immunogenetics. 9:5D3-5D7 
Klein, J., Figueroa, F. and David, C.S. (1983) H-2 haplotypes, genes and antigens: Second 
listing. II. The H-2 complex. Immunogenetics 17:553-597 
Klein, J., Marusic, M. and Nagy, Z.A, (1982b) The seven rules of MHC restriction. 
Transpl.Proc. XIV: 581-583 
Komuro, K. and Boyse, E.A. (1973) Induction of T lymphocytes in vitro by a product of the 
thymus. J.Exp.Med. 138:479-482 
Komuro, K., Goldstein, G. and Boyse, E.A. (1975) Thymus-repopulating capacity of cells that 
can be induced to differentiate toT cells in vitro. J.Immunol. 115:195-198 
Kretchmar, A.L. and Conover, W.R. (1969) Early proliferation of transplanted spleen 
colony-forming cells. II. Circulation of cells Proc.Soc.Exp.Biol.Med. 131:7D3-7D6 
Kruisbeek, A.M. (1979) Thymic factor and T cell maturation in vitro: a comparison of the 
effects of thymuc epithelial cultures with thymic extravts and thymus dependent serum factors. 
Thymus 1:163-185 
Kruisbeek, A.M., Sharrow, S.D., Mathieson, B.J. and Singer, A. (1981) The H-2 phenotype of 
the thymus dictates the self-specificity expressed by thymus but not splenic cytotoxic 
lymphocyte precursors in thymus-engrafted nude mice. J.Immunol. 127:2168-2176 
Kruisbeek, A.M., Hathcock, K.S., Hodes, R.J. and Singer, A. (1982) T cells from fully H-2 
allogeneic (A- B) radiation bone marrow chimeras are functionally competent and host restricted 
but are alloreactive against hybrid Ia determinants expressed on (A*B)F1 cells. J.Exp.Med 
155:1864-1869 
Kruisbeek, A.M., Fultz, M.J., Sharrow, S.D., Singer, A. and Mend, J.J. (1983a) Early 
development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia 
antibodies interferes with differentiation of !-restricted T cells but not KID-restricted T 
cells. J.Exp.Med. 157:1932-1946 
Kruisbeek, A.M., Andrysiak, P.M. and Singer, A. (1983b) Self recognition of accessory cell Ia 
determinants is required for the in vitro generation of hapten-specific cytotoxic T lymphocyte 
responses. J.Immunol. 131:165D-1655 
Kruisbeek, A.M., Sharrow, S.D. and Singer, A. 
self-recognition repertoire of intra-thymic and 
J.Immunol. 13D:1027-1D32 
(1983c) Differences in the MHC-restricted 
extra-thymic cytotoxic T lymphocyte precursors. 
Kruisbeek, A.M., Davis, M.L., Matis, L.A. and Longo, O.L. (1984) Self-recognition specificity 
expressed by T cells from nude mice. Absence of detectable I-a restricted T cells in nude mice 
that do exhibit self-KID-restricted T cell responses. J.Exp.Med. 160:839-BS?Z 
Kruisbeek, A.M., Mend, J.J., Fowlkes, B.J •• Carmen, J.A., Bridges, S~ and Longo, D.L. (1985) 
Absence of the Lyt-2-, L3T4+ lineage of T cells in mice treated neonatally with antiii-A 
correlates with absence of intrathymic I-A bearing antigen-presenting cell function. 
J.Exp.Med. 161:1029-1047 
Kyewski, B.A. and Kaplan, H.S. (1982) Lymphoepithelial interactions in the mouse thymus: 
phenotypic and kinetic studies on thymic nurse cells. J.Immunol. 128:2287-2294 
160 
Kyewski, B.A., Rouse, R.V. and Kaplan, H.S (1982) Thymocyte rosettes: Multicellular complexes 
of lymphocytes and bone marrow-derived stromal cells in the mouse thymus. 
Proc.Natl.Acad.Sci.USA 79:5646-5650 
Kyewski, B.A., Travis, M. and Kaplan, H.S. (1984) Intrathymic lymphopoiesis: stromal 
cell-associated proliferation ofT cells is independent of lymphocyte genotype. J.Immunol. 
133:1111-1116 
Lahiri, S.K. and van Putten, L.M. (1969) Distribution and multiplication of colony forming 
units from bone marrow and spleen after injection in irradiated mice. Cell Tissue Kinet. 
2:21-28 
Lahiri, S.K., Keizer, H.J. and van Putten, L.M. (1970) The efficiency of the assay for 
haemopoietic colony forming cells. Cell Tissue Kinet. 3:355-362 
Ledbetter, J.A., Rouse, R.V., Micklem, H.S. and Herzenberg, L.A. (1961) T cell subsets 
defined by expression of Lyt 1,2,3 and Thy-1 antigens. Two parameter immunofluorescence and 
cytotoxicity analysis with monoclonal antibodies modifies current views. J.Exp.Med. 
152:260-295 
Leiserson, W.M., Fowlkes, B.J., Chused, T.M. and Mathieson, B.J. (1983) Analysis of a new 
thymus subpopulation delineated by Ly1 and Ly2 surface markers. Intercell.Comm.in Leuc.Func., 
eds. Parker, J.W. and O'Brien, R.L., John Wiley and Sons Ltd. 181-188 
Lennon, V.A., Unger, M. and Dulbecco, R. (1978) Thy-1: A differentiation marker of potential 
mammary myoepithelial cells in vitro. Proc.Natl.Acad.Sci.USA 75:6093-6097 
Lepault, F. and Weissman, I.L.{1981) An in vivo assay for thymus-homing bone marrow cells. 
Nature 293:151-154 
Lepault, F., Coffman, R.L. and Weissman, I.L. (1983) Characteristics of thymus-homing bone 
marrow cells. J.Immunol.131:64-69 
Levy, J., Rabinowitz, R. and Schlesinger, M (1985) Implication of the Thy-1 antigen on mouse 
thymus cells in the recognition of 'self' structures. Thymus 7:85-93 
Lewis, J.P. and Trobaugh, F.E. (1964) Haemopoietic stem cells. Nature 204:589 
Lewis, J.P., Grady, L.F. and Trobaugh, F.E. (1968) Studies of hematopoiesis in murine spleen: 
significance of hematopoietic colonies formed on the surface of the spleen. Cell Tissue.Kinet. 
1:101-109 
Lim, 8., Jamal, N. and Messner, H.A. (1984) Flexible association of hemopoietic 
differentiation programs in multilineage colonies. J.Cell.Physiol. 121:291-297 
Longo, D.L. and Schwartz, R.H. (1980) T-cell specificity for H-2 and Ir gene phenotype 
correlates with the phenotype of thymic antigen-presenting cells. Nature 287:44-46 
Longo, D.L. and Davis, M.L. (1983) Early appearance of donor-type antigen-presenting cells in 
the thymuses of 1200 R 'tadiation-induced bone marrow chimeras correlates with self-recognition 
of donor I region gene products. J.Immunol. 130:2525-2527 
LOwenberg, B. and Dicke, K.A. 
haemopoietic stem cells. Proc. 
1974, p 374-391 
(1974) Studies on the in vitro proliferation of pluripotent 
Int. Symp. on Leukemia and aplastic Anemia, Naples, sept 
!61 
LOwenberg, B. and Dicke, K.A. (1975) Induction of proliferation of haemopoietic stem cells in 
culture. Exp.Hematol. 5:319-331 
MacDonald, H.R., Lees, R.K., Sordat, 8., Zaech, P., Maryanski, J.L. and Bran, C. (1981) 
Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1, and Lyt-2 in 
congenitally athymic (nu/nu) mice: Analysis by flow microfluorometry. J.Immunol. 126:865-87D 
MacDonald, H.R., Glasebrook, A.L. and Cerottini, J-C. (1982) Clonal heterogeneity in the 
functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: Analysis by antibody 
blocking and selective trypsinization. J.Exp.Med. 1982:1711-1722 
Magli, M.C., Iscove, N.N. and Ddartchenko, N. (1982) Transient nature of early haemopoietic 
spleen colonies. Nature 295:527-529 
Maloy, W.L. and Coligan, J.E. {1983) Structure of murine class I histocompatibility antigens. 
Transpl.Proc. XV, 4:2D16-2020 
Mandel, T. and Russel, P.J. (1971) Differentiation of foetal mouse thymus. Ultrastructure of 
organ cultures and of subcapsular grafts. Immunology 21:659-674 
Manning, J.K. 
nude mice. IV. 
and Hong, R. {1983) Transplantation of cultured thymic 
effect of amount of thymic tissue. Thymus 5:407-417 
fragments: results in 
Manning, J.K. and Hong, R. (1984) Transplantation of cultured thymic fragments: results in 
nude mice V. Reconstitution with xenogeneic (rat) thymic tissue. Scand.J.Immunol 19:4D3-41D 
Marrack, P., Endres, R., Shimonkevitz, R., Zlotnik, A., Oialynas, D., Fitch, F. and Kappler, 
J. (1983a) The major histocompatibility complex- restricted antigen receptor on T cells. II. 
Role of the L3T4 product. J.Exp.Med. 158:1077-1091 
Marrack, P., Shimonkevitz, R., Hannum, C., Haskins, K. and Kappler, J. 
histocompatibility complex-restricted antigen receptor on T cells: IV An 
predicts both antigen and !-specificity. J.Exp.Med. 158:1635-1646 
(1983b) The major 
antiidiotypic antibody 
Mathieson, B.J., Sharrow, S.D., Rosenberg, Y. and Hammerling, U. (1981) Lyt 1+23- cells 
appear in the thymus before Lyt 123+ cells. Nature 289:179-181 
Mathieson, B.J. and Fowlkes, B.J. (1984) Cell surface antigen expression on thymocytes: 
development and phenotypic differentiation of intrathymic subsets. Immunol.Rev. 82:142-173 
Mcintyre, B.w., and Allison, J.P. {1983) The mouse T cell receptor: Structural heterogeneity 
of molecules of normal T cells defined by xenoantiserum. Cell 34:739-746 
McPhee, D., Pye, J~ and Shortman, K. (1979) The differentiation ofT lymphocytes. V. 
Evidence for intrathymic death of most thymocytes. Thymus 1:151-162 
Merchav, S. Wagemaker, G. (1984) Detection of bone marrow granulocyte/macrophage progenitor 
cells (GM-CFU) in serum-free cultures stimulated with purified M-CSF or GM-CSF. 
Int.J.Cell.Clon. 2:356-365 
Mesner, H.A., Izaguirre, C.A. and Jamal, N. (1981) Identification ofT lymphocytes in human 
mixed hemopoietic colonies. Blood 58:402-405 
Metcalf, D. (1966) The thymus: its role in immune responses, leukemia development and 
carcinogenesis. Recent results in cancer research, vel 5 Springer-Verlag Berlin 
162 
Metcalf, D., Johnson, G.R. and Mandel, T.E. (1979) Colony formation in agar by multipotential 
hemopoetic cells. J.Cell.Physiol. 98:401-420 
Meuer, S.C., Fitzgerald, K.A., Hussey, R.E., Hodgdon, J.C., Schlossman, S.F. and Reinherz, 
E.L. (1983) Clonotypic structure involved in antigen-specific human T-cell function. 
Relationship to the T3 molecular complex. J.Exp.Med. 157:705-719 
Micklem, H.S., Clarke, C.M., Evans, E.P. and Ford, C.E. {1968) Fate of chromosome-marked 
mouse bone marrow cells transfused into normal syngeneic recipients. Transplantation 6:299-302 
Micklem, H.S., Anderson, N. and Ross, E. (1975) Limited potential of ciculating haemopoietic 
stem cells. Nature 256:41-43 
Micklem, H.S. (1983) Factors affecting serially transplanted bone marrow. Blood Cells 
9:527-531 
Migliaccio, A.R. and Visser, J.W.M. (1986) Proliferation of purified murine hemopoietic stem 
cells in serum-free cultures stimulated with purified stem cell activating factor. 
Exp.Hematol. submitted 
Miller, J.F.A.P., Marshall, A.H.E. and White, (1962) The immunological significance of the 
thymus. Adv.Immunol. 2:111-162 
Miller, J.F.A.P. (1962) Effect of neonatal thymectomy on the immunological responsiveness of 
the mouse. Proc.Roy.Soc.Ser.B.Bio.Sci. 156:415-
Miller, J.F.A.P. and Stutman, 0. (1982) Monoclonal antibody to Lyt 2 antigen blocks - H-21-
and H-ZK- specific mouse cytotoxic T cells. Nature 296:76-78 
Miller, R.G. and Philips, R.A. (1969) Separation of cells by velocity sedimentation. 
J.Cell.Physiol. 73:191-
Minden, M., Toyonaga, B., Ha, Y., Yanagi, Y., Chin, 8., Gelfand, E. and Mak, T.W. (1985} 
Somatic rearrangement of the T-cell antigen receptor gene in human T-cell malignancies. 
Proc.Natl.Acad.Sci.USA 82:1224-1228 
Monette, F.C. and Demello, J.B. (1979) The relationship between stem cell seeding efficiency 
and position in cell cycle. Cell Tissue Kinet. 12:161-175 
Monette, F.C. (1979) Antibodies against pluripotent stem cells: Their use in studying stem 
cell function. Blood Cells 5:179-191 
Moore, M.A.S., McNeill, T.A. and Haskill, J.S. (1970) Density distribution of in vivo and in 
vitro colony forming cells in developing fetal liver. J.Cell.Physiol. 75:181-192 
Moore, M.A.S. and Metcalf, D. 
Frontiers of Biology, Vol. 24, 
(1971} Haemopoietic Cells. North-Holland research monographs. 
North-Holland Publishing Company, Amsterdam, London. 
Moriuchi, T., Chang, H-C., Denome, R. and Silver, J. (1983) Thy-1 eDNA sequence suggests a 
novel regulatory mechanism. Nature 301:8D-82 
Mulder, A.H., and van Bekkum, O.W. (1983) The effect of gamma irradiation on thymic nurse 
cells. Abstract. Int.J.Radiat.Biol. 43:693 
Mulder, A.H., Bauman, J.G.J., Visser, J.W.M., Boersma, W.J.M. and van den Engh, G.J. (1984) 
163 
Separation of spleen-colony-framing units and prothymocytes by use of a monoclonal antibody 
detecting an H-2K determinant. Cell.Immunol. 88:401-410 
Mulder, A.H., Visser, J.W.M. and van den Engh, G.J. (1985) Thymus regeneration by bone marrow 
cell suspensions differing in the potential to form early and late spleen colonies. 
Exp.Hematol. 13:768-775 
Muramatsu, S., Monnot, P. and Duplan, J.F. (1976) Competitive proliferation in the 
heamopoietic tissues of irradiated hybrid mice engrafted with parental bone marrow and spleen. 
Exp.Hematol. 4:188-200 
Nakahata, T. and Ogawa, M. (1982) Identification in culture of a class of hemopoietic 
colony-forming units with extensive capability to self-renewal and generate multipotential 
hemopoietic colonies. Proc.Natl.Acad.Sci.USA 79:3843-3847 
Nakahata, T., Gross, A.J. and Ogawa, M. (1982) A stochastic model of self-renewal and 
commitment to differentiation of the primitive hemopoietic stem cells in culture. 
J.Cell.Physiol. 113:455-458 
Nakayama, E.w., Shiku, E., Stockert, H.F. and Old, L.J. (1979) Cytotoxic T cells: Lyt 
phenotype and blocking of killing activity by Lyt antisera. Proc.Natl.Acad.Sci.USA 
76:1977-1981 
Nowell, P.C., Cole, L.J., Habermeyer, J.G. and Roan, P.L. (1956) Growth and continued 
function of rat marrow cells in X-radiated mice. Cancer Res. 16:258-261 
O'Connor, N.T.J., Wainscoat, J.S., Weatherall, O.J., Gatter, K.C., Feller, A.C., Isaacson, P., 
Jones, D., Lennert, K., Pallesen, G., et al. (1985) Rearrangement of the T-cell receptor 
b-chain gene in the diagnosis of lymphoproliferative disorders. The Lancet I:1295-1297 
Ogawa, M., Porter, P.N. and Nakahata, T. {1983) Renewal and commitment to differentiation of 
hemopoietic stem cells {an interpretive review). Blood 61:823-829 
Ogden, O.A. and Micklem, H.S. (1976) The fate of serially transplanted bone marrow cell 
populations from young and old donors. Transplantation 22:287-293 
Oi, V.T., Jones, P.P., Goding, J.w., Herzenberg, L.A. and Herzenberg, L.A. (1978) Properties 
of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. 
Curr.Top.Microbiol.Immunol. 81:115-129 
Orbach-Arbouys, s., Ghazal, I and Berardet, M. (1982) Direct measure of the destruction of 
bone marrow cells after their injection into variously pretreated syngeneic hosts. 
Transplantation 34:205-208 
Owen, J.J.T. and Ritter, M.A. (1969) Tissue interaction in the development of thymus 
lymphocytes. J.Exp.Med. 129:431-437 
Palm, J., Heyner, S. and 8rinster, R.L. 
mouse eggs with H-2 and non-H-2 antibody. 
(1981) Differential immunofluorescence of fertilized 
JaExp.Med. 133:1282-1293 
Papiernik, Ma, Nabarra, 8., Savino, W., Pontoux, C. and 8arbey, S (1983) Thymic reticulum in 
mice. II. Culture and characterization of nonepithelial phagocytic cells of the thymic 
reticulum: their role in the syngeneic stimulation of thymic medullary lymphocytes. 
Eur.J.Irmunol. 13:147-155 
Patten, P., Yokota, T., Rothbard, J., Chien, Y-h, Arai, K-i, Dais, M.M. (1984) Structure, 
164 
expression and divergence ofT-cell receptor -chain variable regions~ Nature 312:40-45 
Ponder, B.A.J., Wilkinson, M.M., Wood, M. and Westwood, J.H. (1983) Immunohistochemical 
demonstration of H2 antigens in mouse tissue sections. J.Histochem~Cytochem. 31:911-919 
Pont, s., van Agthoven, A., Naquet, P., Pierres, A., Schmitt-Verhulst, A-M. and Pierres, M. 
(1985) Clonospecific structural heterogeneity in the Thy-1 molecule from mouse T lymphocytes. 
Immunogenetics 21:459-467 
Popp R.A. (1961) Repopulation of thymus by immunologically-competent cells derived from donor 
marrow~ Proc.Soc.exp.Biol.Med. 108:561-564 
Prystowsky, M.S., Khan, K.M. and Marovitz, W.F. (1978) Detection of H2-b and Thy1.2 surface 
antigens on the differentiating murine otocyst using Nomarsky optics. Differentiation 12:53-58 
Prystowski, M.S., Otten, G., Naujokas, M.F., Vardiman, J., Ihle, J.N., Goldwasser, E. and 
Fitch, F.W. (1984) Multiple hemopoietic lineages are found after stimulation of mouse bone 
marrow precursor cells with interleukin-3. Am.J.Pathol. 117:171-179 
Ptak, w., Rozycka, D., Askenase, P.W. and Gershon, R.K. (1980) J.Exp.Med. 151:362-375 
Pugh, c.w., MacPherson, G.C. and Steer, H.W. 
derived from rat peripheral lymph. J.Exp.Med. 
(1983) Characterization of nonlymphoid cells 
157:1758-1779 
Pyke, K.W. and Bach, J.F. (1981) In vitro migration of potential hemopoietic precursors from 
the murine fetus. Thymus 3:1-7 
Pyke, K.W., Bartlett, P.F .. and Mandel, T.E. {1983) Lyrrphocyte depletion of murine fetal 
thymus and subsequent chemeric recolonization in vitro. Thymus 5:95-104 
Quesenberry, P. and Levitt, L. Hematopoietic stem cells. New. Engl. J. Med. 301:755-760, 
819-823, 868-872 
Raff, M.C. (1973) 0-bearing lymphocytes in nude mice. Nature 246:350-351 
Rao, A., Allard, W.J., Hogan, P.G., Rosenson, R.S. and Cantor, H. (1983) Alloreactive T-cell 
clones. Ly phenotypes predict both function and specificity for major histocompatibility 
products. Immunogenetics 17:147-165 
Reif, A.E. and Allen, J.M.v. (1963) Specificity of isoantisera against leukemic and thymic 
lymphocytes. Nature 200:1332-1333 
Reif, A.E~ and Allen, J.M.V. 
and nervous tissue. J.Exp.Med. 
(1964) The AKR thymic antigen and its distribution in leukemias 
120:413-433 
Reimann, J. and Miller, R.A. (1983) Differentiation from precursors in athymic nude mouse 
bone marrow of unusual spontaneously cytolytic cells showing anti-self-H-2 specificity and 
bearing T cell markers. J.Exp.Med. 158:1672-1692 
Robinson, C.V. (1967) Decrease in numbers of mouse spleen nodules with time post-irradiation. 
Proc.Soc.Exp.Biol.Med~ 124:118-122 
Robinson, J.H. and Owen7 J.J.T. (1976) Generation ofT-cell function in organ culture of 
foetal mouse thymus I. ~itogen responsiveness Clin.exp.Immunol. 23:347-354 
Robinson, J.H. and Owen, J.J.T. {1977) Generation ofT-cell function in organ culture of 
165 
foetal thymus II. Mixed lymphocyte cultue reactivity Clin.exp~Immunol 27:322-327 
Robinson, J .H. 
MLR stimulation~ 
(1983) The ontogeny of antigen-presenting cells in fetal thymus evaluated by 
J.Immunol. 130:1592-1595 
Rock, K.L. and Benaceraff, B (1984) Thymic T cells are driven to expand upon interaction with 
self-class II major histocompatibility complex gene products on accessory cells. 
Proc.Natl.Acad.Sci.USA 81:1221-1224 
Roehm, N., Herron, L., Cambier, J., DiGuisto, D., Haskins, K., Kappler, J. and Marrack, P. 
(1984) The major histocompatibility complex-restricted antigen receptor on T cells: 
Distribution on thymus and peripheral T cells. Cell 38:577-584 
Ropke C. (1984) Characterization ofT lymphocyte colony-forming cells in the mouse. The 
colony-forming cell is confined to Lyt-1,2,3+ subsets in the thymus and the lymph nodes. 
J.Immunol. 132:1625-1631 
Rosendaal, M., Hodgson, G.S. and Bradley, T.R. (1976) Haemopoietic stem cells are organised 
for use on the basis of their generation age. Nature 264:68-69 
Rosendaal, M., Hodgson, G.S. and Bradley, T.R. (1979) Organization of haemopoietic stem 
cells: The generation-age hypothesis. Cell Tissue Kinet. 12:17-29 
Rosendaal, M., Dixon, R. and Panayi, M. {1981) Haemopoietic stem cells: Possibility of toxic 
effects of 5-fluorouracil on spleen colony formation~ Blood Cells 7:561-569 
Rosenthal, A.S. and Shevach, E.M. (1973) Function of macrophages in antigen recognition by 
guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes. 
J.Exp.Med. 138!1194-1229 
Ross, E.A.M., Anderson, N. and Micklem, H.J. (1982) Serial depletion of the murine 
hematopoietic system. Implications for hematopoietic organization and the study of cellular 
aging. J.Exp.Med. 155:432-444 
Russel, J.L. and van den Engh, G.J. (1979) The expression of histocompatibility-2 antigens on 
hemopoietic stem cells. Tissue antigens 13:45-52 
Sachs, L. (1980) Constitutive uncoupling of pathways of gene expression that control growth 
and differentiation in myeloid leukemia: A model for the origin and progression of malignancy. 
Proc.Natl.Acad.Sci.USA 77:6152-6156 
Samelson, L.E., Lindsten, T., Fowlkes, B.J., van den Elsen, P., Terhorst, C., Davis, M.M.m 
Germain, R.N. and Schwartz, R.H. (1985) Expression of genes of the T-cel.l antigen receptor in 
precursor thymocytes. Nature 315:765-768 
Santos, G.W., Cole, L.J. and Roan, P.L~ (1958) Effect of X ray dose on the protective action 
and persistence of rat bone marrow in irradiated penicillin treated mice. Am.J.Physiol. 
194!23-27 
Sarmiento, M., Glasebrook, A.L. and Fitch, F.W. (1980) IgG or lgM monoclonal antibodies 
reactive with different determinants on the molecular complex bearing Lyt-2 antigen bloch T 
cell-mediated cytolysis in the absence of complement. J.Irrmunol. 125:2665-2672 
Sate, C. and Sakka, M. (1969) Cell population analysis of radiation damage and recovery of 
thymus and lymph nodes in mice. Rad.Res. 38:204-213 
166 
Scheid, ~., Boyse, E.A., Carswell, E.A. and Old, L.J. {1972) Serologically demonstrable 
alloantigens on mouse epidermal cells. J.Exp.Med. 135:938-955 
Schlesinger, M. {1972) Antigens of the thymus. Progr.Allergy 16:214-299 
Schofield, R. and Lajtha, L.G. {1973) Effect of isopropyl methan sulphonate {IMS) on 
haemopoietic colony forming cells. Brit. J. Haematol. 25:195-202 
Schooley, J.C. {1966) The effect of erythropoietin on the growth and development of spleen 
colony-forming cells. J.Cell Physiol. 68:249-
Schrader, J.W., Battye, F. and Scollay, R. {1982) Expression of Thy-1 antigen is not limited 
to T cells in cultures of mouse hemopoietic cell. Proc.Natl.Acad.Sci.USA 79:4161-4165 
Scollay, R.G., Butcher, E.C. and Weissman, {1980) Thymus cell migration. Quantitative aspects 
of cellular traffic from the thymus to the periphery Eur.J.Immunol. 10:210-218 
Scollay, R. {1982) Inconsistencies detected by flow cytometry following immunofluorescence 
staining with anti-Thy-1 antibodies. J.Immunol.Meth. 52:15-23 
Scollay, R. and Shortman, K. (1983) Thymocyte subpopulations: an experimental review, 
including flow cytometric cross-correlations between the major murine thymocyte markers. 
Thymus 5:245-295 
Scollay, R., Bartlett, P. and Shortman, K. (1984) T cell development in the adult murine 
thymus: changes in the expression of the surface antigens Ly2, L3T4 and 82A2 from early 
precursors to emigrants. Immunol.Rev. 82:79-104 
Sharp, J.G. and Watkins, E.B. {1981) Cellular and immunological consequences of thymic 
irradiation. Immunopharmacological effects of radiation therapy, edited by J.B. Dubois, 8. 
Serrou, and C Rosenfeld. Raven press, New York. 137-179 
Sharrow, S.D., Ozato, K. and Sachs, O.H. (1980) Phenotypic expression of I-A and I-E/C 
subregion determinants on murine thymocytes. J.Irrmunol. 125:2263-2268 
Sharrow, S.D., Singer, A., Hammerling, U. and Mathieson, B.J. (1983) Phenotypic 
characterization of early events of thymus repopulation in radiation bone marrow chimeras. 
Transplantation 35:355-~ 
Shinohara, N. and Sachs, L. (1979) Mouse alloantibodies capable of blocking cytotoxic T cell 
function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 
locus. J.Exp.Med. 150:432-444 
Shinohara, N. and Kojima, M. (1984) ~ouse alloantibodies capable of blocking cytotoxic T cell 
function. V. The majority of I region-specific CTL are Lyt-2+ but are relatively resistant to 
anti-Lyt-2 blocking. J.Immunol. 132:578-583 
Shisa, H., Daculsi, R. and Duplan, J.F. (1977) Production of thymic cells by mouse spleen and 
bone marrow. Biomedicin~ 27:73-75 
Shortman, K. and Jackson, H. {1974) The differentiation of T lymphocytes. I. Proliferation, 
kinetics and interrelationships Df subpopulations of mouse thymus cells. Cell. Immunol. 
12:230-246 
Shortman, K. Linthicum, o.s., Battye, F.L., Goldschneider, I., Golstein, P. Clark, E.A. and 
Lake, P. (1979) Cytotoxic and fluorescent assays for thymocyte sub-populations differing in 
167 
surface Thy-1 level. Cell Biophysics 1:255-270 
Siminovitch, L., McCulloch, E.A. and Till, J.E. (1963) The distribution of colony forming 
cells among the spleen colonies. J.Cell.Comp.Physiol. 62:327-336 
Singer, A., Hathcock, K.S. and Hodes, R.J. (1981) Self recognition in allogeneic radiation 
bone marrow chimeras. A radiation-resistant host element dictates the self specificity and 
immune response gene phenotype of helper T-cells. J.Exp.Med. 153:1286-1301 
Singer, A.S., Hathcock, K.S. and Hodes, R.J. (1982) Self recognition in allogeneic thymic 
chimeras. Self recognition by helper T cells from thymus-engrafted nude mice is restricted to 
the thymic H-2 haplotype. J.Exp.Med. 155:339-344 
Singer, A.S., Kruisbeek, A.M. and Andrysiak, P.M. (1984) T cell-accessory cell interactions 
that initiate allospecific cytotoxic T lymphocyte responses: existence of both !a-restricted 
and !a-unrestricted cellular interaction pathways. J.Immunol. 132:2199-2209 
Small, M., 8arr-Nea, L. and Aronson, M. {1984) Culture of thymic epithelial cells from mice 
and age-related studies on the growing cells. Eur.J.Immunol. 14:936-942 
Smith, L.H. and Clayton, M.L. (1970) Distribution of injected 59 Fe in mice. Exp.Hematol. 
20:82-86 
Smith, W.W., Wilson, S.M. and Fred, S.S. (1968) Kinetics of stem cell depletion and 
proliferation: Effects of vinblastin and vincristin in normal and irradiated mice. 
J.Natl.Can.Inst. 40:847-854 
Snodgrass, H.R., Kisielow, P., Kiefer, M., Steinmetz, M. and von Boehmer, H. (1985) Ontogeny 
of the T-cell antigen receptor within the thymus. Nature 313:592-595 
Sprent, J. (1978) Role of H-2 gene products in the function ofT helper cells from normal and 
chimeric mice measured in vivo. Immunol.Rev. 42:108-137 
Steinman, R.M., Lustig, D.S. and Cohn, Z.A. (1974) Identification of a novel cell type in 
peripheral lymphoid organs of mice. III. Functional properties in vivo. J.Exp.Med. 
139:1431-1445 
Stern, P.L. (1973) Thy-1 alloantigen on mouse and rat fibroblasts. Nature Biol. 246:76-78 
Stimson, W.H. and Crilly, P.J. (1981) Effects on steroids on the secretion of 
immunoregulatory factors by thymic epithelial cell cultures. Immunology 44:401-407 
Stockinger, H., Pfizenmaier, H., Hardt, C., Rodt, H., Rollinghoff, M. and Wagner, H. (1980) 
H-2 restriction as a consequence of intentional priming: T cells of fully allogeneic chemeric 
mice as well of normal mice respond to foreign antigens in the context of H-2 determinants not 
encountered on thymic epithelial cells. Proc.Natl.Acad.Sci.USA 77:7390-7394 
Stutman, 0., Yunis, E.J. and Good, R.A. (1969) Carcinogen induced tumors of the thymus. IV. 
Humoral influences of normal thymus and functional thymomas and influence of post-thymectomy 
period on restoration. J.Exp.Med. 130:809-920 
Stutman, 0. (1976) Migration of yolk sac cells to thymus grafts: Requirement of prior sojourn 
in the bone marrow {or liver?). Ann.D'Immunol.(Inst.Pasteur) 127C:943 
168 
Stutman, 0. (1977) Two main feature of T-cell development: Thymus traffic and postthymic 
maturation. Contemporary topics in Immunobiology Vol. 7, ed. Stutman, D., Plenum Press. 
1-46 
Suda, T., Suda, J. and Ogawa, M. (1983) Proliferative kinetics and differentiation of murine 
blast cell colonies in culture: Evidence for variable Go periods and constant doubling rates of 
early pluripotent hemopoietic progenitors. J.Cell.Physiol. 117:308-318 
Swain, S. (1981) Significance of Lyt phenotypes: Lyt2 antibodies block activities ofT cells 
that recognize class I major histocompatibility complex regardless of their function. 
Proc.Natl.Acad.Sci.USA 78:7101-7105 
Swain, S., Oialynas, D.P., Fitch, F.W., English, M. (1984) Monoclonal antibody to L3T4 blocks 
the function of T cells specific for class 2 major histocompatibility complex antigens. 
J.Irrrnunol. 132:118-1123 
Takada, T. and Takada, T. (1973) Proliferation of donor marrow and thymus cells in the 
myeloid and lymphoid organs of irradiated syngeneic host mice. J.Exp.Med. 137:543-546 
Thierfelder, s. (1977) Haemopoietic stem cell of rats but not of mice express Th-1.1 
alloantigen. Nature 269:691-693 
Till, J.E. and McCulloch, E.A. (1961) A direct measurement of the radiation sensitivity of 
normal bone marrow cells. Radiat.Res. 14:213-222 
Till, J.E., McCulloch, E.A. and Siminovitch, L. (1964) A stochastic model of stem cell 
proliferation, based on the growth of spleen colony-forming cells. Proc.Natl.Acad.Sci.USA. 
51 :29-36 
Till,-J.E. and McCulloch, E.A. (1972) The 'f-Factor' of the spleen-colony assay for 
hemopoietic stem cells. Ser. Haemat. 2:15-21 
Triebel, F., Robinson, W.A., Hayward, A.R. and Gaube de Laforest, P. (1981) Existence of a 
pool of T-lymphocyte colony-forming cells (T-CFC) in human bone marrow and their place in the 
differentiation of the T-lymphocyte lineage. Blood 58:911-915 
Tyan, M.L.(1964) Thymus: Role in maturation of fetal lymphoid precursors. Science 145:934 
Tyan,M.L.(1968) Studies on the ontogeny of the mouse immune system. I. Cell bound immunity. 
Immunology 100:5351 
Vakharia, D.O. and Mitchison, N.A. (1984) Helper T cell activity demonstrated by thymic nurse 
cells (TNC-T). !ITITil..n'lology 51 :269-273 
Varlet, A., Lenaerts, P., Houben-Defresne, M-P. and Boniver, J. (1982) Migration des cellules 
de moelle hematopoietique vers le thymus chez la souris apres uni irradiation unique a dose 
sublethale. C.R.Soc.Biol. 176:384-390 
Vidovic, 0., Klein, J. and Nagy, Z.A. (1984) The role of T cell subsets in the generation of 
secondary cytolytic responses in vitro against class I and class II major histocompatibility 
complex antigens. J.Immunol. 132:1113-1117 
Visser J.W.M., van den Engh, G.J., Williams, N. and Mulder, A.H. (1977) Physical separation 
of the cycling and non-cycling compartments of murine hemopoietic stem cells. In Baum, S.J., 
and Ledney, G.D., eds., Experimental Hematology Today, Springer Verlag, N81JI York, 1977, p21-27 
169 
Visser, J.w.~., Haayman, J. and Trask, B. (1978a) Quantitative immunofluorescence in flow 
cytometry. In Knapp, et al., eds. Immunofluorescence and related staining techniques. 
Amsterdam: Elsevier/North Holland, p 
Visser, J.W.M., van den Engh, G.J., Williams, N. and Mulder, A.H. (1978) Boyant densities and 
sedimentation rates of the murine haemopoietic stem cells. Adv.Comp.Leukemia Res. 1977, 
editors Bentvelzen et al. 1978 Elsevier/North-Holland Biomedical Press 
Visser, J.W.M. and Bol, S.J.L. (1981) A two-step procedure for obtaining 80-fold enriched 
suspensions of murine pluripotent hemopoietic stem cells. Stem Cells 1:240-249 
Visser, J.W. and Eliason, J.F. (1983) In vivo studies on the regulation kinetics of enriched 
populations of haemopoietic spleen colony-forming cells from normal bone marrow. Cell Tissue 
Kinet. 16:385-392 
Visser, J.w.~., Bauman, J.G.J., ~ulder, A.H. Eliason, J. F. and de Leeuw, A.M. (1984) 
Isolation of murine pluripotent hemopoietic stem cells. J.Exp.~ed. 59:1576-1590 
van Vliet, P.w., Melis, M. and van Ewijk, W. {1984) Monoclonal antibodies to stromal cells 
types of the mouse thymus. Eur.J.Immunol. 14:524-529 
van Vliet, P.W. (1985) Thesis. Stromal cells in the mouse thymus. Erasmus University 
Rotterdam. 
Vogel, H., Niewisch, H. and Matioli, G. (1968) The self renewal probability of hemopoietic 
stem cells. J .Cell.Physiol. 72:221-228 
van Voorhis, W.C., Witmer, O.G. and Steinman, R.~. (1983) The phenotype of dendritic cells 
and macrophages. Fed.Proc. 42:3114-3118 
Vos, 0., Davids, J.A.G., Weyzen, W.W.H. and van Bekkum, o.w. (1956) Evidence for the cellular 
hypothesis in radiation protection by bone marrow cells. Acta Physiol.Pharmacol.Neerl. 
4:484-486. 
Vos, 0., Goodman, J.W. and Congdon, CC. (1960) Donor type lymphatic tissue cells in lethally 
irradiated mice treated with homologous fetal liver. Transpl.8ull. 7:408-411 
Vos, 0. and Dolmans, ~.J.A.S. (1972) Self-renewal of colony forming units (CFU) in serial 
bone marrow transplantation experiments. Cell Tissue Kinet. 5:371-385 
Wagemaker, G. (1980) Early erythropoietin-independent stage of in vitro erythropoiesis: 
relevance to stem cell differentiation. In. Baum, S.J., David, G.D. and van Bekkum, D.W. 
(eds) Experimental Hematology Today 1980. New York: Springer-Verlag, p47 
Wagemaker, G., Merchav, S. and Burger, H. {1982) Multiplication of pluripotent stem cells 
induced by purified stem cell activating factor (SAF) in serum free suspension cultures, abstr. 
Exp~Hematol.(suppl.) 11:162 
Wagner, H., Hardt, C., Heeg, K., Pfizenmaier, K., Solbach, W., Bartlett, P., Stockinger, H. 
and Rollinghof, M. (1980) T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: 
T cell-derived helper factor (interleukin 2) as a probe to analyse CTL responsiveness and 
thymic interactions of CTL progenitors. Immunol.Rev. 51:215-256 
Waksal, S.D., Cohen, I.R., Waksal, H.W., Wekerle, H., StPierre, R.L., Feldman, ~- (1975) 
Induction ofT-cell differntiation in vitro by thymus epithelial cells. Ann.N.Y.Acad.Sci 
249,492-498 
170 
Walden, P., Nagy, Z.A. and Klein, J. (1985) Induction of regulatory T-lymphocyte responses by 
liposomes carrying major histocompatibility complex molecules and foreign antigen. Nature 
315:327-329 
Wallis, V.J., Leuchars, E., Chwalinski, S. and Davies, A.J.S. (1975) On the sparse seeding of 
bone marrow and thymus in radiation chimeras. Transplantation 19:2-11 
Weissman, I.L. {1967) Thymus cell migration. Proc.Soc.Exp.8iol.Med. 124:99-103 
Weissman , I. L. 
lymphocytes. 
(1973) Thymus maturation. 
J.Exp.Med. 137:504-510 
Studies on the origin of cortisone resistant thymic 
Wekerle, H., Ketelsen, U.P. and Ernest, M. (1980) Thymic nurse cells. Lymphoepithelial cell 
complexes in murine thymuses: morphological serological characterization. J.Exp.Med. 
151 :925-944 
Wilde, 0.8., Marrack, P.,Kappler, J., Oialynas, D.P. and Fitch, F.W. {1982) Evidence 
implicating L3T4 in class II antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks 
class II antigen-specific proliferation, release of lymphokines, and binding by cloned murine 
helper T lymphocyte lines. J.Irrrnunol. 131:2178-2183 
Williams, A.F. and Gagnon, J. {1982) Neuronal cell Thy-1 glycoprotein: Homology with 
immunoglobulin. Science 216:696-703 
Winn, H.J. (1969) Ann.N.Y.Acad.Sci. 2:113 
Wolf, N.S. and Priestly, G.V. (1984) The source and potential of late appearing spleen 
colonies. Abstract. Exp.Hematol. 12:361 
Worton, R.G., McCulloch, E.A. and Till, J.E. {1969a) Physical separation of hemopoietic stem 
cells differing in their capacity for self-renewal. J.Exp.Med. 130:91-103 
Worton, R.G., McCulloch, E.A. and Till, J.E. (1969b) Physical separation of hemopoietic stem 
cells from colonies in culture. J.Cell.Physiol. 74:171-182 
Wright, E.G., Larimore, S.A. and Lord, 8.1. (1985) Effect of haemopoietic stem-cell 
proliferation regulators on early and late spleen colony-forming cells. Cell Tissue Kinet. 
18:193-199 
Wu, A.M., Till, J.E. and McCulloch, E.A. (1967) A cytological study of the capacity for 
differentiation of normal haemopoietic clony forming cells. J. Cell. Physiol. 69:177-184 
Wu, A.M., Till, S.M., Siminovitch, L. and McCulloch, E.A. (196Ba) Cytological evidence for a 
relationship between normal hematopoietic colony-forming cells and cells of the lymphoid 
system. J.Exp.Med. 127:455-463 
Wu, A.M., Siminovitch, L., Till, J.E. and McCulloch, E.A. (1968b) Evidence for a relationship 
between mouse hemopoietic stem cells and cells forming colonies in culture. 
Proc.Natl.Acad.Sci.USA. 59:1209-1215 
van de Wijngaert, F.P., Rademakers, L.H.P.M., Schuurman, H-J., de Weger, R.A. and Kater, L. 
(1983) Identification and in situ localization of the "thymic nurse cell" in man. J.Immunol. 
130:2346-2351 
Yanagi, Y., Yoshikai, Y., Leggett, K., Clark, S.P., Aleksander, I. and Mak, T.W. (1984) A 
171 
human T-cell specific eDNA clone encodes a protein having extensive homology to immunoglobulin 
chains. Nature 308:145-149 
Yoshida, Y. Osmond, O.G. (19?8) Homing of bone marrow lymphoid cells. Localization and fate 
of newly formed cells in lymphocyte-rich marrow fractions injected into lethally X-irradiated 
recipients. Transplantation. 25:246-250 
vanZant, G. (1984) Studies of hematopoietic stem cells spared by 5-fluorouracil. J.Exp.~ed. 
159:679-690 
Zepp, F. , Schul te-Wissermann, H. 
intrathymic T-cell development. 
Thymus 6:2?9-293 
and ~annhardt, w. {1984a} Macrophage subpopulations regulate 
I: !a-positive macrophages augment thymocyte proliferation. 
Zepp, F., Schulte-Wissermann, H. and Mannhardt, W. (1984a) Macrophage subpopulations regulate 
intrathymic T-cell development. II: !a-negative macrophages decrease thymocyte viability and 
proliferation by formation of thymocyte-macrophage-rosettes. Thymus 6:295-308 
Zinkernagel, R.M. (19?8) Thymus and Lymphohemopoietic cells: Their role in T cell maturation 
in selection of T cells' H-2-restriction-specificity and H-2 linked Ir gene control-
Immunol.Rev. 42:224-270 
Zinkernagel, R.M. (1982) Selection and restriction specificities of virus specific cytotxic T 
cells in the thymus: no evidence for a crucial role of antigen presenting cells. J.Exp.Med. 
156:1842-184? 
Zinkernagel, R.M. (1983) MHC and cell interactions 1982. Transpl.Proc. XV. No. 1:48-49 
Zinkernagel, R.M. and Doherty, P.C. {19?9) MHC-restricted cytotoxic T-cells: Studies on the 
biologic role of polymorphic major transplantation antigens determining T-cell 
restriction-specificity, function and responsiveness. Adv.Immunol.27:51-
Zinkernagel, R.M., Althage, A. and Callahan, G.N. {1980} J.Immunol. 124:2356-2365 
Zucali, J.R. 
cells. Brit. 
(1982) Self-renewal and differentiation capacity of bone marrow and fetal stem 
J. Haematol. 52:295-306 
172 
CURRICULUM VITAE 
Andries Hans Mulder werd in 1954 in Delfzijl geboren. ~a het Atheneum 8 
werd in 1972 begonnen met de medische studie aan de Erasmus Universiteit te 
Rotterdam. Na het kandidaatsexamen werd gedurende een jaar onderzoek verricht 
aan de Purdue University, W-Lafayette, In. onder leiding van Prof.Dr. E.S. 
Golub. Eind 1976 werd de medische studie te Rotterdam voortgezet en in november 
1980 afgesloten met het artsexamen. Hierna vend aanstelling plaats in dienst 
van de Nederlandse Drganisatie veer Zuiver Wetenschappelijk Dnderzoek in het 
kader van het Zwaartepunt Programma Hemopoietische Regulatie in het 
Radiobiologisch Instituut TNO te Rijswijk onder leiding van Prof.Or. D.W. van 
Bakkum. Hier vend het in dit proefschrift beschreven onderzoek plaats. Vanaf 
januari 1985 tot maart 1986 volgde aanstelling bij het Integraal Kankercentrum 
Rotterdam met als standplaats het Radiobiologisch Instituut. In deze periode 
werd medewerking verleend aan een project van het Koningin Wilhelmina Fonds. 
Per 1 maart 1986 is A.H.M. werkzaam als arts-assistant op de afdeling Klinische 
Pathologie aan de Erasmus Universiteit te Rotterdam onder leiding van Prof.Dr. 
R.D. van der Heul. 
173 

